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ABSTRACT
Coxsackievirus B4 (CVB4) is a common infection. Most cases are symptom-free but 
occasionally chronic sequelae emerge such as insulin-dependent diabetes mellitus, 
and dilated myocardiopathy and virus persistence is thought to contribute to these 
conditions. Persistent vimses frequently possess mechanisms that promote sui*vival of 
the infected cell and inhibit apoptosis. Mitochondria play a central role in mediating 
apoptotic effects and may tlius be targeted by viruses. Recently, poliovirus was shown 
both to inliibit apoptosis and to disrupt mitochondrial function and thus we have 
sought similar effects in the related virus CVB4. CVB4 infection of HeLa cells did 
not disrupt mitochondrial function and energy levels were maintained. In contrast to 
cells entering apoptosis, mitochondrial membrane potential increased after infection; 
at the same time infected cells developed resistance to drug-induced apoptosis via 
both death receptor and mitochondrial pathways. Despite this resistance, the apoptotic 
machinery was fully activated by drug treatment of infected cells and the processing 
of procaspase-3 to its cleaved form (caspase-3) was normal. However, DEVDase 
activity was inhibited in dmg-treated CVB4 infected cells and extracts from infected 
cells suppressed the activity of recombinant caspase-3 in vitro. We conclude that this 
effect was mediated at least in part by virus protein 2BC since immunoprécipitation of 
caspase-3 from infected cells co-precipitated a 2BC-sized (481cDa protein). Further, 
protein 2BC expressed in vitro was shown to bind to caspase-3, and expression of 
2BC alone in HeLa cells led to the inliibition of caspase-3 activity. Taken together 
these data imply that CVB4 protein 2BC acts to mitigate the consequences of 
apoptosis induction by associating with caspase-3 and inhibiting its function. These 
results suggest that 2BC is acting as a viral lAP and this is the first report of such an 
ability for an RNA vims.
TABLE OF CONTENTS
ABSTRACT.................................................................................................................... i
TABLE OF CONTENTS.............................................................................................ii
LIST OF TABLES...............................................................   vii
LIST OF FIGURES...................................................................................................viii
LIST OF ABBREVIATIONS...............................    xi
ACKNOWLEDGEMENTS.......................................................................................xv
1 GENERAL INTRODUCTION............................................................................1
1.1 The Picomaviruses..........................................................................................2
1.1.1 Enteroviruses: General features of replication and disease....................3
1.1.1.1 Classification of enteroviruses............................................................ 4
1.1.1.2 Poliovims pathogenecity..................................................................... 6
1.1.1.3 Coxsackievirus pathogenicity...............................   7
1.1.2 Enterovirus Morphology......................................................................... 9
1.2 Molecular biology of human enterovimses..................................................10
1.2.1 Genome organization.............................................................................10
1.2.2 Polyprotein translation and processing- the roles of non-stmctural
proteins ............................................................................................................... 12
1.2.3 Enteroviral-host cell interaction and replication................................... 16
1.2.4 Assembly maturation and release......................................................... 20
1.3 Mitochondria.................................................................................................22
1.3.1 Mitochondrial stmcture......................................................................... 22
1.3.2 Mitochondrial Function........................................................................ 25
1.4 Apoptosis......................................................................................................29
1.4.1 Brief overview of cell death.................................................................. 29
1.5 Apoptosis in development and disease........................................................ 30
1.6 Characteristics of apoptosis and necrosis  ................................................ 32
1.6.1 Moiphological features......................................................................... 33
1.6.2 Biochemical features........................................  36
1.7 Caspases..................................................................   37
1.7.1 Classification of the caspase family...................................................... 38
1.7.2 Structure of caspases............................................................................. 39
1.8 Caspase activation pathways......................................................................... 44
1.8.1 The death receptor (extrinsic) pathway................................................ 44
1.8.2 The mitochondrial (intrinsic) pathway............................................ .....46
1.9 Caspase substrates......................................................................................... 47
1.10 The Bcl-2 family and apoptosis....................................................................49
1.10.1 The bcl-2 family members and their structure......................................50
1.10.2 Regulation of apoptosis by Bcl-2 family members...............................53
1.10.2.1 Regulation via the permeability transition pore........................... 54
1.10.2.2 Regulation via pre- and post-translational modifications............56
1.11 Non-Bcl-2 mediated regulation of apoptosis................................................58
1.12 Viruses and apoptosis................................................................................... 62
1.12.1 Enteroviruses and apoptosis.................................................................. 64
1.13 Aims and objectives of the study.................................................................. 65
2 GENERAL MATERIALS AND METHODS.................................................. 66
2.1 Introduction....................................................................................................67
2.2 Materials........................................................................................................67
2.2.1 Suppliers................................................................................................67
2.2.2 Plasticware............................................................................................ 72
2.2.3 Cell lines, bacteria and plasmids........................................................... 72
2.3 Solutions and Buffers.....................................................................................73
2.3.1 General...................................................................................................73
2.3.2 SDS-FAGE solutions............................................................................ 73
2.3.3 Western blot solutions........................................................................... 76
2.3.4 Microbial growth medium.................................................................... 76
2.3.5 Gel electrophoresis solutions................................................................ 78
2.3.6 Caspase activity solutions..................................................................... 80
2.3.7 Radio-immunoprecipitation (RIPA) solutions...................................... 80
2.4 General Procedures........................................................................................81
2.4.1 Mammalian cell culture........................................................................ 81
2.4.2 Freezing of cell lines..............................................................................82
2.4.3 Cell counting..........................................................................................83
2.5 Viral culture teclmiques.................................................................................84
in
2.5.1 Vims strain and growth......................................................................... 84
2.5.2 Viras titration (plaque assay)................................................................ 84
2.5.3 Viras infection of cell lines................................................................... 85
2.6 Flow cytometric analysis..............................................................................86
2.7 Immunoprécipitation..................................................................................... 86
2.7.1 Preparing radiolabelled lysate............................................................... 86
2.7.2 Immune Precipitation............................................................................ 87
2.7.3 Autoradiography..........................................     87
2.7.4 Quantitation of radioactivity using scintillation...................................88
2.8 Separation of proteins in SDS-polyacrylamide gels.................................   88
2.8.1 SDS-polyacrylamide-gel-elctrophoresis (SDS-PAGE)........................88
2.8.2 Coomassie blue staining....................................................................... 89
2.9 Western blotting............................................................................................ 90
2.9.1 Protein transfer...................................................................................... 90
2.9.2 Immunostaining of Western b lo t.................................................  90
2.10 Cloning techniques.........................................................................................91
2.10.1 Polymerase chain reaction...........................  91
2.10.1.1 PCR amplification of DNA...........................................................91
2.10.2 Purification of DNA.............................................................................. 92
2.10.2.1 Ethanol precipitation..................................................................... 92
2.10.2.2 Phenol-chloroform extraction and ethanol precipitation............. 92
2.10.2.3 Small scale purification of plasmid DNA (plasmid minipreps)...93
2.10.2.4 Large scale purification of plasmid DNA (plasmid midipreps)...93
2.10.3 Enzymes.................................................................................................93
2.10.3.1 Restriction enzyme digestion........................................................93
2.10.3.2 DNA ligations............................................................................... 94
2.10.4 Growth and manipulation of bacterial cells..........................................95
2.10.4.1 Preparation of competent E.coli DH5...........................................95
2.10.4.2 Transformation of DH5a E.coli competent cells..........................95
2.10.5 Agarose gel DNA electrophoresis........................................................ 96
2.10.5.1 Gel electrophoresis........................................................................ 96
2.10.5.2 Gel purification of digested DNA fragments................................97
2.10.6 Sequence analysis..................................................................................97
2.11 Protein quantification.....................................................................................97
IV
2.12 Statistical analysis..........................................................................................98
3 EFFECTS OF COXSACKIEVIRUS INFECTION ON MITOCHONDRIAL 
FUNCTION...........................   99
3.1 Introduction.................................................................................................. 100
3.2 Measur ement of total cellular oxygen consumption................................... 104
3.3 Assessment of mitochondrial electron tansport chain integrity..................104
3.4 TMRE-based flow cytometry to measure mitochondrial membrane potential
using TMRE............................................................................................................ 105
3.5 Confocal microscopic analysis of mitochondrial membrane potential....... 105
3.6 Oxygen consumption in HeLa cells.............................   107
3.7 PV blocks the mitochondrial electron transport chain................................ 110
3.8 CVB4 does not inhibit HeLa cell respiration.............................................. 113
3.9 CVB4 promotes an increase in A'Pm............................................................114
3.10 CVB4 infection does not reduce mitochondrial membrane potential........117
3.11 Discussion.................................................................................................... 122
4 COXSACKIEVIRUS B4 INFECTION AND PERTURBATION OF THE 
APOPTOTIC CASCADE........................................................................................125
4.1 Introduction................................................   126
4.2 Phase contrast microscopic analysis of cellular morphology..................... 129
4.3 Fluorescence microscopic analysis of cell nuclei....................................... 129
4.4 Flow cytometric analysis of phosphatidylserine translocation................... 130
4.5 Flow cytometric deteiinination of DNA content........................................ 130
4.6 Confocal microscopic analysis of mitochondrial membrane potential during
apoptosis................................................................................................................. 131
4.7 Flow cytometric analysis of caspase-3 activation........................................131
4.8 Analysis of caspase-3 activity......................................................................132
4.9 Confocal microscopic analysis of cell nuclei...............................................133
4.10 CVB4 infection does not induce apoptosis early in infection......................134
4.11 Effect of CVB4 infection on plasma membrane integrity...........................138
4.12 Confirmation of apoptotic induction in CVB4 infected cells ................ 141
4.13 Confirmation of nuclear morphology in CVB4 infected cells.....................141
4.14 Anti-apoptotic effect of CVB4 infection in HeLa cells...............................144
4.15 Maintenance of mitochondrial membrane potential in CVB4 infected STS
treated cells............................................................................................   148
4.16 Maintenance of nuclear morphology in CVB4 infected STS treated cells 150
4.17 CVB4’s anti-apoptotic function does not prevent caspase-3 activation.... 151
4.18 CVB4’s anti-apoptotic function induces direct suppression of caspase-3
activity..................................................................................................................... 155
4.19 CVB4’s anti-apoptotic function protects HeLa cells against other apoptotic 
stimuli..............................................................   158
4.20 Discussion....................................................................................................165
5 EFFECTS OF THE COXSACKIEVIRUS NON-STRUCTURAL
PROTEINS ON THE APOPTOTIC MACHINERY........................................... 170
5.1 Introduction..................................................................................................171
5.2 Immunoprécipitation and co-precipitation studies...................................... 173
5.3 In vitro coupled transcription-translation experiments (TnT reaction)...... 174
5.4 Immunoprécipitation of TnT reaction products with caspase-3.................174
5.5 Preparation of capped RNA from DNA...................................................... 174
5.6 RNA transfection expression studies.......................................................... 176
5.7 RNA transfection of HeLa cells.................................................................. 177
5.8 Detection of active caspase-3 using immunoprécipitation and Western blot 
analysis.................................................................................................................... 178
5.9 Interaction of CVB4 proteins with active caspase-3...................................181
5.10 Cloning of the 2BC and 2B coding sequences............................................ 183
5.10.1 Cloning of the 2BC coding sequence  .................................. 185
5.10.2 Cloning of the 2B coding sequence................................................... 191
5.10.3 Sub-cloning of 2BC and 2B coding sequences into vector pGEM-3Z.... 
 194
5.11 In vitro expression and immunoprécipitation of 2BC and 2B....................197
5.12 Recombinant protein 2BC inhibits caspase-3 activity................................200
5.13 Discussion....................................................................................................204
6 GENERAL DISCUSSION............................................................................... 207
7 REFERENCES.................................................................................................. 223
VI
LIST OF TABLES
Table 1.1 Taxonomic structure of the Picomavirus family..........................................3
Table 1.2 Taxonomic structure of the human enterovirus genus................................. 6
Table 1.3 Diseases associated with the deregulation of apoptosis..............................32
Table 1.4 Summary of the differences between apoptosis and necrosis.................... 35
Table 1.5 Members and classification of the caspase family..................................... 41
Table 1.6 Regulation of apoptosis by Bcl-2 family members.................................... 51
Table 1.7 Selected examples of viruses and viral proteins that induce or inhibit
apoptosis........................................................................................................................ 63
Table 2.1 Resolving and stacking gel volumes........................................................... 74
Table 2.2 The components of the SDS-PAGE marker................................................89
Table 2.3 Restriction enzymes used in this study........................................................94
Table 3.1 The metabolic reagents used to donate electrons to complex I and II of the
respiratory chain................................................................................................................ 110
Table 3.2 The metabolic inliibitors used to block electron flow through complex I and
III of the respiratory chain...........................................................................................110
Table 4.1 CVB4 infection suppresses caspase-3 activity in HeLa cells.....................157
Table 4.2 CVB4 infection leads to the expression of a protein that directly inhibits
caspase-3 activity.........................................................................................................157
Table 5.1 Sequences of the three primers, 2BCsta,t, 2BCend and 2Bend used for the
cloning of the genes corTesponding to proteins 2BC and 2B..................................... 183
Table 6.1 Serpin domain, XIAP and Caspase-3 alignments of CVB4 2BC sequences. 
..........................................................................................  214
VII
LIST OF FIGURES
Figui'e 1.1 Schematic representation and 3D view of the icosahedral structure of
enterovirus..................................................................................................................... 10
Figure 1.2 Schematic representation of enterovims genomic organization and
polyprotein processing...................................................................................................16
Figure 1.3 Enterovirus replication complex.................................................................19
Figure 1.4 Enterovims infectious cycle....................................................................... 21
Figure 1.5 Mitochondrial structures............................................................................ 24
Figure 1.6 Representative scheme of oxidative phosphorylation in mitochondria 28
Figure 1.7 The apoptotic and necrotic cell death program.........................................35
Figure 1.8 Representation of the structure and proteolytic activation of caspases 43
Figure 1.9 The Bcl-2 homology domains....................................................................51
Figure 1.10 Apoptosis signalling pathways.................................................................61
Figure 3.1 The mitochondrial respiratory chain........................................................ 101
Figure 3.2 Increase in cell number results in an increase in oxygen consumption... 108
Figure 3.3 Antimycin A blocks HeLa cell oxygen consumption................  109
Figure 3.4 Effect of polio I infection on the mitochondrial respiratory chain.......... I l l
Figure 3.5 CBV4 infection has no effect on HeLa cell respiration........................... 113
Figure 3.6 CBV4 infection causes an increase in ............................................. 116
Figure 3.7 CVB4’s maintenance of AYm conelates with morphologically and
fiinctionally homogeneous mitochondria..............................   121
Figure 4.1 Morphological changes of HeLa cells during CVB4 infection................136
Figme 4.2 CVB4 does not trigger apoptosis during early permissive infections 137
Figure 4.3 Effect of CVB4 replication on HeLa cell membrane integrity................ 140
Figure 4.4 Effect of CVB4 replication on DNA fragmentation................................ 143
Figure 4.5 CVB4 does not trigger apoptosis between 8 and 12 h.p.i........................ 144
Figure 4.6 CVB4 confers an anti-apoptotic state to infected HeLa cells.................. 146
Figure 4.7 CVB4 infection can maintain AYm during apoptotic induction...............149
Figure 4.8 CVB4 infection suppresses STS induced nuclear destmction................. 150
Figure 4.9 CVB4 infection suppresses little caspase-3 activation with STS.............154
Figure 4.10 CVB4 suppresses Act D and TRAIL induced PS translocation............ 160
Figure 4.11 CVB4 suppresses Act D and TRAIL induced nuclear degradation 161
Figure 4.12 CVB4 suppresses nuclear degradation induced by various stimuli 162
virr
Figure 4.13 CVB4 suppresses little caspase-3 activation induced by Act D or TRAIL.
......................................................................................................................................164
Figure 5.1 Schematic representation of the principle of co-immunoprecipitation. ..173
Figure 5.2 Isolation of active caspase-3 by immunoprécipitation............................179
Figure 5.3 Isolation of pro-caspase-3 by immunoprécipitation................................180
Figure 5.4 CVB4 protein interaction with caspase-3................................................182
Figure 5.5 Diagrammatic representation of pGEM-T Easy vector...........................184
Figure 5.6 1.2% agarose gel of the PCR product containing the 2BC coding
sequence.......................................................................................................................185
Figure 5.7 1.2% agarose gel of EcoR I digested recombinant pGEM-T Easy-2BC
plasmids....................................................................................................................... 187
Figure 5.8 1.2% agarose gel of Spe I  digested recombinant pGEM-T Easy-2BC
plasmids......................  188
Figure 5.9 Sequence chromatograms of the pGEM-T Easy-2BC recombinant clone.
....................  190
Figure 5.10 2% agarose gel of the PCR product containing the 2B coding sequence.
......................................................................................................................................191
Figure 5.11 2% agarose gel of Spe I digested recombinant pGEM-T Easy-2B
plasmids........................   192
Figure 5.12 Sequence chromatograms of the pGEM-T Easy-2B recombinant clone.
..................................................................................................................................... 193
Figure 5.13 Diagrammatic representation of pGEM-3Z vector................................ 194
Figure 5.14 1.2% agarose gel of pGEM-3Z-2BC construct digested with Acc65 I and
Sal 1..............................................................................................................................196
Figure 5.15 2% agarose gel of pGEM-3Z-2B construct digested with Acc65 I and Sal
1.................................................................................................................................... 196
Figure 5.16 CVB4 protein 2BC interacts with active caspase-3............................... 198
Figure 5.17 CVB4 protein 2B does not interact with active caspase-3.....................199
Figure 5.18 1.2% agarose gel of mRNA products.....................................................201
Figure 5.19 Expression of luciferase mRNA in HeLa cells...................................... 202
Figure 5.20 Ectopically expressed protein 2BC but not 2B inhibits caspase-3 activity.
.....................................................................................................................   203
Figure 6.1 Schematic diagram of domain stmctures of PV 2C.................................215
Figure 6.2 Sequence alignments of PV and CVB4 2B and 2C proteins................... 216
IX
Figure 6.3 Schematic representation of the suppression of apoptosis by CVB4 protein 
2BC in HeLa cells....................................................................................................... 222
LIST OF ABBREVIATIONS
A1 Bcl-2-related protein A1
A179L African swine fever vims late stmctural protein (has similarity to
A224L African swine fever vims late stmctural protein (has similarity to
a.a. amino acid
AA antimycin A
Ac-DEVD-AFC N-acetyl-Asp-Glu-Val-Asp-7-amino-4-trifliioromethyl coumarin
ActD actinomycin D
AFC 7-amino-4-trifluoromethyl coumarin
AIDS acquired immune deficiency syndrome
AIF apoptosis inducing factor
Amp ampicillin
ANT adenine nucleotide translocase
Apaf-1 apoptosis activating factor-1
Approx. approximately
AY annexin V
AX2 resolving gel buffer (2X concentrated)
Bad Bcl-2-antagonist of cell death
Bak Bcl-2-homologous antagonist/killer
BALFl BamHI A fragment leftward open reading frame 1
Bax Bcl-2-associated x protein
Bcl-2 B-cell lymphoma
B c1-xl Bcl-2-Like-l (long form)
Bcl-w Bcl-2-Like 2
B-gal B-galactosidase
BH Bcl-2 homology domain
BHRFl BamHI H fragment rightward open reading frame 1
Bid BH3 interacting domain death agonist
Bik Bcl-2-interacting killer
BIK Bcl-2-interacting killer
Bim Bcl-2-interacting mediator of cell death
BIR baculovims lAP repeat
BNIP3 Bcl-2/adenovims ElB 19 kDa interacting protein 3
Bok Bcl-2-related ovarian killer
Bp base pair
BSA bovine semm albumin
Buffer TE buffer Trypsin-EDTA
BX2 Stacking gel buffer (2X concentrated)
CAD caspase activated DNase
CAR Coxsackie and adenovirus receptor
CARD caspase recmitment domain
caspases cysteinyl aspartate-specific proteinases
cDNA complimentaiy deoxyribonucleic acid
ced cell-death abnormal
CMegans Caenorhabditis elegans
c-FLIFs cellular FLICE inliibitoiy proteins
CHAPS 3 - [(3 -chloamidopropy l)-dimethylammonio] -1 -propanesulfate
conc. concentration
CPE cytopathic effect
XI
CrmA Çowpox virus product cytokine response modifier A
C-termînus carboxy-temiinus
CVB4 Coxsackievirus B type 4
Cyto c cytochrome c
D aspartate
dATP deoxyadenosine triphosphate
DD death domain
DED Death effector domain
DIABLO direct inhibitor-of-apoptosis-protein-binding protein
DISC death-inducing signalling complex
DMSG dimethyl sulfoxide
dNTP deoxy-nucleotide-tri-phosphate
ds double stranded
DTT dithiothreitol
E glutamate
E3-10.4K transmembrane protein (10.4kDa) in E3 region of the adenoviral genome
E3-14.5K transmembrane protein (14.5kDa) in E3 region of the adenoviral genome
E3-6.7K transmembrane protein (6.7kDa) in E3 region of the adenoviral genome
E4orf6 early region 4/open reading fr ame 6 of adenovims
EBV Epstein-Barr viras
E.coli Escherichia coli
EDTA ethylene diamine tetraacetic acid
elF eukaiyotic initiation factor
ETC electron transport chain
F ADD fas-associated death domain
FasR fas receptor
FasL fas ligand
FBS foetal bovine serum
FITC fluoroscein isothiocyanate
FLICE fas-associated death-domain-like IL-1 beta-converting enzyme
G glycine
Gly glycine
Gin glutamine
gp glycoprotein
HEX hepatitis B viras X protein
HCV Hepatitis C virus
HIV human immunodeficiency virus
HIV-1 human immunodeficiency viras type 1
h.p.i. hour post infection
HRP horesradish peroxidase
HtrA2 high temperature requirement serine protease A2
lAP inhibitor of apoptosis protein
ICAD inhibitor of caspase activated DNase
ICE interleukin 1 (3-converting enzyme (caspase-1)
ICTV International Committee on Taxonomy of Virases
Ig immunoglobulin
IL-lp interleukin Ip
IPTG isopropyle-P-D-thiogalactopyranoside
1RES internal ribosome entry site
kb kilo base
xii
kDa kilodalton
KSbcl-2 Kaposi’s sarcoma-associated y herpesvirus Bcl-2 homologue
LMPl latent membrane protein 1 of EBV
MBq megabecquerel
MC159 molluscum contagiosum virus 159
Mcl-l myeloid cell leukaemia sequence 1
MCR multiple cloning region
MEM minimum essential medium
m.o.i multiplicity of infection
MilliQ water milli Q water (deionised)
mPT mitochondrial permeability transition
M-T2 myxoma vims transcriptionally active ORF
MW molecular weight
NADH nicotinamide adenine dinucleotide
Nbk natural bom killer
Nef negative factor in HIV-1
NF-kB nuclear factor kB
nt nucleotide
N-terminus amino-terminus
ORF open reading frame
p35 baculovhns protein 35kDa
p53 transcriptional regulator
PAGE polyacrylamide gel electrophoresis
PARP poly(ADP-ribose) polymerase
PBS phosphate buffered saline
PBSa-g phosphate buffered saline plus calcium chloride and D-glucose
PCR polymerase chain reaction
p.f.u plaque fonning unit
PI propidium iodide
pro-pol protease-polymerase
PS phosphatidylserine
PUMA p53 upregulated modulator of apoptosis
PV poliovims
PVR poliovims receptor
Q glutamineRep78 adeno-associated vims type 2 required for replication protein
RI replicative intermediate
RT room temperature
SD standard deviation
SDS-PAGE sodium dodecyl sulphate-polyaciylamide gel electrophoresis
SEM standard error of the mean
Smac second mitochondria activator of caspases
SPI-2 serpin-like protein inliibitor
STS staui'osporine
SV40 simian vims 40
T-antigen transformation antigen
TAE buffer tris-acetate disodium EDTA
Tat trans-acting transcription factor of HIV
TB transformation buffer
TBE tris-borate EDTA
X lll
tBid truncated Bid
TBS/Tween 20 tris buffered saline-Tween buffer
TEMED N,N,N ’ ,N ’ -tetrmethylethylenediamine
TE buffer tris-HCL disodium EDTA
TM transmembrane domain
TNF tumour necrosis factor
TNFR tumour necrosis factor receptor
TnT transcription and translation (reactions)
TRADD tumour necrosis factor receptor-associated death domain
TRAFl type 1 tumour necrosis factor receptor-associated factor
TRAIL tumour necrosis factor-related apoptosis-inducing ligand
TRAIL-R tumour necrosis factor-related apoptosis-inducing ligand receptor
tRNA transfer ribonucleic acid
Tyr tyrosine
U unit (of enzyme activity)
UQ ubiquinone
UTR untranslated region
vICA viral inhibitor of caspase-8-induced apoptosis of cytomegalovims
VDAC voltage dependent anion channel
VPg virus protein-genome linked
Vpr viral protein R of HIV
v/v volume/volume
w/v weight/volume
X represents any amino acid
XIAP X-chromosome linked inhibitor of apoptosis protein
X-Gal 5-bromo-4-chloro-3-indoyl-P-galactopyranoside
Y tyrosine
XIV
ACKNOWLEDGEMENTS
I would like to extend my deepest and equal thanks to my supeiwisors Dr Mike Carter 
and Dr George Kass for giving me the opportunity to undertake this exciting project. 
Their never diminishing, always present, enthusiasm, knowledge and support really 
allowed me to push my ideas ‘out there’ and use this to develop workable 
experiments. Cheers Guys!
I would also like to thank Dr Margaret Carter for her extremely helpful technical 
advice during this study. The value of her thorough understanding of all things 
scientific can never be underestimated. Additionally, I would like to thank Dr Kate 
Plant for her invaluable help during the end of this study.
Being part of two labs has allowed me to interact with a wide group of people from 
different parts of the world and with different perspectives on life, which made the 
science even more enjoyable. Although there are many, I would like to thank a few of 
my colleagues from the mol. tox lab, namely Anthony, Liz, Sihem, Fadila, Ian, Kat, 
Dr Nick Plant, and PK. I would also like to thank my colleagues from mol. virology, 
namely Elizabetta, Mohammed, Fadila, Mehian, Zila, Ting and Dr Lisa Roberts. All 
of you have helped me greatly through the course of my work in many different ways 
and I sincerely thank you all. A special thank you must go to Alessandro. A great 
friend and someone with whom I had great discussions and great times with and also 
someone who worked the same un-sociable hours as me; I’ll never forget the early 
hours of Christmas day running experiments! I also would like to send my greatest 
thanks to my ‘Pharm girls’ Beth, Lucy and Lisa. I am sincerely grateflil to all of you 
for your encouragement, support and advice and for being great dancers! Not 
forgetting the Phann man; a big thank you must go to Alexis for his great friendship 
and for his ability to always get me out of the lab and to the pub.
A special thank you must go to all of my colleagues who I met on my PhD journey 
namely, Susan, Maria, Kath, loamia, Naema, Natalia, Patricia, Debs, Michelle, 
Vincent, Eve, and Jean Lou. I thank you all for the great times I had and for all the 
things you each taught me.
I wish to also acknowledge the many people outside of the lab who have contributed 
to me getting this far. Namely, Ian, Mr Rzadkiewicz, Ms Byrne, Katrin and Ralf, Dr 
Steve Rigby and Professor Conrad Lichtenstein.
Da boyz, namely Richard, Jonathan, Gareth, Gordon, Andrew, Geiiy, Edward and 
Edney. I thank you all for your support and encouragement through the years 
especially as some of you were unsure of what my research actually was.
A special thank you must be extended to the security staff at Suney who would 
always come to the lab during the early hours of the morning for a chat which stopped 
me from going mad during long time courses.
I could not have achieved any of this without the love, support and encouragement of 
my family. My darling mother and sister thank you with all my heart for eveiything; 
words alone cannot stress how important you both are to me.
XV
Chapter 1
1 GENERAL INTRODUCTION
INTRODUCTION
Enterovimses, which are members of the Picomaviridae family, have been implicated 
in the aetiology of a range of diseases by inducing or inhibiting the death of their host 
cells by apoptosis. Despite extensive research on the mechanism of enterovims- 
mediated induction of apoptosis, little is known about the enteroviral-mediated 
suppression of this cell death mechanism. As persistence of the enterovims, 
Coxsackie B vims, in the beta cells within the islets of Langerhans in the pancreas has 
been linked with the aetiology of type 1 diabetes (Yoon et al., 1979) as well as other 
diseases, and evidence from work on the enterovirus poliovims (PV) has shown that 
suppression of apoptosis may lead to viral persistence (Gosselin et al., 2003), this 
investigation set out to investigate the mechanism of any anti-apoptotic effect 
mediated by enteroviruses and also the identity of the possible protein(s) mediating 
this suppression. The Picomaviral family will be mentioned further below.
1.1 The Picornaviruses
The Picomaviridae are responsible for a wide spectmm of diseases in both humans 
and animals. This large family of non-enveloped small RNA vimses (Latin- Pico 
RNA) contain positive stranded RNA and use the mechanisms of cap-independent 
translational initiation and proteolytic processing of polyproteins to regulate 
expression of their viral genome. The Picomaviridae comprise nine genera, namely: 
Enterovimses, Rhinovimses, Cardiovimses, Apthovimses, Hepatoviiuses, 
Parechovimses, Erbovimses, Kobuvimses and Teschovimses; several unassigned 
vimses are likely members of the family (King et al., 2000) (Table 1.1). Notable 
agents include human Rhinovims, responsible for the common cold and Foot and 
Mouth disease vims which occurs in sheep and cattle.
This investigation focused on the effects of two members of the enterovirus genus on 
their host cell’s ability to generate energy and resist/induce apoptosis. These were the 
Mahoney strain of type 1 poliovims (PV) and Coxsackievims type B4 (CVB4). A 
more detailed consideration of the Enterovimses follows.
Genus Representative species Clinical features
Enterovirus Poliovims Poliomyelitis
Coxsackievims Myocarditis
Rhinovirus Human rhinovims Common cold
Cardiovirus Encephalomyocarditis Encephalomyelitis and
vims tachycardia
Aphthovirus Foot and mouth Foot and mouth disease in
disease virus livestock
Hepatovirus Hepatitis A vims Liver disease
Parechovirus Human parechovims Chronic meningoencephalitis;
neonatal carditis
Erbovirus Equine rhinitis B vims Respiratoiy infection in horses
Kobitvirus Aichi virus Gastroenteritis
Teschovirus Porcine teschovims Neurological disease
Table 1.1 Taxonomic structure of the Picomavirus family.
The representative species, along with hwnan and animal diseases caused by 
members o f the genus are shown. Adapted fi'om King et al, (2000) and Hughes,
1.1.1 Enteroviruses: General features of replication and disease
The enterovirus genus are the most common human viruses infecting an estimated one 
billion people per year worldwide (Oberste et a l, 2000). Most infections are
inapparent but occasionally enteroviruses cause conditions such as meningitis, 
encephalitis, muscle pain (Bornholm disease) respiratoiy diseases, paralysis and 
myocarditis (Melnick, 1996). As their name suggests, these viruses all infect via the 
gut, they are acid stable to resist passage thiough the stomach and are spread chiefly 
through the faecal oral route, particularly through sewage and contaminated water. 
Replication takes place mainly in the gastrointestinal tract but also occurs in epithelial 
and lymphoid cells in the phaiynx. The incubation period is usually between 7 to 14 
days but can vary from 2 to 35 days; initial infection may present as a flu-like illness 
with sore throat and painful, enlarged cervical lymph nodes. Under most 
circumstances multiplication of one vims may interfere with the growth of the 
heterologous type, though two or more enterovimses may propagate simultaneously 
in the gastrointestinal tract. Vims is shed from the pharynx for 3-4 weeks, and slightly 
longer (5-6 weeks) in faeces. Viremic spread to secondary target tissues (e.g heart, 
liver, lungs central nervous system and pancreas) is usually blocked by the developing 
immune response but may induce more specific symptoms of illness when it does 
occur. However, although rare, the vast number of human infections translates into a 
significant number of serious outcomes even fatality.
1.1. L I  Classification o f enterovimses
Traditionally, classification of vimses has been mainly based on the pathogenic 
effects, the nature of the genomic nucleic acid, the morphology of the virion (vims 
particle) and the replication process of the vims (King et al., 2000). Genera have been 
defined largely on the basis of physiochemical properties such as acid sensitivity and 
virion density. Increasingly, this procedure is being superseded by molecular analysis 
of vims genomes (Bolanaki et al., 2005). This has led to the reorganisation of the 
Picomaviridae family (Table 1.1) and has also recognised more divisions within the
enterovirus genus itself. This cuiTently consists of five subgroups of human viruses 
that include 63 serotypes (two additional human serotypes have not yet been assigned 
to a subgroup). Changes in nomenclature have been made and thus what was known 
as Coxsackievirus B4 (CVB4) is now officially human enterovirus B, serotype B4, 
abbreviated HEV-B (B-4); although, tlii'oughout this study the term CVB4 will be 
used. Human enterovirus A includes 12 serotypes, predominately Coxsackievims A 
serotypes in the previous classification scheme. Human enterovirus B includes 37 
serotypes, predominately Coxsackievirus B serotypes and echovimses. Human 
enterovims C includes 11 serotypes, predominantly Coxsackievims A serotypes. 
Human enterovims D includes two serotypes, with the fifth subgroup, Poliovims, 
including tliree serotypes (Hyypia et al., 1997; King et al., 2000) (Table 1.2).
Species Serotypes
Human enterovirus A (HEV-A) A2-A8, AlO, A12, A14, A16, HEV 
71
12
Human enterovirus B (HEV-B) B1-B6, A9, echovims 1-7, 9, 11-21, 
24-27, 29-33, HEV 69, HEV 73
37
Human enterovirus C (HEV-C) A l, Al l ,  A13, A15, A17-A24 11
Human enterovirus D (HEV-D) 68, 70 2
Human poliovirus (PV) 1-3 3
Table 1.2 Taxonomic structure of the human enterovirus genus
The representative sub group and serotype members along with the total number o f 
serotypes members for each subgroup are shown. Adapted from King et al., (2000).
1.1.1.2 Poliovirus pathogenecity
PV (a vims investigated during this study) is the prototypic and most widely studied 
enterovirus, and the aetiologic agent of poliomyelitis, a human disease affecting the 
central nervous system and leading to destmction of motor neurons. PV consists of 
three serotypes (Table 1.2) and like all enterovimses replicates very efficiently in the 
gastrointestinal tract (up to 28 days post infection). However, neurological sequelae 
are seen at only a low rate, 10'  ^ (for serotype 1) to 10'  ^ (for serotype 2 and 3). Thus, 
the propensity of PV to invade the central nervous system and target motor neurones 
is a rare event unconnected with the usual mode of infection/ transmission of the
virus. CNS invasion is independent of the gender, age or socioeconomic position of 
the infected person (Melnick, 1996), and has afflicted people for millennia. The 
earliest record of presumptive poliomyelitis is an Egyptian tomb carving, dating back 
from the 18^  ^ Dynasty (1580-1350 BC). The carving shows a young man with a 
withered shortened leg, with his foot held in a position typical of flaccid paralysis- a 
sign indicative of poliomyelitis (Melnick, 1983). The Egyptians of course would have 
had little idea of the tme nature of the condition and the first demonstration of 
infectious poliomyelitis was made in 1909, by inoculating monkeys with specimens 
from cases of human paralytic poliomyelitis (Melnick, 1983). However, it was not 
until 1949 when the virus was grown in culture, that the importance of PV as the 
cause of this human disease could be fully realised (Weller et al., 1949). This step 
spurred on pioneering research which ultimately led to the development of the 
fonnalin-inactivated vaccine by Jonas Salk (Salk et al., 1954) and the live-attenuated 
vaccme by Albert Sabin (Sabin, 1957). Thanks to vaccination, poliovirus is no longer 
a major public health threat in the developed world. However, in the developing 
world poliomyelitis outbreaks still arise even with an intense eradication program, and 
the WHO campaign to eliminate the vims suffers from political as well as practical 
difficulties which have allowed the resurgence of illness in some areas.
1.1.1.3 Coxsackievirus pathogenicity
Coxsackievimses are named from the town of Coxsackie in New York State, USA. 
Although these viruses also replicate in the gastrointestinal tract they are additionally 
myotropic and can infect cardiac and skeletal muscle. Coxsackievimses circulate 
constantly in the community with the most prevalent serotypes changing from year to 
year. Although most infections are asymptomatic, all serotypes can occasionally cause 
a variety of symptoms. As control of PV progresses, the Coxsackie vimses are
becoming more significant as inducers of disease. The most common is a flu-like 
illness with fever, malaise and muscular ache. Upper respiratory tract involvement, 
diarrhoea and vomiting can occur, though in the absence of other generalised 
symptoms, these vimses are not a cause of gastroenteritis. Aseptic meningitis and less 
commonly, transient paralysis can be caused by these viruses. They have also been 
implicated in epidemic and sporadic cases of Chronic Fatigue Syndrome (CFS) 
largely based on serological studies revealing both antibody and virus antigens in 
patients with CFS, myocarditis and chronic pericarditis (Behan et al., 1985; Bell et al., 
1988). These viruses have been assigned to two subgroups of Coxsackievims A and B 
based on the lesions they induce in new born mice. Coxsackie A viruses (which 
induce lesions in the muscle of mice) tend to affect skeletal muscle, while Coxsackie 
B vimses (which cause lesions in the liver of mice) cause pathological changes in 
several tissues, including the central nervous system, pancreas, liver and brown fat 
(Bolanaki et al., 2005).
Epidemiological studies have shown that Coxsackievims infections are associated 
with the development of insulin-dependent diabetes mellitus (IDDM), also Imown as 
type I diabetes, which is caused by persistent destmction of pancreatic beta cells 
(Yoon et al, 1979; Banatvala, 1987). The most commonly detected strain in diabetic 
and pre-diabetic patients is Coxsackievims B4 (Banatvala, 1987). Although this virus 
infects several tissues, it primarily causes degenerate destruction of large regions of 
exocrine pancreas as well as beta islets leading to IDDM. Little is known about the 
mode and modulation of cell death caused by this vims and this investigation sought 
to better understand the control of apoptosis by this vims in relation to its ability to 
avoid cell death in host cells by the host immune system and thereby persist.
1.1.2 Enterovirus Morphology
Enteroviruses were amongst the first viruses to be studied using X-ray crystallography 
due to their small size, and non-enveloped icosahedral morphology (Hogle et al., 
1985). The enteroviral capsid (virion) contains four proteins (VP1-VP4), in a densely 
packed icosahedral arrangement of sixty repeating protomeric units (Rueckert, 1996). 
These sixty protomeric units are arranged in twelve pentamers (VP2) and twenty 
hexamers (VPl and VP3). Polypeptides VP1-VP3 are folded in a characteristic 
manner fonning an eight-stranded beta pleated sheet that folds into a baiTel structure 
(Hogle et al., 1985). Despite this common structure, variations within the sequence of 
these capsid proteins (VP1-VP3) generates antigenic diversity among the genus. VP4 
lies buried in close association with the RNA and viral uncoating is accompanied by 
the exposure and removal of VP4. VP1-VP4 are all derived from the cleavage of the 
primary protomer -  VPO, although currently it is unknown if VPO assembles with the 
viral RNA before it is cleaved to VP1-VP4 (Hogle et al., 1985). A distinct feature of 
the capsid is its comigated topography; with a prominent star-shaped peak at the 5- 
fold axis of symmetry, surrounded by a deep depression (the “canyon”), and another 
protmsion (the “propeller”) at the 3-fold axis (Filman et al., 1989; Belnap et al., 
2000). This depression, which lies at the centre of each protomeric unit, is the site into 
which the specific cellular receptor for the vims fits when the vims encounters a 
susceptible host cell (Belnap et al., 2000). Due to the small size of the viral particle 
(~30nm in diameter) and the relatively long viral genome (-2500 bases), the small 
size of the capsid shell confers tight packing of the genome (Hyypia et al., 1997).
Figure 1.1 Schematic representation and 3D view of the icosahedral structure of 
enterovirus.
a) VPl-VP 3 occupy distinct sites in the formation o f the capisid; taken from Rueckert, 
(1996). b) an atomic view showing the actual atomic co-ordinates o f the three 
picornaviral capsid proteins. VPl is shown in blue, VP2 in green and VP3 in red. 
VP4 is not an integral component o f the capsid framework and is buried deep inside 
the particle masking it from view.
Source for atomic view: http://www.virology.net/Big_Virology/BVRNApicorna.html.
1.2 Molecular biology of human enteroviruses
1.2.1 Genome organization
The enterovirus genome consists of a single-stranded, positive-sense RNA molecule 
of about 7.4 kb. The genome contains a long 5' untranslated region (UTR) extending 
to some 600-1200 bases. This is important in the translation of the genome and RNA 
replication. This is followed by a single open reading frame (ORE) coding for a
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polyprotein of about 2200 amino acids (structural and iion-stmctural proteins), and a 
short (50-100 bases) 3' UTR which regulates negative-sense RNA synthesis 
(Kitamura et al, 1981; Racaniello and Baltimore, 1981; Bedard and Sender, 2004) 
(Figure 1.2). The UTRs are the most conseiwed sections of the genome. The 5' UTR 
contains several stemloops that fomi a ‘clover-leaf secondary stmcture known as an 
internal ribosome entry site (1RES), and is capable of initiating translation regardless 
of its location within an RNA molecule (Jang et al., 1988). This stmcture, which is 
required for the initiation of viral protein synthesis (Gebhard and Ehrenfeld, 1992; 
Belsham and Sonenberg, 2000; Bushell and Samow, 2002), is not exclusive to viral 
genomes as it has since also been discovered in the 5' UTR region of many cellular 
niRNAs (Hellen and Sarnow, 2001). Mutations of this region modify the translational 
activity of enterovimses (Svitkin et al., 1988). Less is known about the 3' UTR, 
although it has been shown to contain two stem loops that may interact to form a 
tertiary psuedoknot stmcture (Jacobson et al., 1993). Filipenko et al., (1992) proposed 
a phylogenetically conserved tRNA-like tertiaiy stmcture for the 3'-terminus of 
enterovimses and suggested that this could be important in the enterovims life cycle. 
Evidence of the existence of such a stmcture has been obtained (Mimiomeni et al., 
1997), but vimses with at least partial deletions in the 3’UTR are still viable so the 
essential features remain to be fully identified and delineated (Todd et al., 1997; 
Meredith et a l, 1999).
Both temiini are modified: the 5’ genomic RNA of enterovimses does not carry the 
usual eukaiyotic m7G cap structure, but instead a small basic protein, VPg (vims 
protein, genome-linked; approximately 23 amino acids), is covalently linked here 
(Lee et al, 1977). This protein however, is not a replacement for the cap and plays a 
role in the initiation of enterovims RNA synthesis. The 3' end is polyadenylated (~ 60
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nucleotides), which is added by templated transcription of a poly-U tract at the 5’ end 
of the negative sense RNA (Yogo and Wimmer, 1972). Little is known about the 
precise function of this poly(A) tract although it is understood to be important in vims 
infectivity (Spector and Baltimore, 1974) and is thought to increase the stability of the 
viral RNA,
1.2.2 Polyprotein translation and processing- the roles of non-structural 
proteins
The genome of enteroviruses contain the necessaiy signals for translation and 
replication. Much of our knowledge about the function(s) of enterovims proteins has 
been obtained from studies of PV. Upon infection, the virion RNA is released into the 
cytoplasm of the host cell and is translated into a polyprotein. This is processed both 
CO- and post-translationally by vims proteases to generate the individual vims proteins 
(Wimmer et al., 1993) (Figure 1.2). Although expression of the enterovims genome 
occurs through syntliesis of a single polyprotein, the viral proteins are not produced at 
an equimolar ratio. Instead, the relative amounts of each of the viral proteins is 
regulated by an intricate cascade of fast and slow proteolytic cleavages mediated by 
the vims proteinases 2A^ ™ (cysteine protease) and 3C '^Y3CD^^°. 2Af™ cleavages 
occur between Tyr*Gly [Y/G]pair and 3C^ '^ °/3CD^ '^ ° occur at a Gln*Gly [Q/G]pair 
(Ki’ausslich and Wimmer, 1988). The polyprotein consists of three fimctional sections 
PI, P2 and P3 (Figure 1.2). The PI precursor is co-translationally myristoylated and 
cleaved into VPO, VP3 and VPl stmctural proteins by the proteinase 300^ ^^ °. VPO is 
then autocatalytically cleaved to the VP2 and VP4 stmctural capsid proteins during 
vims assembly, this step being essential for infectivity (Wimmer et al., 1993). P2 and 
P3 are the precursors of the non-stmctural proteins involved in the maturation of the 
polyprotein and RNA replication. Proteolytic processing of the precursor protein P2
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yields three different end products, 2A^ ™, 2B and 2C and a long-lived partially 
cleaved molecule precursor protein, 2BC (Wimmer et al, 1993),
Separation of protein PI (capsid precursor) from the nascent polypeptide occurs by cis 
cleavage of a Tyr-Gly bond at the junction between PI and P2 and is carried out by 
autocatalysis of 2A*’'° at its N-terminus (Toyoda et al., 1986). In addition to 
processing of the viral polyprotein, 2A^ ™ has been shown to also cleave p220, a 
component of the cap recognizing complex of the cellular protein eukaryotic initiation 
factor 4F (eIF-4F) (Krausslich et al., 1987). Cleavage of this protein disrupts cap- 
dependent initiation of translation and promotes synthesis of virus proteins by 
diverting cellular resources from this activity. 2A^ ™ has also been implicated in viral 
RNA replication as mutants of 2A^ ™ (defective in protease cleavage activity) 
introduced into full length PV cDNA clones, have been shown to be defective in viral 
RNA replication (Yu et al., 1995). The characteristics and functions of the protein 
2BC and its cleavage products 2B and 2C, are less well defined compared with 2AP™. 
Processing of 2BC to its cleaved products 2B and 2C is mediated by 30^ ™. These 
proteins are localized at the outer surface of virus-induced membrane vesicles that 
accumulate in the cytoplasm of the infected cell. These are the sites of viral RNA 
replication suggesting that these proteins are involved in this process. (Bienz et al., 
1990; Bienz et al., 1992; Bienz et al., 1994). All of these proteins can associate with 
membranes but only 2BC and its cleavage product 2C, can induce vesicle fonnation 
(Clio et al., 1994). It has been demonstrated that protein 2C is needed for continual 
viral RNA synthesis and may have a fiinction in virion stmcture determination (Li and 
Baltimore, 1988; Baltera and Tershak, 1989; Li and Baltimore, 1990; Pfister et al., 
2000). 2C has also been shown to have an affinity for nucleic acids and also possesses 
ATPase and GTPase frmctions which might imply a role in handling, unwinding or
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manipulating vims RNA (Rodriguez and Carrasco, 1993). Studies using mutants in 
vims protein 2B have shown that this protein may be necessaiy for RNA 
amplification, and also that 2B multimerisation, as well as 2BC and 2C 
multimerisation, is required for the occurrence of viral replication (Johnson and 
Sarnow, 1991; van Kuppeveld et al., 1995; Cuconati et al., 1998; de Jong et al., 2002; 
van Kuppeveld et al., 2002; de Jong et al., 2004). The 2B protein has also been 
implicated in the disassembly of the Golgi complex, the modification of membrane 
permeability and the inhibition of protein secretion by forming pores in the membrane 
(Doedens and Kirkegaard, 1995; Aldabe et al., 1996; Sandoval and CaiTasco, 1997; 
van Kuppeveld et al., 1997; Van kuppeveld et al., 1997). The identification of 2B 
mutations that interfere with vims growth but do not disturb the ability of the 2B 
protein to inhibit protein secretion or increase membrane permeability argues for 
additional and separable functions of protein 2B or its precursor 2BC (Van kuppeveld 
et al., 1997).
Cleavage at the amino teiminus of the 3A-coding region generates the P3 precursor 
(Figure 1.2). Following this, rapid processing yields the relatively stable 
inteimediates 3AB and the proteinase 3CD^‘°. Slow processing of 3AB and 3CD*’‘^° 
generates the four cleavage products 3A; the genome-linked protein VPg (also Imown 
as 3B); the proteinase 3C '^° and the RNA-dependent RNA polymerase 30^ *^ ’ 
(Wimmer et al., 1993). 3AB is a cytoplasmic membrane-associated protein and serves 
as a precursor to VPg and 3A (Takegami et al., 1983; Lama et al., 1994). The role of 
3AB in the enterovims replication cycle remains largely unknown, although purified 
3AB has been shown to stimulate greatly the polymerase activity of 3D^°' in vitro 
(Lama et al., 1994). 3AB has also been found to induce cell membrane permeability 
(Lama and Carrasco, 1996). Moreover protein 3A has been found to be essential for
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viral RNA replication, inhibition of cellular protein secretion and plays a role in 
immune response interference (Doedens and Kirkegaard, 1995; Xiang et al., 1995; 
Doedens et al., 1997; Deitz et a l, 2000; Choe et a l, 2005; Wessels et al, 2005). VPg 
lias been shown to be necessary for the initiation of RNA replication (Takeda et al, 
1986; Reuer et a l, 1990). Autocatalytic cleavage of 3CD^ ™ to 3C^ ™ and 3D^°' is 
stimulated by 3AB and to a lesser extent by 3B (Molla et a l, 1994). In addition, 
cellular transcription and translation has been reported to be irreversibly inhibited by 
3 Cpro (çiiark et al, 1991; Yalamanchili et a l, 1996). The polymerase 3D^ °* catalyses 
chain elongation of viral RNA in vims infected cells (Flanegan and Van Dyke, 1979; 
Young et a l, 1985). Furthermore, the fonnation of a complex between 3D^ °^  and 3AB 
stimulates polymerase activity above that of 3D^°‘ alone (Paul et a l, 1994; Plotch and 
Palant, 1995).
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5'UTR Ooen Reading Frame 3TTR
Translation
Polyprotein-
VPg (3B)
Figure 1.2 Schematic representation of enterovirus genomic organization and 
polyprotein processing.
The domains and organization o f the enterovirus genome are shown. The open 
reading frame o f the polyprotein is divided into a structural region (precursor PI) 
and a non-structural region (P2 and P3 precursors). The roles for the individual 
cleavage products are highlighted above. Adapted from Rueckert, (1996). 
Abbreviations: UTR, untranslated region; VPg, virus protein, genome-linked
1.2.3 Enterovirai-host cell interaction and replication
Despite many years of active research, details concerning the mechanism of 
enterovirus replication in vivo remain largely unknown. The time required for a 
complete replieation cycle, from infection to completion of virus assembly, ranges 
from 5 to 12 hours depending on the infecting enterovirus and the host cell. 
Approximately 10'*-10^  infectious virus particles can be produced in a single infected 
cell, and ultimately this leads to cell destruction and the release of virus particles. 
Enteroviruses were amongst the first viruses isolated beeause their replication leads
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rapidly to a characteristic cytopathic effect (CPE) and cell death. However, under 
some circumstances the vims can set up a persistent infection during which it may 
replicate at a reduced level, thereby avoiding host cell death (Hyypia et al., 1997), or 
possibly may use an anti- cell death function. Indeed, Coxsackieviral RNA is known 
to persist in human tissues for many years (Feuer et al., 2004) and there is clear 
evidence from work on PV (Gosselin et al., 2003) that suppression of apoptosis may 
lead to viral persistence. Given the fact that enteroviral persistence has been 
implicated in the pathogenesis of several chronic human diseases, including dilated 
cardiomyopathy, insulin-dependent diabetes mellitus (IDDM- also known as type 1 
diabetes), and chronic inflammatory myopathy, this investigation set out to elucidate 
the possible anti-apoptotic mechanism that may confer the ability of Coxsackie B 
viruses to persist in their hosts.
Vims infection is initiated when the vims attaches to its specific receptor [CD 155 also 
known as PVR (poliovims receptor) for PV and CAR (Coxsackie and adenovims 
receptor) for Coxsackie B vimses]. These receptors have a similar stmcture in that 
they are members of the immunoglobulin superfamily. Their C termini are embedded 
in the cell membrane and there is a small intracellular domain beneath. The bulk of 
the molecule however protmdes from the cell surface as a series of immunoglobulins. 
The N-terminal domain is carried at the tip of this finger-like molecule and can 
penetrate the canyon binding the vims to the cell. Receptors differ in the number of 
domains and the degree of similarity to a constant or variable immunoglobulin fold 
(Racaniello, 1996; Bergelson et al., 1997; Evans and Almond, 1998; Selinka et al., 
1998; Belnap et al., 2000; van Raaij et al., 2000; Cohen et al., 2001; Rossmann et al., 
2002; Polacek et al., 2005). Interaction of the vims with its cellular receptor(s) leads 
to stmctural rearrangement of the virion, exposing/extmding the myristoylated capsid
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protein VP4 and the N-terminal amphipathic helix of VPl, both of which are buried 
inside the virus paiticle prior to this reorganisation (Section 1.1.3). This change 
precedes the uncoating of the RNA genome (Hogle, 2002).
After the release of the viral RNA from the capsid and subsequent translation, 
replication then proceeds. Enterovirus replication occurs entirely in the cytoplasm of 
infected cells using the products of newly translated viral proteins and various 
components of the host translational machinery. Replication occurs in a rosette-like 
membranous structure known as a replication complex (RC) that accumulates in the 
cytoplasm (Caliguiri and Tamm, 1969; Bienz et al., 1990; Bienz et al., 1992; Bienz et 
al., 1994) (Figure 1.3). Studies have shown that the rosettes can be reversibly 
dissociated into their components, the virus induced vesicles that are capable of 
initiation and elongation of viral RNA on their own (Egger et al., 1996) (Figure 1.3). 
Immunoprécipitation has shown that the non-stmctuial proteins 2C, 2BC, and 
3 Cdp*o can attach to tliese vesicles, with the intracellular formation of these vesicles 
attributed to proteins 2BC and 2C (Bienz et a l, 1990; Clio et al, 1994; Aldabe and 
Carrasco, 1995; Barco and Carrasco, 1995; Teterina et al, 1997). The membranous 
material in the RC vesicular structures is derived from the host cell endoplasmic 
reticulum. A hydrophobic domain in 3AB is thought to insert into the membranes and 
then recruit the RC to the site by its affinity for 3D^ °* and SCD^ "^ ". Subsequently, with 
the aid of viral and cellulai' host factors, the polymerase 3D^ °* catalyses the replication 
reaction of the viral RNA genome. This replication occurs in two steps. Initially, the 
genomic RNA of the infecting virus is copied into a minus (-) sense strand which 
leads to the fonnation of a partially double stranded replicative intermediate (RI) 
(Girard, 1969) (Figure 1.4). The (-) sense strand of the RI then serves as a template 
for the synthesis of new plus progeny strands of positive (+) sense polarity
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(Butterworth et al., 1976; Etchison and Ehrenfeld, 1981). These (+) sense RNA 
strands are then translated and as the concentration of the protein increases, an 
increasing fraction of (+) sense RNA is packaged into virions. An excess of (+) sense 
RNA strands always arises within an infected cell as a single (-) sense RNA strand 
can serve as a template for the production of several (+) sense RNA strands. This 
imbalance leads to a ratio of positive to negative viral RNA strands being between 
30:1 and 50:1. This is sensible given that the (+) sense RNA strands must serve two 
purposes in the infected cell; as mRNAs for viral protein synthesis and as progeny 
genomes for encapsidation (Giachetti and Semler, 1991; Novak and Kirkegaard, 
1991).
f
Figure 1.3 Enterovirus replication complex.
Electron micrograph o f an enterovirus replication complex (RC) surrounded by virus- 
induced vesicles (V). Bar, 100 nm. Taken from Bienz et ai, (1992).
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1.2.4 Assembly maturation and release
The encapsidation of progeny genomes into procapsids (virus assembly) is poorly 
understood. Thus far, an encapsidation signal in the enterovirus genomic RNA has not 
been identified although it is thought that cleavage of the precursor PI into a protomer 
consisting of VPO, VP3 and VPl surrounds the viral RNA genome to complete the 
assembly or another possibility is that vhal RNA translocates into an already 
preformed capsid. The precise mechanism remains to be elucidated but empty capsids 
which do not contain viral RNA are regularly found suggesting that the capsid may be 
preformed and in some instances not packaged with viral RNA. Following 
encapsidation, a maturation cleavage of VPO occurs to form VP4 and VP2, which has 
the effect of locking in the RNA and stabilizing the capsid; this step is required for 
infectivity of the vims. As no viral proteinases (i.e. 3C^ "^ ° or 3CD^ ™) or cellular 
proteinases seem to be required for this encapsidation process, a cuirent working 
hypothesis assumes an autocatalytic mechanism, possibly in conjunction with the 
RNA (Hogle, 2002). Completed enterovims particles are ultimately released by 
infection-mediated disintegration of the host cell. Persistent infections may be non- 
lytic and may or may not be associated with significant virion release, (Cunningham 
et al., 1990; Klingel et al., 1992; Galbraith et al., 1997; Kandolf et al., 1999; Tam and 
Messner, 1999; Brilot et al., 2002)
As mitochondria play a central role in apoptosis and enteroviruses such as PV have 
been shown to target this organelle (Koundouris et al., 2000), as this could be a 
possible mechanism of controlling the fate of their host cells, this study investigated 
the effect of enterovimses on mitochondrial function and this organelle will be 
considered in more detail in the following section.
20
Cell membrane
Receptors
\ ’P4 lost P3
RNA uncoated
PI cleavageProtoiiiers 
\  P(),3, 1^^ (ienoiiie replication (-)
l< i 'p l ic i it i \c
in l f r i i u 'd iu lv
Genome 
Replication (+)
N irion
\  iri(»ii 
(infectious)
exit Proxir ion
(non- infect ious)\  P4 + \  P2 Smooth Endoplasmic Reticulum
Key
V P g  
#  Poly-(A) 
Ribosome 
^  Replicase 
I  Poly-(U)
Figure 1.4 Enterovirus infectious cycle.
An overview o f the enterovirus infectious cycle including virion attachment to host, 
replication o f viral RNA, assembly and maturation. Note: poly-(U) is the (-) sense for 
the (+) sense poly-(A) tail. A key is included to explain what the different objects 
shown in the diagram represent. Adapted from Rueckert (1996).
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1.3 Mitochondria
1.3.1 Mitochondrial structure
The mitochondiion (from Greek mitos- thread and khondrion- granule), is an 
organelle that contains the enzymes and redox proteins involved in electron transport 
and oxidative phosphorylation. Within each human cell the number of mitochondria 
may vaiy from hundreds to thousands, depending on the cell type and level of 
metabolic activity (Perkins and Frey, 2000). Morphologically, they are heterogeneous, 
uncoimected and vaiy substantially in length and cellular distribution within 
individual cells although their shape is often represented as regular, being either 
spherical or cylindrical. Spherical mitochondria are most commonly found in liver 
and vaiy between 0.5pm to 5pm in diameter. Simple cylindrical mitochondria have a 
size of at least 0.2pm and can be up to 20pm long (Perkins and Frey, 2000). However, 
highly branched mitochondria and mitochondria exhibiting specialized shapes, such 
as cup or disc shapes have been reported (Munn, 1974). As the surface area to volume 
ratio of this organelle is dictated by its moiphology, such specialized shapes may 
enhance the exchange of metabolites between mitochondria and the cytosol.
As depicted (Figure 1.5), mitochondria are double membrane bound, comprising an 
outer membrane that completely encloses the organelle, serving as its boundary, and 
an inner mitochondrial membrane which contains folds (cristae), that project inward. 
Controlled dismption of the organelle has shown that most of the cellular machineiy 
responsible for aerobic respiration and ATP formation are attached to the cristae folds 
(Kadenbach, 2003). The folded formation increases the capacity for these processes 
by increasing the surface area of the inner mitochondrial membrane. The membranes 
divide the mitochondrion into two distinct compartments; one within the interior of
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the mitochondrion called the matrix and a second, the inteiinembrane space, which 
lies between the inner and outer membranes. Although the two membranes are 
composed of a phospholipid bilayer containing embedded proteins, the two 
membranes have different properties. The outer membrane is composed of about 50% 
phospholipids by weight and contains a variety of enzymes involved in activities such 
as the oxidation of adrenaline, the degradation of tryptophan and the elongation of 
fatty acids (Emster and Schatz, 1981; Gennis, 1989). In contrast, the inner membrane 
contains more than 100 different polypeptides and has a high protein to phospholipid 
ratio (Gennis, 1989). Additionally, the inner membrane is rich in the phospholipid 
cardiolipin (a characteristic of bacterial plasma membranes). The outer membrane 
also contains integral proteins called porins. These form channels (about 2-3nm) that 
restrict die transport of large molecules and conduct ions and small molecules into 
and out of the mitochondrion. The inner membrane is impermeable and lacks porins 
(Ernster and Schatz, 1981; Gennis, 1989).
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Figure 1.5 Mitochondrial structures.
(a) The “baffle” model, a representation most commonly depicted in textbooks; 
source Perkins and Frey, (2000). (b) Electron tomography o f mitochondria. 1) a 
three-dimensional model o f mitochondria: the outer membrane is displayed in 
translucent dark blue, the inner membrane in translucent light blue and the cristae in 
yellow. 2) a three dimensional model o f four cristae displayed in different colours. 
The yellow crista is the most typical as an example o f a lamellar compartment; source 
Frey et al, (2002).
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1.3.2 Mitochondrial Function
The primary function of mitochondiia is the generation of energy through ATP 
production. This energy generation occurs through the metabolism of pyruvate and 
NADH which are the major products of glycolysis in the cytosol. Each pymvate 
molecule is actively transported across the inner mitochondrial membrane to the 
matrix, where it is then combined with Coenzyme A to form acetyl CoA. Acetyl CoA 
is then shuttled into the Krebs cycle (also known as the tricarboxylic (TCA) cycle or 
citric acid cycle). This process creates the reducing equivalents NADH (3 molecules) 
and FADH2 (1 molecule).
The system of mitochondrial enzymes and redox carrier molecules, which transfers 
reducing equivalents from substrates to oxygen, is collectively known as the electron 
transport chain. Fractionation of mitochondria have shown there to be four large 
multisubunit complexes named complex I-IV. These proteins float in the sheet of 
inner membrane lipids, presenting one face to the mitochondrial matrix and another to 
the inter-membrane space (Figure 1.6). Except for succinate dehydrogenase (complex 
II), which is bound to the inner mitochondrial membrane, all of these complexes 
(which are present in the matrix space) pump protons from the matrix into the 
inteimembrane space as they transfer reducing equivalents from one carrier to the 
next (Ernster and Schatz, 1981; Kadenbach, 2003). Electrons are earned from 
complex I and II to complex III by ubiquinone (UQ) and from complex III to complex 
IV by cytochrome c. Complex I catalyses the oxidation of NADH by UQ, complex III 
catalyses the oxidation of UQ by cytochrome c and complex IV catalyses the 
oxidation of cytochrome c by O2 -  the terminal electron acceptor (Kadenbach, 2003; 
Tsang and Lemire, 2003). Complex II catalyses the oxidation of FADH2 by UQ 
(Figure 1.6 see also Figure 3.1 on page 101). This study investigated the effect of
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enterovims infection on mitochondrial electron flow to determine whether 
mitochondrial function was being modulated to inhibit cell death.
Peter Mitchell in 1961 (Mitchell, 1961) proposed a theory linking respiration to ATP 
generation. This widely accepted ‘Chemiosmotic Theoiy’ showed that the transfer of 
electrons (to reduce oxygen to water) along the electron transport chain promoted the 
pumping of protons from the matrix to the intemiembrane space. The theory 
postulates that this transfer of protons occurs via an active transport (energy requiring) 
system as the protons are pumped against their natural tendency. This creates a pH 
and electrical potential gradient across the imier mitochondrial membrane (the 
concentration of protons in the intermembrane space is higher than that in the matrix). 
A strong diffusion gradient is then built up as the proton concentration in the 
intermembrane space increases. Due to the restrictive permeability of the imier 
membrane, proton exit can only be mediated through the ATP synthase protein 
complex (also known as complex V or the Fq/Fi ATPase). By transporting protons 
down an electrochemical concentration gradient from the intermembrane space back 
into the matrix (facilitated diffusion- no energy required), the ATP synthase complex 
makes ATP from ADP and inorganic phosphate (Pj) (Dimroth et al., 2000).
The mitochondrial membrane potential (A'FnO is the teim used for the electrical 
potential established across the imier membrane by the pumping of protons during 
electron transfer. Measurements of the A'Pm require a permeant cationic dye such as 
TMRE (Tetramethylrhodamine ethyl ester). TMRE is a lipophilic cation that 
partitions preferentially into mitochondria in response to the mitochondrial potential 
(Scaduto and Grotyohann, 1999; Collins et al., 2002). This dye was used through the 
course of this investigation.
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Although the primary function of mitochondria is to convert organic materials into 
cellular energy in the form of ATP, this organelle has other functions. Mitochondria 
play an important role in metabolic tasks such as glutamate-mediated excitotoxic 
neuronal injury, heme synthesis, steroid synthesis and also apoptosis. Mutations in the 
genes regulating any of these flinctions can result in a variety of mitochondrial 
diseases. This study investigated the modulatoiy effect of an enterovirus on host cell 
apoptosis induction, and this process of apoptosis is detailed in the next section.
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Figure 1.6 Representative scheme of oxidative phosphorylation in mitochondria.
Pyruvate and fatty acids are substrates for glycolysis with NADH and CO2 being 
released as by-products. The outward translocation o f protons by complexes I (NADH 
dehydrogenase). III (cytochrome c reductase) and IV (cytochrome c oxidase) and the 
uptake o f the protons by the ATP synthase, accompanied by the synthesis o f ATP 
make up the pathway. The formation o f the superoxide anion radical (Oi) by the 
transfer o f one electron from ubiquinone (UQ) to dioxygen is also indicated. 
Reduction o f O2 to H2 O completes the electron transfer process. Adapted from 
Kadenbach, (2003). Note: the complexes in reality lie solely in the inner membrane 
although the representation doesn ’t truly depict this (see Figure 3,1).
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1.4 Apoptosis
1.4,1 Brief overview of ceil death
Although the idea of cell death was originally documented in 1842 to occur during 
amphibian metamorphosis, the discovery that cell death can play a crucial role in 
animal development was only made in the middle of the last centuiy, after it was 
recognized that organisms are made of cells (Saunders, 1966; Clarke and Clarke, 
1996; Vaux, 2002).
Pathologic cell death, which occurs at the centre of acute lesions such as ischemia and 
trauma, leads to the swelling and mpturing of cells and their organelles. This results in 
the subsequent leakage of the cellular contents in a process called necrosis. This 
process, in most cases, leads to an inflammatory response. In contrast, cell death 
during nomial development or tissue homeostasis leads to retention of organelle and 
plasma membrane integrity but causes cellular shrinkage and condensation (Samuilov 
et al., 2000). This clear distinct morphological difference between the cell deaths that 
occui' in both animal development and tissue homeostasis from that which occurs 
during trauma (necrosis) led to the widely accepted teiin apoptosis. This physiological 
form of cell death, was first proposed by Currie and colleagues to describe a common 
type of programmed cell death that was repeatedly observed in various tissues and 
cells types (KeiT et ah, 1972). The term was derived fi'om Greek, meaning “to fall 
away from”, conjuring notions of the falling of leaves in the autumn from deciduous 
trees (Ken* et ah, 1972). Ken* et ah, (1972) reported that apoptotic cells shared 
morphological features distinct from those associated with necrotic cell death. This 
suggested an underlying common, conseiwed endogenous cell death programme.
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Apoptosis allows organisms to control cell number and natural tissue turnover, it is 
also important in guarding against malignancy (Hengartner, 2000). Knowledge of 
apoptosis has expanded greatly over the last 20 years and it is now recognised as an 
intrinsic cell suicide programme, important in biological processes conducted by 
vertebrates, plants and unicellular organisms (Samuilov et al., 2000).
1.5 Apoptosis in development and disease
All multicellular organisms are genetically pre-programmed to accomplish apoptosis 
as this process plays a central role in development and is a key event tlnoughout life 
(Vaux and Korsmeyer, 1999; Ameisen, 2002). Removal of superfluous cells formed 
during normal development is common in embiyogenesis permitting the formation of 
tubes, the separation of digits, and the reorganization of organs (Shearwin-Whyatt and 
Kumar, 1999; Vaux and Korsmeyer, 1999)
In vertebrates this cell death process can maintain the normal fimctioning of the 
immune system by eliminating virally infected cells. This has forced viruses (such as 
enterovimses), to evolve counter measures to prevent this form of cell death, which 
will be discussed in other sections below. Apoptosis induced by the immune system 
can also eliminate mutated cancerous cells or lymphocytes that do not develop 
appropriate antigen specificities or are self-reactive clones (Sheaiwin-Whyatt and 
Kumar, 1999; Krammer, 2000). In the adult, apoptosis plays a cracial role in 
promoting tissue homeostasis and the defence against other infectious agents. 
Moreover, it has a pivotal role in maintaining the nomial Rmction of the biological 
system of the adult as a whole by eliminating cells which fail to differentiate correctly
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or are damaged, or cells which have completed their life cycle or harbour mutations 
which could be potentially lethal to the organism (Vaux and Korsmeyer, 1999; 
Samuilov et al., 2000; Ameisen, 2002; Melino, 2002). By controlling the balance 
between cell proliferation and cell death, apoptosis can maintain the cell number of an 
organism. This is an active process in humans where approximately one hundred 
thousand cells are produced every second by mitosis and a similar number are 
eliminated by apoptosis (Vaux and Korsmeyer, 1999).
Due to the inherent importance of apoptosis in the development, health and biological 
stability of organisms, this process is tightly regulated in cells to prevent too much or 
too little cell death. Thus, its deregulation can promote many disease states (Table 
1.3) and it is cunently estimated that over 70% of human diseases are caused by a 
malfunction or improper regulation of apoptosis (Kiammer, 2000). Its aberrant 
activation can cause disease such as acquired immunodeficiency syndrome (AIDS) 
(precipitated by the apoptosis inducing pathogenic effects of the human 
immunodeficiency virus (HIV) on T cells of the immune system), stroke damage, 
diabetes and neurodegenerative disorders such as Alzheimer’s disease and 
Parkinson’s disease (Cheiwonsky et al, 1997; Barinaga, 1998; Krammer, 2000; Yuan 
and Yankner, 2000; Eberhardt and Schulz, 2003). In contrast, impaired apoptosis is a 
significant factor in the aetiology of diseases such as cancers (i.e. lymphoid 
malignancies), autoimmune disorders (i.e. human systemic lupus eiythematosus) and 
viral syndromes (i.e. persistent infection of B cells by the herpesvims, Epstein-Barr 
virus) (Straus et a l, 1985; Henderson et al, 1993; Mysler et a l, 1994; Krammer, 
2000; Danial and Korsmeyer, 2004; Hammerschmidt and Sugden, 2004)
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Diseases associated with 
increased apoptosis
Diseases associated with 
inhibition of apoptosis
AIDS Cancer
Ischemic injury Carcinomas with p53 mutations
-Stroke Follicular lymphomas
-Reperfusion injmy Hormone dependent breast tumours
-Myocardial infarction -Ovarian cancer
Diabetes -Breast cancer
Neurodegenerative disorders -Prostate cancer
-Parkinson’s disease Viral infections
-Alzheimer’s disease -Herpesvirus
-Cerebellar degeneration -Poxvirus
Myelodysplastic syndromes -Adenovirus
-Aplastic anaemia Autoimmune disorders
Toxin-induced liver disease -Systemic lupus eiythematosus
-Alcohol -Immune-mediated glomerulonephritis
Table 1.3 Diseases associated with the deregulation of apoptosis.
1.6 Characteristics of apoptosis and necrosis
Apoptotic cell death is a physiological process that is morphologically, biochemically 
and molecularly distinct from necrotic cell death (Table 1.4). Necrotic cell death is a 
pathological uncontrolled process occurring as a result of tissue injury causing, most 
typically, cell lysis and release of cell contents. This provokes an inflammatoiy 
response (Columbano, 1995; Samuilov et al., 2000). The terms, apoptosis and 
necrosis, relate to morphological descriptions of cell death; and in some cases 
(although rare) it remains possible that the two processes might be linked, with 
necrosis being the ultimate fate for cells undergoing apoptotic changes (Dong et ah, 
1997). Indeed in vitro, a late stage event of apoptosis can be the rupturing of the 
plasma membrane allowing penneability to vital dyes, and this is sometimes termed 
“secondaiy necrosis”; occurring most commonly in vivo after apoptotic cells have 
been removed by immune cells (Arends and Wyllie, 1991). Moreover, the final death 
event may also depend on the intensity of the initial insult (Bonfoco et al., 1995).
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1.6.1 Morphological features
Morphologically, apoptosis is characterised by a series of featui'es that are caused by 
structural changes in dying cells. Cellular shrinkage is one of the first obsei'ved 
changes, whieh subsequently results in the detachment from neighbouring cells 
(Arends and Wyllie, 1991). The most commonly described feature of apoptosis is 
chromatin condensation in which the chromatin aggregates at the periphery of the 
nuclear membrane into sharply delineated dense masses and becomes extensively 
cleaved between nucleosomes (Arends and Wyllie, 1991; Kass et al., 1996). 
Following this, subsequent nuclear shrinkage and migration of the nucleus at the 
periphery eventually lead to the break down of the nuclear envelope, the 
fragmentation of the nucleus and the break up of the cell into discrete membrane- 
bound acidophilic containing globules, called apoptotie bodies (Allen et al., 1997; 
Wilson, 1998). Apoptotie bodies (Figure 1.7) are membrane-bound cell fragments 
composed of cytoplasm, closely packed cellular organelles such as morphologically 
intact ruitochondria, and nuclear fragments (Kerr et al., 1972; Arends and Wyllie, 
1991; Saraste and Pulkki, 2000). As the plasiua membrane is kept intact in cells 
undergoing apoptosis, intracellular leakage of cytosolic constituents into the 
extracellular space is prevented avoiding an inflammatory response (Savili et al., 
1989).
Apoptotie bodies bud off from the cell structure and are rapidly phagocytosed by 
neighbouring cells such as macrophages and parenchymal cells. Apoptotie bodies are 
degraded within lysosomes, with adjacent cells migrating or proliferating to replace 
the space occupied by the deleted apoptotie cell (Reed, 2000).
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In apoptosis, the characteristic controlled digestion of the cell by phagocytosis 
without eliciting an inflammatory response is directly contradictory to necrotic cell 
death. In contrast to apoptotie cell death, necrosis is a passive form of cell death that 
affects contiguous cells and is characterised by rapid swelling of the cytoplasm and 
organelles, breakdown of the plasma membrane, release of lysosomal enzymes and 
release of pro-inflammatoiy intracellulai' constituents into the extracellular space 
resulting in an inflammatory response in the surrounding tissue (Fadeel et al., 1999a).
Cell death can be expressed as either apoptosis or necrosis depending on the intensity 
and duration of the stimulus, the extent of ATP depletion suffered by the cell and the 
rapidity of the death process (Bonfoco et al, 1995; Columbano, 1995; Kolesnick and 
Kronke, 1998; Kroemer et al, 1998).
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Changes Apoptosis Necrosis
Stimuli Physiological Pathological
Occurrence Single cells Clumps of cells
Cell to cell adhesion Lost in early stages Lost in late stages
Cytoplasmic organelles Late stage swelling Very early stage swelling
Nucleus Karyorrhexis (breakdown) 
and pyknosis
Karyolysis
(disappearance)
Nuclear chromatin Compact and in uniformly 
dense masses
Clumping, not sharply 
defined
Lysosomal enzyme 
release
Absent Present
DNA breakdown Intemucleosomal Random
Cell Formation of apoptotie 
bodies
Swelling and 
disintegration
Phagocytosis by other 
cells
Present Late onset
Exudative inflammation Absent Present
Scar formation Absent Present (dependent on 
tissue)
Table 1.4 Summary of the differences between apoptosis and necrosis
Necrosis
Swelling of cell
Membrane rupture 
and release of cell 
contents inducing 
an inflammatory 
response
Normal cell\
Apoptosis
Cell shrinkage and nuclear 
chromatin condensation
Nuclear fragmentation 
and apoptotie body 
formation
Phagocytosis without 
eliciting inflammation
Figure 1.7 The apoptotie and necrotic cell death program
Schematic representation illustrating the basic differences between necrotic (left) and 
apoptotie cell death. Adapted from Marshall and Watson, (1997).
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1.6.2 Biochemical features
One of the most characterised features of apoptotis is the irreversible degradation of 
DNA by cleavage between nucleosomes generating a ladder of fragments (Wyllie, 
1980). The first cleavages generate high-molecular weight (HMW) fragments (>700 
kbp). This is followed by fiirther digestion forming 50- to 300 kbp and then smaller 
fragments that are monomers and multimers of 180- 200 base pairs (Wyllie, 1980; 
Bortner et al., 1995). These DNA fragments produce a ladder formation when the 
DNA is resolved by agarose gel electrophoresis which, for many years was used as 
the prime hallmark of a cell undergoing apoptosis (Columbano, 1995; Marshall and 
Watson, 1997; Nagata, 2000). The production of HMW DNA fragments has also been 
observed in some forms of necrosis (Columbano, 1995). Despite this distinctive 
nuclear DNA fragmentation, mitochondrial DNA has been found to remain intact 
(Murgia et al., 1992). As the aim of apoptosis is to eliminate damaged or hannful cells 
(i.e. virally infected or cancerous cells), it is important that the DNA from the 
defective cells is fragmented prior to phagocytosis. This fragmentation prevents the 
phagocytosing cell from harbouring oncogenes, any activated viral genes and also 
prevents the induction of an autoimmune response (Nagata, 2000). As fragmentation 
of the DNA commits the cell to die this process is probably the most effective way to 
kill the cells (Nagata, 2000).
Other important biochemical features that occur during this cell death process involve 
the degradation of cytoskeletal proteins such as fodrin, lamin, gelsolin and cytokeratin 
18, which subsequently results in a loss of cell architecture and shape. Many proteins 
are also cleaved during this process including proteins involved in translation, DNA 
replication, as well as kinases and phosphatases (Nagata, 2000). Additionally, loss of 
AYm is also a characteristic feature during this process (Zamzami et al., 1995a).
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One of the most important and early stage biochemical events is the translocation of 
phospholipid phosphatidylserine (PS) from its usual position on the inner side of the 
plasma membrane to exposure on the outer surface of the cell. This permits the 
recognition and removal of apoptotie cells. Detection of PS on the cell’s external 
surface has become one of the most widely used and accepted markers of cells 
undergoing apoptosis (Connor et ah, 1994; Boas et al., 1998; Duffield et al, 2000; 
Savill and Fadok, 2000; Geske et a l, 2001; Schlegel and Williamson, 2001; Ameisen, 
2002; Danial and Korsmeyer, 2004)
1.7 Caspases
Caspases are a distmct family of cysteine proteases that are aspartate-specific and 
cleave their substrates on the carboxyl side of aspartate residues (Cohen, 1997; 
Earnshaw et a l, 1999). The first caspase to be identified was given the name 
interluken-1 P-converting enzyme (ICE), as it was found to be responsible for 
converting pro-inflammatory cytokine pro-interluken-lp in monocytes (Cohen, 1997; 
Shi, 2002a). ICE was reported to be related to the Caenorhabditis elegans protein 
CED-3 (Miura et a l, 1993) which is a protein shown to be necessary for apoptotie cell 
death in this nematode worm (Yuan et a l, 1993). Due to improved molecular cloning 
teclmiques and the rapid expansion of the expressed sequence tag database, many 
research groups were identifying and deriving names for these proteases that had 
previously been named by other groups which led to different names being assigned 
to the same protein, causing confusion (Table 1,5). Following recommendations of 
the ICE/Ced-3 Nomenclature Committee it was decided that the term caspases would 
be used, with the “c” referring to the cysteine protease and the “aspase” referring to
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the families preferential ability to cleave after aspartate residues (Asp-Xxxx) (Alnemri 
et ah, 1996). It was also recommended that individual family members would be 
refeiTed to in the order of their publication and thus ICE was subsequently named 
caspase-1 as it was the first member to be discovered (Alnemii et ah, 1996; Cohen, 
1997). An individual caspase’s distinct substrate specificity is determined by the four 
amino acids (Xxxx) distal to the cleavage site (Cohen, 1997). Several lines of 
evidence indicate that caspases are important for apoptosis. For example, caspase 
activation coixelates with the onset of apoptosis, with caspase inhibition using 
synthetic or natural inhibitors, attenuating this process, and more recently research 
using knock-out animals lacking certain caspases have shown them to have profound 
defects in developmental apoptosis (Nicholson, 1999; Wolf and Green, 1999).
1.7.1 Classification of the caspase family
Caspases are highly conseiwed through evolution and have been found in insects, 
plants, nematode worms and hydra as well as humans (Cikala et ah, 1999; Shearwin- 
Whyatt and Kumar, 1999; Samuilov et ah, 2000). To date, at least 14 caspases have 
been identified in mammals and about two thirds of these members have been 
implicated in having a role in apoptosis. All except caspases-11, -12 (mouse) and 
caspase-13 (bovine), are found in humans (Shi, 2002a; LeBlanc, 2003). Caspases are 
divided into two major subfamilies based on phylogenetic analysis (Table 1.5). The 
caspase-1 (ICE) subfamily members (caspases-1, -4, -5, -11, -12, -13 and -14) have 
been found to predominantly play a role in inflammation by activating cytokines, 
whereas members of the other subfamily, CED-3 (caspases-2, -3, -6, -7, -8, -9 and - 
10), have been found to be primarily involved in apoptosis (Nicholson and 
Thoniberiy, 1997; Nicholson, 1999; Zimmemiann et ah, 2001). The CED-3 subfamily 
can be further divided (based on sequence similarities) into two groups, namely the
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caspase-3 subfamily (caspases-3, -6, -7, -8 and -10) and the caspase-2 subfamily 
(caspases-2 and -9) (Zhivotovsky, 2003). Caspases can also be divided into two 
groups based on the size of their profomi N-terminal prodomains; with these 
prodomains being protein interaction sites which modulate activation of the caspase 
cascade (Wolf and Green, 1999). Long prodomain caspases (caspases-1, -2, -4, -5, -8, 
-9, -10, -11, -12, -13 and -14) have a prodomian of more than 90 amino acids, 
whereas short prodomain caspases (caspases-3, -6 and -7) have a domain of no more 
than 30 amino acids (Shi, 2002a). The long prodomain caspases-2, -8, -9 and -10 are 
known as upstream or initiator caspases as they are the first caspases to be activated in 
response to apoptotie stimuli. In contrast, the short prodomain caspases-3, -6 and -7 
are activated after activation of the initiator caspases and are called downstream or 
effector caspases as the activation of these latter caspases results in the irreversible 
morphological and biochemical changes which leads to cell death (Thornberiy and 
Lazebnik, 1998; Budihardjo et al., 1999; LeBlanc, 2003). Initiator caspases have 
protein-protein interaction domains, such as a caspase recmitment domain (CARD) or 
a death effector domain (DED), which interact with homologous domains present on 
specific adaptor proteins thereby bringing multiple initiator caspases into close 
proximity with one another which subsequently facilitates their activation (Cohen, 
1997; Muzio et al, 1998; Budihardjo et al, 1999; Shi, 2002a)
1.7.2 Structure of caspases
Caspases are expressed as inactive proenzymes (zymogens) of 32-56kDa that 
comprise three domains: an N-terminal prodomain (2-25kDa); a large subunit (17- 
21kDa) and a C-temiinal small subunit (10-13kDa). There is little similarity in the N- 
terminal prodomain between caspases, but all are similar in the catalytic domain 
which is made up of the folding of the large and small subunit chains. Additionally, a
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short inter-domain Tinker’ region containing one or two aspartate cleavage sites 
separating the large and small subunits is conserved among some caspases (Earnshaw 
et al., 1999; Wolf and Green, 1999; Zimmermann et al., 2001). The catalytic site 
contains a conserved QACXG pentapeptide motif. Caspases which are constitutively 
present in most cell’s, are activated to fully functional proteases by an initial cleavage 
to divide the proenzyme chain into the large and small subunits and then a second 
cleavage to remove the N-terminal prodomain (cleavages shown as DfX Figure 1.8). 
This permits the assembly of one large and one small subunit into a heterodimeric 
formation, with a fully active mature caspase forming a tetrameric arrangement 
composed of two such heterodimers. Each active site contains a positively charged 
primary recognition pocket (Si) that binds the substrate’s negatively charged aspartate 
side chain, with additional pockets (S2-S4) varying between caspases and thus 
confeiTing different substrate specificities (Table 1.5) (Salvesen and Dixit, 1997; 
ThornbeiTy et al., 1997). As proteolytic cleavage generates this mature form, caspases 
can thus be activated by the proteolytic activity of other caspases. Alternatively 
caspases can be activated by other proteases such as the serine proteinase granzyme 
B, which is introduced into cells by cytotoxic lymphocytes (Stennicke and Salvesen, 
2000).
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Caspase Subfamily New Name Old Name Size of
pro-
domain
Presence of 
CARD or 
DED
Preferred
Peptide
substrates
Caspase-1 (ICE) Caspase-1 ICE Long CARD WEHDfX
[Inflammation] Caspase-4 TX, ICH-2, 
ICErel-II
Long CARD (W/L)EHDiX
Caspase-5 TY,
ICErel-II
Long CARD (W/L)EHDiX
Caspase-11 ICH-3 Long CARD -
Caspase-12 ICH-4 Long CARD -
Caspase-13 ERICE Long CARD (W/L)EHDjX
Caspase-14 MICE Long —
CED-3
[Apoptosis]
Caspase-2 Caspase-2
(initiator)
Caspase-9
(initiator)
Nedd2/IC
H-1
Mch6,
ICH-LAP6
Long
Long
CARL)
CARD
VDVADfX
LEHDfX
Caspase-3 Caspase-3
(effector)
CPP32,
Apopain,
Yama
Short DEVDfX
Caspase-6
(effector)
Mch2 Short - VEIDjX
Caspase-7
(effector)
Mch3,
ICE-LAP3,
CMH-1
Short DEVDjX
Caspase-8
(initiator)
FLICE
MACH,
Mch5,
Long DED IETD|X
Caspase-10 
(initiator)
Flice-2
Mch4,
Long DED IEADJ.X
Table 1.5 Members and classification of the caspase family.
The members have been assigned numbers based on the chronological order o f their discoveiy. 
Abbreviations: ICE, inteîAeiildn If-converting enzyme; CARD, caspase-recruitment domain; DED, death 
effector domain; -  not yet reported; DfK, caspase-mediated cleavage at aspartate residue in the preferred 
substrate specificity. Amino acid notations: W, tryptophan; L, leucine; E, glutamate; H, histidine; D, 
aspartate; V, valine; A, alanine; I, isoleucine; T, threonine; X, represents any amino acid. Adapted from  
(Cohen, 1997; Thornberiy et al, 1997; Green, 1998; Reed, 2000; Shi, 2002a).
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As previously mentioned (Section 1.7.1), caspases with long N-terminal prodomains 
contain distinct protein-protein interaction sites required for caspase activation known 
as DED and CARD domains. Caspases with short prodomains lack these motifs 
(Figure 1.8) (Reed, 2000). The DED are exclusively found in caspases -8 and -10, 
which are associated with death receptor mediated apoptosis and are essential for the 
recmitment of these caspases to the receptor via specific adapter molecules (i.e. 
F ADD). The CARD domains are found in caspases that initiate apoptosis (caspases-2, 
-9) as well as those involved in cytokine activation (caspases-1, -4, -5, -11, -12, -13 
and -14) (Cohen, 1997; Aslikenazi and Dixit, 1999; Budihardjo et al., 1999; Reed, 
2000).
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Procaspase (32-56 kDa)
(2-25 kPa) (17-21 kD a)'° V ° ' (10-13 kDa)
HzN-f Prodomain OOH
□ ▼X □▼X [Proteolysis
Linker
I E I  =  #
I c m  Ü
Association
Heterodimers
Procaspase-8
Procaspase-9
Procasoase-3
Tetramer (active caspase)
Figure 1.8 Representation of the structure and proteolytic activation of caspases.
(a) Caspases are expressed as procaspases containing an N-terminal prodomain, a large 
subunit containing the active site cysteine within a conserved QACXG motif, and a C- 
terminal small subunit. A short ‘linker ’ region between the large and small subunits is also 
present on some caspases. Proteolytic cleavage o f the procaspase results in the removal o f 
the N-terminal prodomain, separation o f the large and small subunits and if present, 
release o f the ‘linker’ segment. The active site is formed by a heterodimer containing one 
large and one small subunit, with the active caspase being a tetramer composed o f two 
such heterodimers, (b) Long prodomain caspases contain either DED (death effector 
domain) or CARD (caspase recruitment domain) that are required for their activation. 
Caspase-mediated cleavage at aspartate residues is represented by DfX, where X  
represents any amino acid. Adapted from Cohen, (1997) and Samuilov et ai, (2000).
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1.8 Caspase activation pathways
Currently two major pathways have been characterised that lead to the activation of 
caspases. A pathway known as the death receptor pathway or “extrinsic pathway”, involves 
the activation of specific cell surface death receptors. The other pathway called the 
mitochondrial pathway or “intrinsic pathway” involves the dysfunction of the 
mitochondrial organelle (Kaufimann and Hengai*tner, 2001; Zimmermann et al., 2001). 
These pathways, along with their regulatoiy mechanisms are all summarized in Figure 
1 . 1 0  and the features of these pathways are discussed below.
1.8.1 The death receptor (extrinsic) pathway
The engagement of cell surface death receptors with their specific ligands initiates caspase 
activation. Cell surface death receptors belong to a family of transmembrane proteins 
known as the tumour necrosis factor (TNF) receptor superfamily (Wallach et al., 1997; 
Bodmer et al., 2002; Zhang, 2004). Mammalian death receptors include: Fas/CD95, which 
binds Fas ligand (FasL); the type 1 tumour necrosis factor receptor (TNFRl), which binds 
tumour necrosis factor (TNF) and the tumour necrosis factor-related apoptosis-inducing 
ligand receptor (TRAIL-R), which binds TRAIL (Earnshaw et al., 1999; Reed, 2000). 
Although activated by specific ligands, these transmembrane proteins contain a conserved 
cytoplasmic motif called the death domain (DD) (Cohen, 1997) (Figure 1.8). Binding of 
death receptors to their respective ligands results in a recognition event, inducing the 
activation and recmitment of adaptor proteins to the DDs. The most characterised death 
receptor ligand interaction is the Fas-FasL interaction. The binding of FasL to Fas receptor 
induces trimerization of Fas (Bratton and Cohen, 2001). The cytoplasmic DD containing 
region of Fas then recmits a type of protein known as an adaptor protein. One such adaptor 
is the Fas-associated DD (FADD) protein, which interacts with Fas using its C-terminal
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DD. FADD also contains an N-temiinal DED which is a critical region in recmiting 
upstream procaspases such as procaspases- 8  (Muzio et al., 1997; Denecker et al., 2001). 
The DED of FADD then binds to the DED m the prodomain region of procaspase-8 , 
resulting in the formation of a complex termed the death-inducing signalling complex 
(DISC) which clusters procaspase- 8  molecules into close proximity. Procaspases (whose 
intracellular concentrations are negligible) possess weak activity, amounting to 1 -2 % of the 
activity of a mature caspase and as such, they remain as pro-fomis while in the monomeric 
state (Green, 1998; Samuilov et al., 2000). Since caspases cleave one another in an 
activation cascade, and as procaspase- 8  molecules are the most apical cysteine proteases in 
this Fas pathway and these proteins aggregate, currently, activation of procaspase- 8  in the 
DISC complex is believed to follow an “induced proximity” model whereby a high local 
concentration of procaspase- 8  leads to its autoproteolytic activation (Muzio et al., 1998). 
Activated caspase- 8  then further propagates the death signal by activating other important 
down-stream procaspases such as procaspases-3 and -7 (Hirata et al., 1998; Zimmermann 
et al., 2001) (Figure 1.10). Activated caspase-3 is an important effector caspase that is 
responsible for the cleavage of various cellular substrates resulting in the biochemical and 
morphological characteristics of apoptosis, such as inhibitor of caspase-activated DNase 
(ICAD), lamins and gelsolin. Active caspase-3 also activates downstream effector caspases 
such as caspase-2 and caspase- 6  (Slee et al., 1999; Zimmermann et al., 2001; Eberhardt and 
Schulz, 2003). However, although active caspase-3 is widely reported to be responsible for 
the cleavage of poly(ADP)-ribose polymerase this cleavage may also be aided by active 
caspase-7 (Geimain et al., 1999; Slee et al., 2001).
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1.8.2 The mitochondrial (intrinsic) pathway
The mitochondrial apoptosis pathway can be activated by various stimuli such as exposure 
to cytotoxic drugs (staurosporine, actinomycin D), giowth factor withdrawal (interleukin-3 
withdrawal), DNA damage (ultraviolet iiTadiation) as well as death receptor activation, and 
this activation involves a family of proteins known as the Bcl-2 family (Section 1.10) 
which regulate apoptosis by controlling mitochondrial permeability and the release of 
cytochrome c from mitochorrdria (Danial and Korsmeyer, 2004). Mitochondrial function is 
critical in coordinating and integrating tire death stimulus. As described (Section 1.8.1), 
Fas binding to its receptor (FasL) leads via binding of an adaptor protein (FADD), to the 
self-proteolysis and activation of procaspase-8 . Although active caspase- 8  cleaves and 
activates procaspases-3 and -7, a cross talk between the mitochondrial and death receptor 
pathways can be established leading to the cleavage of a cytosolic protein called Bid (a 
Bcl-2 pro-apoptotic protein) (Li et al., 1998; Luo et al., 1998). The activated or tmncated 
Bid (tBid) then binds Bax (a Bcl-2 pro-apoptotic protein) which activates this protein, 
inducing a conformational change in the N-terminus of Bax. Active Bax then translocates 
from the cytosol to the outer membrane of the mitochondria, oligomerizes and fonns a 
channel to release cytochrome c into the cytosol. Released cytochrome c in the presence of 
dATP/ATP induces multimerization of apoptosis protease-activating factor (Apaf) -1 which 
then binds procaspase-9 to form the so called “apoptosome” complex and which 
subsequently leads to autoproteolysis and activation of procaspase-9 (Li et al., 1997; 
Schultz and Harrington, 2003). Binding of procaspase-9 to Apaf-1 to fonn the apoptosome 
complex occurs due to the presence of an N-terminal CARD on Apaf-1 which permits a 
homotypic protein-protein interaction with the CARD in procaspase-9 (Budihardjo et al., 
1999; Shi, 2002b). Active caspase-9 then mediates the activation of downstream effector 
caspases such as caspases-3 and -7 (Slee et al., 1999).
46
In addition to cytochiome c, other proteins are released from mitochondria and promote 
apoptosis. Endonuclease G (Li et al., 2001) and AIF (apoptosis inducing factor) (Susin et 
al., 1999b) are two mitochondrial matrix proteins that upon release from the mitochondria 
translocate to the nucleus where they contribute to the cleavage of DNA (Parone et al., 
2002). Smac/DIABLO (second mitochondria-derived activator of caspases/ direct LAP 
binding protein) is also released from mitochondria in response to an apoptotie stimuli and 
promotes apoptosis by sequestering lAPs (inhibitor of apoptosis proteins) from caspases 
thereby facilitating caspase activation and their subsequent effects (Du et al., 2000; 
Verhagen et al., 2000) (Figure 1.10). HtrA2 (high temperature requirement serine protease 
A2) is another mitochondrial protein that has lAP inhibitor function (Hegde et al., 2002). 
Additionally, mitochondria have been found to be the main store of procaspases-2 and -9 
and release active caspase-2 and -9 along with the mitochondrial apoptogenic proteins 
during early stages of apoptosis (Susin et al., 1999a). Permeabilization of the outer 
mitochondrial membrane is responsible for the release of these apoptosis inducing factors 
and control of this release is by the Bcl-2 family members.
1.9 Caspase substrates
Within their active site, caspases recognize a core tetrapeptide of amino acids known 
as P4-P3-P2-P1 (Thornberry et al., 1997; Wolf and Green, 1999). Despite having an 
absolute requirement for an aspartate (D) residue in PI their requirements for other 
residues differ. Most caspases are promiscuous in P2, prefer glutamate (E) in P3, with 
the P4 site being the most critical detemiinant of substrate specificity (Thornberry et 
al., 1997). Based on their substrate specificities, largely dictated by the residue in P4, 
caspases can be divided into tluee subgroups (Thornberiy et al., 1997). Group-I
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(caspases-1, -4, -5, -13) preferentially cleave after the motif (W/L)EHD, group II 
(caspases-3, -7), which have a stiict requirement for aspartate at P4, cleave after 
DEXD, whereas group III (caspases-6 , -8 , -9, 10), which are less discriminating at P4 
cleave at the (I/LV)EXD motif (Ciyns and Yuan, 1998; Eberhardt and Schulz, 2003). 
Only caspase-2 is known to preferentially cleave after the sequence VDVAD, and 
currently, the cleavage sites for caspases-11, -12 and -14 have not been elucidated 
(Zhivotovsky, 2003) (Table 1.5). Cleavage of caspase substrates results in the 
morphological and biochemical manifestations of apoptosis. Although proteolytic 
cleavage by caspases can lead to the activation of substrates, inactivation of substrates 
by these proteases is a more common occurrence (Cryns and Yuan, 1998; Hengartner, 
2000). Among the proteins that are inactivated by cleavage are cytoskeletal proteins 
such as lamins, fodrin and actin, and proteins involved in DNA repair, such as PARP. 
Moreover, duiing apoptosis caspase cleavage of nuclear lamins causes nuclear 
shrinkage and budding (Rao et al., 1996; Buendia et al, 1999) and cleavage of the 
kinase p21-activated kinase 2 (PAK2) promotes the characteristic cell blebbing 
(Rudel and Bokoch, 1997); although all of these stmctural cleavages may induce cell 
blebbing caused by the disassociation of the plasma membrane from the cytoskeleton 
(Zimmermann et al, 2001). Examples of caspase substrates that are activated upon 
cleavage are gelsolin and ICAD/DFF (inhibitor of CAD/ DNA fragmentation factor). 
Cleavage and activation of gelsolin contributes to the loss of cell shape during 
apoptosis (Kothakota et a l, 1997). Activated gelsolin promotes both nuclear and 
cytoplasmic apoptosis, including DNA fragmentation (Wolf and Green, 1999). In 
normal cells, the apoptotie DNase CAD (caspase-activated DNase) forms an inactive 
complex with the inhibitor ICAD/DFF. During apoptosis, caspase-mediated cleavage 
results in the activation and release of CAD, allowing free CAD to cleave DNA into 
oligonucleosomal subunits and induce the fragmentation of the chromatin (Liu et al,
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1997; Enari et al, 1998; Liu et al, 1998; Wolf et al., 1999). Interestingly, all the 
cleavages mentioned above are due to caspase-3, which is the most prevalent caspase 
ill the cell and has been shown to cleave a wide range of substrates, indicative of its 
role as an executioner caspase (Slee et al., 2001; Zimmermann et al, 2001). At 
present almost 1 0 0  additional substrates have been reported, suggesting that more are 
likely to be found (Earnshaw et al, 1999; Nicholson, 1999). In addition to the proteins 
mentioned above, caspases are also responsible for the cleavage of DNA-dependent 
protein kinase (DNA-PK), apoptotie regulatory proteins such as Bcl-2, B c1-xl and Bid 
as well as being responsible for the externalisation of the phospholipid 
phosphatidylserine (Section 1.6.2) and cleaving themselves (Martin et al, 1996; 
Srinivasula et al, 1996a; Srinivasula et al, 1996b; Vanags et al, 1996; Wolf and 
Green, 1999; Zimmermaim et al, 2001).
1.10 The Bcl-2 family and apoptosis
Members of the Bcl-2 family of intracellular proteins are essential regulators of 
apoptosis. The name Bcl-2 arose due to the identification of a gene which was 
isolated at the cliromosomal breakpoint of a t(14;18)- bearing human follicular B-cell 
lymphoma {bel) (Cleaiy and Sklar, 1985; Tsujimoto et al, 1985; Reed et al, 1987; 
Vaux et a l, 1988). Subsequently, Bcl-2 was identified as a mammalian homologue of 
the C. elegans gene ced-9, with both proteins found to have a regulatoiy role that 
suppresses apoptosis (Vaux et a l, 1992; Hengartner and Horvitz, 1994). Since then, at 
least 19 Bcl-2 family members have been identified in mammalian cells 
(Zimmermann et a l, 2001).
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1.10.1 The bcl-2 family members and their structure
Based on their structure and function, Bcl-2 family members have been divided into 
three distinct subfamilies (Table 1.6), namely the anti-apoptotic Bcl-2 subfamily 
(such as Bcl-2, B c1-xl , Bcl-w, Mcl-l, Boo and Al), the pro-apoptotic Bax subfamily 
(such as Bax, Bak and Bok) and the pro-apoptotic BH3-only subfamily (such as Bid, 
Bad, Bik, BIk, Bim, Noxa and PUMA), where BH means Bcl-2 homology (Daniel et 
al., 2003; Danial and Korsmeyer, 2004). DNA and protein sequence alignment 
analysis identified five homologous conserved a helical regions in Bcl-2 family 
members that are a requirement for flinction and protein-protein interaction, namely, 
four BH domains temied BHl, BH2, BH3, and BH4 (Gross et al., 1999; Antonsson 
and Martinou, 2000; Daniel et al., 2003; Danial and Korsmeyer, 2004), and a 
transmembrane domain critical for the targetmg of family members to intracellular 
membranes such as the outer mitochondrial membrane (Nguyen et al., 1993), the 
endoplasmic reticulum and the nuclear envelope, with most of the protein exposed to 
the cytoplasmic surface (Akao et al., 1994; Adams and Coiy, 1998; Antonsson and 
Martinou, 2000; Daniel et al, 2003; Danial and Korsmeyer, 2004) (Figure 1.9). 
Mutagenesis experiments revealed that the presence of BHl, BH2 and BH3 domains 
allow Bcl-2 proteins to foim heterodimeric complexes with family members and the 
presence of the BH4 domain permits the formation of homodimeric complexes with 
Bcl-2 (Adams and Cory, 1998). For instance, Bcl-2 (anti-apoptotic) heterodimerizes 
with Bax (pro-apoptotic) to inhibit apoptosis (Yin et al, 1994). However, mutations in 
both BHl and BH2 domains of Bcl-2 prevent this heterodimerization and abolish the 
cell survival inhibitoiy action (Yin et al, 1994).
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Bcl-2 family members Effects
Bcl-2 subfamily:
Bcl-2 Anti-apoptotic
B c1-Xl Anti-apoptotic
Bcl-w Anti-apoptotic
Bax subfamily:
Bax Pro-apoptotic
Bak Pro-apoptotic
Bok Pro-apoptotic
BH3 subfamily:
Bad Pro-apoptotic
Bid Pro-apoptotic
Bim Pro-apoptotic
Bik Pro-apoptotic
Table 1.6 Regulation of apoptosis by Be -2 family m em bers.
Bcl-2 subfamily
Bax subfamilycz Receptor Domain (Hydrophobic pocket)
BH3-only subfamilyI [
Pore 
Formation 
DomainI 1
Membrane
insertion
Domain
Bcl-2
Bcl-x,
CED-9
Bad
Bid
Bim
Bik
Figure 1.9 The Bcl-2 homology dom ains.
Representation o f the structure and subfamily classification o f the Bcl-2 protein 
members based on domain organization (not drawn to a representative scale). Bcl-2 
homology domains (BH) and transmembrane domains (TM) are labelled. All proteins 
are mammalian, except for CED-9 which is from C. elegans. Adapted from Kelekar 
and Thompson, (1998), Hengartner, (2000) and Zimmermann et al., (2001).
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Further, the elucidation of the structure of a B c I-Xl (anti-apoptotic) monomer revealed 
that it has BHl, BH2 and BH3 domains which are in close proximity and create a 
hydrophobic pocket that can accommodate a BH3 domain of a Bcl-2 family member, 
suggesting that requirements for dimerization by Bcl-2 family members are 
detennined by their BH domains (Gross et al., 1999). In addition, the BH3 domain 
serves as a critical death domain in pro-apoptotic members as mutation of this domain 
abrogates apoptosis (Daniel et al., 2003). This prompted the designation of tlie pro- 
apoptotic BH3-only subfamily, which possess only the BH3 domain (Wang et al., 
1996; Zimmermann et al., 2001). Based on the presence of BH domains, members of 
the Bcl-2 subfamily, which possess anti-apoptotic activity and protect cells from 
death, are characterised by having four BH domains (BH1-BH4) and a C-teiminal 
transmembrane domain (Hengartner, 2000; Daniel et al., 2003). In contrast, the pro- 
apoptotic Bax subfamily have just three domains (BH1-BH3) and are sometimes 
called the multidomain subfamily (Daniel et al., 2003; Newmeyer and Ferguson- 
Miller, 2003). In healthy cells, Bax exists as an inactive monomer widely distributed 
in the cytosol, however, upon activation it relocates and integrates into the outer 
mitochondiial membrane (through its transmembrane domain) where it then 
undergoes a conformational change and oligomerizes (Wolter et al., 1997; Hsu and 
Youle, 1998). Conversly to what was mentioned previously, members of the pro- 
apoptotic BH3-only subfamily heterodimerize (via their BH3 domain) with other Bcl- 
2 members which is essential for their pro-cell death activity (Adams and Cory, 1998; 
Daniel et al., 2003; Danial and Korsmeyer, 2004).
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1.10.2 Regulation of apoptosis by Bcl-2 family members
The Bcl-2 family regulate apoptosis by controlling the permeability of mitochondria 
and the release of cytoclnome c. Critical to the regulation is the subcellular location of 
Bcl-2 family members. Anti-apoptotic members Bcl-2 and B c1-xl reside in the outer 
mitochondrial membrane (wiüi the bulk of each protein facing the cytosol) and inhibit 
cytochiome c release and prevent apoptosis (Daniel et al., 2003). However, B c1-xl is 
also found localized in the cytosol, but redistributes to the mitochondria in response to 
apoptotie stimuli such as removal of smwival factors or death receptor activation. The 
pro-apoptotic Bcl-2 proteins such as Bid and Bad are localized in the cytosol but in 
response to a death stimulus translocate to the mitochondria. Here they bind to anti- 
apoptotic Bcl-2 family members such as Bcl-2 and B c1-xl , at the outer mitochondrial 
membrane. Subsequently, this interaction prevents Bcl-2 and B c1-xl from interacting 
and inhibiting the action of pro-apoptotic proteins such as Bax on mitochondria 
(Danial and Korsmeyer, 2004).
BH3-only proteins can also use their BH3 domain to promote apoptosis by 
translocating to the mitochondiia and interacting with pro-apoptotic proteins Bax and 
Bak. In healthy cells, Bax is present as an inactive monomer. However, during 
induction of the mitochondrial pathway it becomes activated and undergoes a 
conformational change which results in the redistribution of Bax from the cytosol, and 
oligomerization at the mitochondria (Daniel et al, 2003; Danial and Korsmeyer, 
2004). The oligomerization of Bax or the heterodimerization of Bax and Bak may 
lead to the fomiation of “pore channels” that are large enough for cytoclirome c to 
pass through from the outer mitochondrial membrane and into the cytosol. 
Cytoplasmic cytochrome c would then activate the adapter protein Apaf-1 which is 
complexed with procaspase-9 and dATP/ATP forming the apoptosome, which would
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in tui’n promote the activation of caspase-9 and subsequently a caspase cascade would 
ensue, ultimately leading to cell death (Shi, 2002b; Daniel et al, 2003; Danial and 
Korsmeyer, 2004) (Section 1.8.2). Anti-apoptotic Bcl-2 members may inhibit the pro- 
apoptotic activity of Bcl-2 members by suppressing their ability to oligomerize 
(Adams and Coiy, 1998; Wang, 2001; Waterhouse et a l, 2002; Degli Esposti and 
Dive, 2003; Danial and Korsmeyer, 2004; Donovan and Cotter, 2004) (Figure 1.10).
The elucidation of the three-dimensional stmcture of B c1-Xl in addition to showing 
that the BH domains can foim pockets also revealed that these proteins resembled the 
stmctuie of bacterial toxins such as diphtlieria which are laiown to insert into lipid 
bilayers and form channels capable of conducting ions (Muchmore et al, 1996; 
Budihardjo et a l, 1999). B c1-xl has been reported to form cation-specific channels in 
vesicles and lipid bilayers and Bax has also been reported to form anion-selective 
channels (Budihardjo et al, 1999).
1.10.2.1 Regulation via the permeability transition pore
Although cytochrome c release may occur through Bax or Bak channels, the 
activation of other channels has also been implicated in the release of this apoptotie 
mediator. As a key feature of apoptosis is the collapse of mitochondrial membrane 
potential (A'Tm) (Zamzami et al, 1995b; Zamzami et al, 1995a) (Sections 1.3.2 & 
1 .6 .2 ), it has widely been suggested that this collapse is due to the opening of a large 
conductance channel known as the mitochondrial peiineability transition pore (mPT 
pore) (Petit et al, 1996; Kroemer et a l, 1998; Crompton, 1999; Halestrap et al, 
2002). Although the exact stmcture and composition of the mPT pore are only 
partially defined, the channel is known to be formed from a complex of the voltage- 
dependent anion channel (VDAC), the adenine nucleotide translocase (ANT) and
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cyclophilin-D, which operate in concert at contact sites between the mitochondrial 
outer and inner membranes, and create a channel tlirough which molecules of < 
l.SkDa pass (Petit et al, 1996). The VDAC (located in the outer mitochondrial 
membrane) is permeable to solutes of up to 5kDa and allows the free exchange of 
respiratory-chain substrates such as NADH, FADH and ATP/ADP between the 
mitochondrial intermembrane space and the cytosol (Zamzami and Kroemer, 2001). 
In contrast, the IMM is impermeable, which is an essential feature in the generation of 
A'Pni- The chamiel is nonselective and upon opening of the inner membrane in 
response to stimuli such as oxidative stress, high calcium or low ATP concentrations, 
it permits the equilibration of ions of up to l.SkDa within the matrix and 
intermembrane space of mitochondria, causing the subsequent dissipation of the 
proton gradient across the inner membrane and uncoupling of the respiratoiy chain 
(Zamzami and Kioemer, 2001). Moreover, due to the hyperosmolarity of the matrix, 
opening of the mPT pore results in the dysregulation of mitochondrial volume which 
causes the matrix space to expand. This expansion of the matrix volume may then 
cause the rupture of the outer mitochondrial membrane, releasing apoptogenic 
proteins (such as cytochiome c) located within the intermembrane space into the 
cytosol (Zamzami et al., 1996; Kroemer et al., 1998; Kioemer and Reed, 2000). Bcl-2 
subfamily members as well as peptides derived from the BH4 domain have been 
reported to reduce the permeability of VDAC and prevent mPT (Zamzami et al., 
1996; Shimizu et al., 1998; Zamzami and Kioemer, 2001; Daniel et al., 2003). By 
contrast, Bax has been shown to promote mPT and induce apoptosis (Xiang et al., 
1996; Crompton, 1999; Daniel et al., 2003).
Doubt however, has been cast on the critical importance of mPT during apoptosis as it 
has been recently shown that mPT can proceed in the absence of an ANT (Kokoszka
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et al., 2004). Studies in single cells have also established that AYm loss during 
apoptosis generally follows cytoclnome c release (Waterhouse et al, 2001; De Giorgi 
et al, 2002). In addition, inhibition of caspase activation or cells lacking Apaf-1 has 
revealed that the rapid loss of A'Fm following cytoclnome c release depends on 
caspase activity (Bossy-Wetzel et a l, 1998; Waterhouse et al, 2001). Surprisingly, 
the low levels of cytochiome c that are dispersed throughout a cell during apoptosis 
have been found to be sufficient to maintain function of the electron transport chain 
and ATP synthesis in permeabilised mitochondria when caspase activity is inhibited 
(Waterhouse et a l, 2001). These findings have raised the possibility that in some 
systems mPT may not be required for mitochondrial outer membrane 
penneabilization or cytochrome c release.
1.10.2.2 Regulation via pre- and post-translational modifications
Dimerization by Bcl-2 family members suggests a model of regulation where the 
cellular susceptibility or threshold for apoptosis is partly influenced by the repertoire 
level of their expression (Oltvai et a l, 1993). Thus, the ratio of anti-apoptotic and pro- 
apoptotic Bcl-2 proteins is a cracial factor in the control of apoptosis and as such, the 
regulation of Bcl-2 family members is under tight control. One method of control 
involves the protein p53, a product of the tumour suppressor p53 gene. p53, a DNA 
binding protein that regulates the expression of genes involved in cell cycle arrest, is 
also known to regulate Bcl-2 family members such as Bax (Pietenpol and Stewart, 
2002; Downward, 2004). Activation of p53 by stimuli such as DNA damage induces 
the expression of Bax; this expression shifting the ratio in the direction of cell death. 
Increased Bax activation leads to increased Bax translocation to the mitochondria and 
the subsequent formation of Bax-Bax homodimers (more than can be sequestered by 
Bcl-2) which in turn leads to the release of cytochrome c and activation of Apaf-1.
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Other apoptotie targets of p53 that have been found to contribute to the release of 
cytochrome c from the mitochondria include p53AIPl (Oda et al., 2000b), Noxa (Oda 
et al., 2000a) and PUMA (Nakano and Vousden, 2001; Yu et al., 2001).
Regulation at the post-translational level can also occur. The BH3-only subfamily 
member Bad (pro-apoptotic) can heterodimerize with B c1-xl via its BH3 domain, and 
in by doing, displace Bax from B c1-xl . Free Bax is then able to forai Bax-Bax 
homodimers on tlie outer mitochondiial membrane through which cytochrome c may 
be released. However, upon activation of protein kinase B (Akt) by P13 kinase, Akt 
phosphoiylates Bad (Datta et al., 1997). Phosphorylated Bad is then sequestered in the 
cytoplasm by a protein designated 14-3-3 preventing it from binding to B c1-xl (Zha et 
al., 1996). Activation of calcineurin, a calcium-dependent phosphatase may shift the 
balance from anti-apoptosis to apoptosis. Calcineurin can de-phosphorylate Bad 
(Wang et al., 1999), causmg it to dissociate from 14-3-3, bind to B c1-xl , leading 
subsequently to apoptosis. During apoptosis mediated upon ligation of death 
receptors. Bid (BH3-only subfamily member) is proteolytically cleaved by active 
caspase- 8  to a pro-apoptotic fonn (tBid) from an inactive form. tBid then translocates 
from the cytosol to the mitochondria where it interacts with Bax to mediate a 
conformational change in the Bax N-terminus, which in turn leads to the release of 
cytochrome c and cell death (Desagher et a l, 1999; Martinou and Green, 2001). 
Hence, Bid activation results in cross-talk between the extrinsic death receptor 
apoptotie pathway and the intrinsic mitochondrial pathway, creating an amplification 
loop. Bid cleavage can also occur through a death receptor independent manner 
downstream of the mitochondria tlirough a caspase-3 and - 8  dependent mechanism 
(Belka et al, 2000). Non-caspase proteases such as granzyme B are also known to 
cleave Bid (Daniel et al, 2003).
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A reversal of the regulatoiy roles of BcI-2 members may occur due to post- 
translational modification. Anti-apoptotic proteins such as Bcl-2 and B c1-xl can be 
converted to pro-apoptotic molecules via cleavage of their N-terminal BH4 domain by 
the executioner caspase, caspase-3; this process in effect turning these Bcl-2 
subfamily proteins into multidomain (BH1-BH3) Bax subfamily proteins (Cheng et 
al, 1997b; Danial and Korsmeyer, 2004).
1.11 Non-Bcl-2 mediated regulation of apoptosis
Caspase- 8  activation can be regulated by a protein called cellular FLICE (FADD-like 
interleukin-1 (3-converting enzyme)-inhibitory protein (c-FLIP) which is recmited to 
the DISC. c-FLIP is a potent inhibitor, blocking the receptor-mediated apoptosis 
pathway upstream of caspase- 8  activation (Micheau et al, 2002). Thus far, although 
multiple splice variants of c-FLIP have been reported, only two forms designated c- 
FLIPl (long form) and c-FLIPg (short form), have been detected at the protein level 
(Krueger et al, 2001a; Kmeger et al, 2001b). c-FLIPs contains two DEDs whereas c- 
FLIPl, in addition to these domains, contains a C-teiminal domain that resembles 
caspase-8 , although this latter c-FLIP foim lacks protease activity due to the absence 
of several conserved residues, most notably the cysteine residue at the caspase active 
site (KiTieger et al, 2001a). In a healthy cell, both isofoims of c-FLIP may bind and 
dimerize with the adapter protein F ADD, procaspase- 8  or procaspase-10 via DED 
interactions and block the processing of procaspases at the DISC due to competition 
for DEDs (Irmler et al, 1997) (Section 1.8.1). Upon death receptor stimulation, rapid 
cleavage of the c-FLIP isoforms occurs inducing a conformational change in the 
proteins and weakening the interaction between them and the pro-caspases resulting
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in their dissociation from the procaspase zymogens (Kmeger et al, 2001a; Micheau et 
al, 2002) (Figure 1.10).
Another method of apoptosis regulation is mediated by the action of a family of 
proteins called inliibitors of apoptosis (lAP) proteins. lAPs were initially identified in 
baculovimses where they inhibit apoptosis in the host cell, thereby allowing time for 
viral replication (Crook et al, 1993). At least eight mammalian lAPs have been 
identified including, XIAP, cIAPl, cIAP2 and survivin (Deveraux et a l, 1997; Roy et 
al, 1997; Vaux and Silke, 2003). These proteins share common (one to three copies), 
approximately 80 amino acid residue motifs termed baculovirus lAP repeat (BIR) 
(Fesik and Shi, 2001; Shi, 2002a). In addition, these mammalian lAPs (except 
suiwivin) also contain a RING finger zinc-binding domain C-teiminal to the BIR 
repeats (Fesik and Shi, 2001; Shi, 2002a). XIAP, c-IAPl and C-IAP2 contain three 
BIR domains each, with these different domains exhibiting distinct functions. For 
instance, these lAPs are potent active-site inhibitors of the catalytically active effector 
proteases, caspase-3 and-7 but do not inhibit caspases-1, -6 , - 8  or -10 (Deveraux et al, 
1997). This is mediated by the linker region between the first and second BIR 
domains (designated BIRl and BIR2) which selectively targets caspases-3 and-7 by 
binding to the substrate grove of these caspases (Shi, 2001, 2002a). The bound lAPs 
adopt a reverse orientation as compared to that of a classic caspase substrate, thus 
blocking a native caspase substi'ates’ access to the active site (Shi, 2001, 2002a; 
Danial and Korsmeyer, 2004). By contrast, these lAPs interfere with the frinction of 
caspase-9 via an essentially different mechanism. The third BIR domain (BIR3) of 
these lAPs binds to inactive procaspase-9, thereby keeping this caspase in its 
monomeric state and preventing it fr om dimerizing and being processed to an active 
protease (Shi, 2001, 2002a; Danial and Korsmeyer, 2004). These differential effects
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show that lAPs can function in both the death receptor pathway of apoptosis and 
mitochondrial dependent pathway. This inliibitory effect by LAPs is relieved by the 
action of Smac/DIABLO (Section 1.8.2) which contains a four amino acid LAP 
binding motif located at the N-terminus of the mature protein and uses this to bind to 
the BIRl and BIR2 domains or the BIR3 domains on LAPs, thus releasing the 
sequestered caspases (Shiozaki et al., 2003; Vaux and Silke, 2003; OiTenius, 2004) 
(Figure 1.10).
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Figure 1.10 Apoptosis signalling pathways.
Two pathways activate the effector caspases, leading to apoptotic cell death. In the 
death receptor pathway, death receptor activation by death ligands results in the 
activation o f caspase-8 and the action o f both pro- (Bax) and anti-apoptotic (Bcl-2 
and Bcl-xi) proteins. In the mitochondrial pathway cellular damage (DNA damage) 
results in mitochondrial dysfunction and cytochrome c release into the cytoplasm. 
Binding o f cytochrome c to Apaf-I together with pro-caspase-9 (forming the 
apoptosome complex) subsequently leads to the activation o f caspase-9. Bid 
activation to truncated Bid results in cross-talk between the two pathways and also 
leads to the release o f cytochrome c into the cytoplasm. AIF and Smac/DIABLO are 
other apoptogenic proteins released from mitochondria. Caspase activation is 
regulated by the inhibitory effects of, c-FLIP and IAPs. Abbreviations: CD95L, CD95 
receptor ligand; FADD, Fas-associated protein death domain; c-FLIP, FLICE 
(FADD-like interleukin-1 ^ -converting enzyme)-inhibitory’ protein; lAPs, inhibitors o f 
apoptosis; Apaf-I, apoptotic protease-activating factor-1; AIF, apoptosis-inducing 
factor; Smac/DIABLO, second mitochondria-derived activator o f caspases/ direct lAP 
binding protein. Taken from Hengartner, (2000).
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1.12 Viruses and apoptosis
Viruses can trigger apoptosis tlirough host cell detection of viral proteins, by viral 
replication causing unscheduled activation of the cell cycle, or by T cell recognition 
of viral peptides presented on the surface of the cell which would signal the cell to die 
(Raff, 1998; Tschopp et al, 1998; Dockrell, 2001; Boya et al., 2003). As early 
apoptosis of an infected cell would reduce virus replication and spread, many vimses 
encode proteins that can either inhibit or promote apoptosis and which target different 
parts of the host’s apoptotic machineiy (Teodoro and Branton, 1997; Boya et al., 
2003; Boya et al., 2004). These apoptotic modulatoiy effects are also important in the 
context of persistent infections where vims mediated inhibition of apoptosis may 
allow vimses to have the ability to establish a latent persistent infection. In addition, 
these vimses may also stimulate apoptosis late in infection to aid in particle release 
(Hay and Kannourakis, 2002; Boya et al., 2003), and release within membranous 
blebs may prevent inflammatory reactions (Everett and McFadden, 1999; Roulston et 
al., 1999; LeGrand, 2000). Vims modulatoiy proteins may find application in therapy; 
helping to destroy tumour cells in cancer or prevent neuronal death in Alzheimer’s 
disease (Hay and Kannourakis, 2002).
Although there are many examples, a selection of vimses together with the apoptotic 
machineiy they target to induce or inhibit apoptosis is summarized in Table 1.7.
6 2
Selected examples of viruses and viral proteins that induce apoptosis
Mechanism Virus Protein References
Induction of Fas/TNF- 
induced apoptosis
Human immunodeficiency 
vims type 1 
Hepatitis C vims
Tat, gpl20 
core protein
(Westendorp et al., 1995) 
(Zhu et al., 1998)
Caspase activation Langat Flavivims 
Adeno-associated vims type 2 
Human immunodeficiency 
vims type 1
NS3
Rep78
Vpr
(Prikhod'ko et al., 2002) 
(Schmidt et al., 2000) 
(Selliah and Finlcel, 
2 0 0 1 )
Inactivation of Bcl-2 Alphavims
Human immunodeficiency 
vims type 1
E2
HIV-1
protease
(Grandgirard et al., 1998) 
(Strack et al., 1996)
p53 activation Hepatitis C vims
Adenovims
Human papillomavims
core protein
ElA
E2
(Yamanaka et al., 2 0 0 2 ) 
(Heise et al., 2000) 
(Desaintes et al., 1997)
Selected examples of viruses and viral proteins that inhibit apoptosis
Mechanism Virus Protein References
Inhibition of Fas/TNF- 
patliway
Bpstein-BaiT vims 
Molluscum contagiosum 
vims
Adenovims 
Equine herpesvirus 2 
Myxoma vims
LMP-I
MC159
E3-10.4K/E3- 
14.5K, E3-6.7K 
E8
M-T2
(Mosialos et al., 1995) 
(Hu et al., 1997)
(Benedict et al., 2001)
(Hu et al., 1997)
(Sclireiber et al., 1997)
Caspase inliibition Cow poxvims 
African swine fever vims 
Baculovims 
Cytomegalovirus 
Vaccinia virus
CrmA
A224L
p35
vICA
SPl-2
(Tewari et al., 1995) 
(Nogal et al., 2001) 
(Bump et al., 1995) 
(Skaletskaya et al., 2001) 
(Dobbelstein and Shenk, 
1996)
Bcl-2 homologues Epstein-BaiT vims 
African swine fever vims 
Human herpesvirus 8  
Adenovims 
Heipesvirus saimiri
BHRFI
A179L
KSbcl-2
E1B-19K
0RF16
(Henderson et al., 1993) 
(Brun et al., 1996) 
(Cheng et al., 1997a) 
(Boyd et al., 1994) 
(Nava et al., 1997)
p53 inhibition Hepatitis B vims 
Simian vims 40 
Adenovirus 
Human papillomavims
HBX
T-antigen
E4orf6
E6
(Wang et al., 1994) 
(Jiang et al., 1993) 
(Dobner et al., 1996) 
(Scheffiier et al., 1990)
Table 1.7 Selected examples of viruses and viral proteins that induce or inhibit apoptosis.
Abbreviations: Tat, trans-acting transcription factor o f HIV; Rep 78, adeno-associated virus type 2 required for replication protein; Vpr, viral protein R 
of HIV; HIV-1 protease, human immunodeficiency virus type 1 protease; LMPl, latent membrane protein I o f  EBV; MCI59, molluscum contagiosum 
virus 159; E3-I0.4K, transmembrane protein (lO.dkDa) in E3 region o f  the adenoviral genome; E3-I4.5K, transmembrane protein (I4.5kDa) in E3 
region o f the adenoviral genome; E3-6.7K, transmembrane protein (6.7kDa) in E3 region of the adenoviral genome; MT-2, myxoma virus 
transcriptionally active ORF; CiwA, Cowpox virus product cytokine response modifier A; A224L, African swine fever virus late structural protein; p35, 
baculovirus protein 35kDa; vICA, viral inhibitor o f  caspase-8-induced apoptosis o f  cytomegalovirus; SPI-2, serpin-like protein inhibitor; BHRFI, 
BaniHI H fragment rightward open reading frame I; A179L, African swine fever virus late structural protein; KSbcl-2, Kaposi's sarcoma-associated y 
herpesvirus Bcl-2 homologue; HBX, hepatitis B virus X  protein; T-antigen, transformation antigen; E4orf6, early region 4/open reading frame 6 o f  
adenovirus. Note- remaining proteins have no abbreviation.
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1.12.1 Enteroviruses and apoptosis
Currently, most of the investigations into enteroviruses and apoptosis have been 
carried out using polioviais (PV). However, as PV is a close relative of the 
enterovirus, Coxsackievims, fimctions found in PV are likely to be conserved in 
Coxsackievirus. Inhibition of PV replication in HeLa cells by guanidine treatment 
produces a classical apoptotic response (Tolskaya et al., 1995). However, PV also 
encodes functions that suppress apoptosis triggered by its own infection or by 
treatment with inhibitors such as cyclohexamide or actinomycin D (Tolskaya et al., 
1995). Thus it was suggested that when poliovims infection is restricted (such as 
inliibition of virus replication) apoptosis occurs, whereas under permissive conditions 
the implementation of an apoptotic program is suppressed by an anti-apoptotic 
function (Agol et al., 1998). It has been shown that the apoptotic response is triggered 
by the effects of the viral proteinases 3C^ ^^ ° and 2 A^ ™, which inhibit cellular 
transcription and cap dependent translation respectively (Barco et al., 2000; Goldstaub 
et al., 2000; Calandria et al., 2004). Coxsackievims B3 has also been found to induce 
apoptosis, which is mediated by the activation of caspases and can be inhibited by 
Bcl-2 or B c1-xl over expression (Carthy et al., 1998; Caithy et al., 2003; Cunningham 
et al., 2003). Further, PV infection has been found to down-regulate B c1-xl (anti- 
apoptotic) which would promote apoptosis (Calandria and Lopez-Guerrero, 2002). 
Despite an anti-apoptotic frinction being shown, the identity of the protein has 
remained unknown. However, it was shown that PV protein 3A inhibits TNF-induced 
apoptosis by inhibiting TNF receptor trafficking to the cell surface, although 3A’s 
role as an anti-apoptotic protein remains uncertain as it could not inhibit apoptosis 
initiated by Fas or staurosporme (Neznanov et al., 2 0 0 1 ; Neznanov et al., 2002).
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1.13 Aims and objectives of the study
Apoptosis in enterovirus infections has previously been described (Tolskaya et al., 
1995; Carthy et al., 1998), and has been attributed to both enteroviral proteins 3C^ ™ 
and 2A^ ™ (Barco et al., 2000; Goldstaub et al., 2000). Further, it has been shown that 
this apoptotic induction occurs via the activation of caspase-3 (Calandria et al., 2004). 
Interestingly, it has also been reported that the enterovirus, PV, encodes both pro- 
apoptotic and anti-apoptotic functions (Tolskaya et al., 1995; Tolskaya et al., 1996; 
Belov et al., 2003; Romanova et al., 2005). Yet, despite the elucidation of the pro- 
apoptotic functions, little is known about the identity of the anti-apoptotic functions. 
Due to World Health Organisation imposed limitations on PV use, we investigated 
whether the closely related Coxsackievirus B4 (CVB4), (a Coxsackievirus reported to 
induce apoptosis (Joo et al., 2002; Alin et al., 2003; Alin et al., 2004)) had anti- 
apoptotic function. The aims and objectives of this project were to;
1. Assess the effects in cultured cells of CVB4 infection on the key apoptotic 
organelle, mitochondria.
2. Assess apoptotic inliibitoiy effects induced by CVB4 in cultured cells.
3. Study the role of the executioner caspase, caspase-3, in an attempt to 
characterize the mechanism and pathway of apoptosis suppression resulting 
from CVB4 infection.
4. Identify the protein(s) that mediate any suppression and detennine their 
mechanism of action.
The initial hypothesis was that based on data suggesting that the enterovirus PV may 
have an anti-apoptotic function (Tolskaya et al., 1995), we believed that this apoptosis 
inhibitory fluiction may also be present in the closely related virus CVB4. This 
hypothesis was tested in the following sections.
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Chapter 2
2 GENERAL MATERIALS AND METHODS
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2.1 Introduction
General experimental procedures used thi'oughout this investigation are described 
within this chapter in detail. Specific methods used in a particular study are outlined 
in the appropriate results chapters. Where procedures used are modifications of 
previously reported methods, the original references are given.
2.2 Materials
2.2.1 Suppliers
All chemicals were purchased at the highest possible grade Analar or above.
Alexis Corporation Ltd, Nottingham, UK 
Staurosporine, SuperK/ï/erTRAIL^'^.
Ambion Ltd, Cambridgeshire, UK 
DNase 1, Ammonium acetate stop solution.
Amersham Biosciences pic (now pari o f GE Healthcare), Buckinghamshire, UK 
L-p^S]-methionine (>37 TBq/mmol), Redivue™ L-  ^S ] -methionine (>37
TBq/mmol), Hyperfilm™ MP, Sensitize™ Preflash Unit, Hypercassette'^'^.
Note: Procedures involving the use of radiochemicals were carried out in accordance 
with the guidelines set out in the ‘Local Rules for Protection against Ionising 
Radiation’, published by the University of Surrey Safety Office.
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Bachem, Biibendorf, Switzerland
Ac-Asp-Glu-Val-Asp-AFC (Ac-DEVD-AFC), AFC (only).
BD Bioscience (PharMingen), Oxford, UK
PE-conjugated monoclonal active caspase-3 antibody apoptosis kit, human anti- pro- 
caspase-3 monoclonal antibody (mouse)- for Western blotting and 
immunoprécipitation (catalogue no. 610322), human anti- active caspase-3 polyclonal 
antibody (rabbit)-for immunoprécipitation (catalogue no. 557035), human anti- active 
caspase-3 polyclonal antibody (rabbit)-for Western blotting (catalogue no. 551150).
Bio-Rad Laboratories Ltd, Hertfordshire, UK
Acrylamide/bis-acrylamide solution (40% w/v), Whatman 3MM filter paper, protein 
assay dye reagent.
Biostatus Ltd, Leicestershire, UK 
DRAQ5™.
British Drug House (BDH)/AnalaR Ltd, UK
Ammonium acetate, polyoxyethelenesorbitan (Tween-20), liquid paraffin, acetone, 
isopropanol, polyethylene glycol, ammonia, Triton X I00, sodium deoxycholate, 
butan-l-ol, sodium chloride (NaCl), p-mercaptoethanol.
Dako Ltd, Cambridge UK
Horseradish Peroxidase (HRP)-conjugated goat anti-mouse immunoglobulin, HRP- 
conjugated goat anti-rabbit immunoglobulin.
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Fisher Scîentifc International Co., UK
Ethanol, paraformaldehyde, methanol, D-Glucose, sucrose, glycine, potassium 
acetate, sodium hydroxide (NaOH), hydrochloric acid (HCl), acetic acid (glacial).
Invitrogen-Gibco, Paisley, UK
Minimum essential medium (MEM) with L-glutamine, Foetal bovine serum (FBS), 
non-essential amino acids (lOOx stock), methionine-free medium, 
penicillin/streptomycin, tiypsin-EDTA solution, sodium bicarbonate, Opti-MEM® 
RNase Zap.
Melford Laboratories Ltd, Suffolk, UK 
Agarose.
Merck Biosciences Ltd-Oncogene Research Products, Nottingham, UK
Annexin V kit -  5x binding buffer, media binding reagent, annexin V FITC and
propidium iodide.
Millipore, Watford, UK 
Immobilon^^ -P  nitocellulose membrane.
Molecular Probes Europe BV, Leiden, Netherlands
Tetramethylrhodamine ethyl ester (TMRE), 4',6-diamidino-2-phenylindole, 
dihydrochloride (DAPI).
New England Biolabs Ltd, Hertfordshire, UK 
Prestained protein marker (broad range)
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OxoidLtd, Basingstoke, UK
Phosphate buffered saline (PBS) tablets, bacto agar, bacto tiyptone, bacto yeast 
extract, nutrient broth.
Pharmacia Biotech, (now part o f GE Healthcare), Buckinghamshire, UK 
Coomassie brilliant blue (R250), dNTPs.
PIERCE (Perbio Science Ltd, Northumberland UK)
SuperSignal West Pico chemiluminescent substrate.
Promega Corporation, Southampton UK
Taq DNA polymerase, T4 DNA ligase buffer, T4 DNA ligase enzyme, lOx PCR 
buffer, buffer TE, restriction endonucleases Acc65 I, Sal I, Kpn I, Xba I, Spe I, 
Nuclease-free water, cell culture lysis reagent (5X), TNT® Quick Coupled 
Transcription/Translation System, 6 x gel loading buffer (blue/orange), lOObp DNA 
ladder, Ikb DNA ladder.
Qiagen Ltd, Crawley UK
QIAprep Spin Miniprep Kit, QIAquick gel extraction kit, Nuclease-free water, 
TransMessenger"^^ transfection reagent.
Roche Ltd, Lewes UK
T7 Cap Scribe, Complete, mini protease inhibitor cocktail tablets.
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Sigma-Aldrich Co. Ltd. Dorset, UK
Ammonium persulphate, actinomycin D, ampicillin, bovine semm albumin (BSA), 
dithiothreitol (DTT), ethidium bromide, isopropyl-beta-D-thiogalactopyranoside 
(IPTG), 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-gal), N, N, N, N- 
tetramethylethylenediamine (TEMED), Trichloroacetic (TCA), sodium acetate, eell 
eulture grade dimethyl sulphoxide (DMSO), trypan blue, sodium dodecyl sulphate 
(SDS), saponin, rotenone, succinic acid, malonate, sodium dithionite, 3-[(3- 
Cholamidopropyl)dimethylammonio]-l-propanesulfonate (CHAPS), chloroform, 4- 
(2-Hydroxyethyl)piperazine-l-ethanesulfonic acid (HEPES), oligomycin, Tris-base, 
[ethyleiiebis(oxyethylenenitrilo)]-tetraacetic acid (EGTA), ethylenediaminetetraacetic 
(EDTA), magnesium chloride (MgCb), magnesium chloride hexahydrate (MgCb 
(6 H2O)), potassium chloride (KCl), calcium chloride (CaCli), glycerol, bromophenol 
blue, RNase A, carbonyl cyanide 3-chlorophenylhydrazone (CCCP), mannitol, 
ethidium bromide, propidium iodide (PI), aprotinin, poly-L-lysine hybrobromide 
(MW 70,000-150,000), manganese chloride (MnCl2), protein A-sepharose.
Recombinant human active caspase-3 was a gift from Dr Don Nicholson (Merck 
Frosst, Canada).
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2.2.2 Plasticware
BD Biosciences, Oxford, UK 
50ml polypropylene tubes.
Greiner Bio-one Ltd, Gloucestershire, UK 
Cell scrapers.
Nunclon (Distributed through VWR International Ltd, Dorset, UK),
35, 60 and 90mm petri dishes, sterile inoculating loops, 6-well plates, 0.22-micron 
filters.
Scotlab Ltd, Strathclyde, UK
0.5ml and 1.5ml Eppendorf microcentriflige tubes.
2.2.3 Cell lines, bacteria and plasmids
BD Biosciences- Clontech, Oxford, UK 
Escherichia coli. strain DH5a.
European Collection o f Animal Cell Cultures (ECACC), Porton Down, UK 
HeLa cell lines, BGMK cell lines.
Promega Corporation, Southampton, UK
pGEM®-T Easy Vector, pGEM®-3Z Vector, Luciferase DNA template containing a 
T7 promoter.
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2.3 Solutions and Buffers
2.3.1 General
Phosphate buffered saline (PBS; Ix)
One tablet was dissolved in 100ml of milliQ water, autoclaved and stored at 4 °C. 
Eaeh 5g tablet contains 3,000mg/l NaCl, 200mg/l KCl, l,150mg/l Na2H? 4  and 
2 0 0 mg/lKH2PO4 .
Poly-L-lysine (for coating coverslips)
A working solution of lOOjig/ml was prepared in sterile milliQ water. 2ml of this 
solution was used to coat each well of 6 -well plates (Nunclon) at room temperature 
for 5 mill. The solution was then aspirated and each well washed onee with sterile 
milliQ water and dried at 37 °C for a minimum of 3 his.
2.3.2 SDS-PAGE solutions
Resolving gel buffer (AX2)
0.75 M Tris-HCl, pH 8 . 8
Tris base 45.3g
Made up to 500ml with milliQ water after adjusting pH to 8 . 8  with eonc. HCl and 
stored at 4 °C.
Stacldng gel buffer (BX2)
0.25 M Tris-HCl, pH 6 . 8
Tris base 15.12g
Made up to 500ml with milliQ water after adjusting the pH to 6 . 8  with eonc. HCl and 
stored at 4 °C.
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Acrylamide.Bis-Acrylamide, 40% stock 
Acrylamide 40g
Bis-aciylamide 1.08g
Made up to 100ml with milliQ water and stored at 4 °C (neurotoxin, disposable nitrile 
gloves should be worn).
Ammonium persulphate, 10% stock 
Ammonium persulphate 0.1 g
Made up to 1ml with milliQ water, stored at 4 °C and used within one week.
Sodium dodecyl sulphate (SDS), 20% stock 
Electrophoresis-grade SDS 20g
Made up to 100ml after adjusting pH to 7.2 with cone. HCl and filter sterilised using 
0 .2 2 -mieron filter.
Resolving and stacking gels:
These were prepared as in the following table:
Stock Solution Resolving Gel Stacking 
gel (4%)10% 12.5% 15%
MilliQ water 4.6ml 3.5ml 2 .1 ml 3.75
Resolving gel buffer (AX2) 1 0 ml 1 0 ml 1 0 ml -
Stacking gel buffer (BX2) - - - 5 ml
Aciykbis-aciylamide (40%w/v) 5ml 6 .2 ml 7.6ml 1 ml
20% SDS lOOpl lOOpl lOOul 50pl
10% Ammonium persulphate 2 0 0 pl 2 0 0 pl 2 0 0 i.ll lOOpl
TEMED 50pl 50ul 50pl 30pl
T le volume is sufficient for two mini gels
Table 2.1 Resolving and stacking gel volumes.
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2x Loading buffer
BX2 5ml
20% SDS 2ml
Glycerol 4g
P-mercaptoethanol 0.5ml
1 % bromophenol blue 0 .1 ml
Made up to 10ml with milliQ water.
SDS-PAGE rimning buffer, pH 8.12 
Tris base 3.02g
Glycine 14.44g
Dissolved in 995ml milliQ water before the addition of 5ml 20% SDS.
Coomassie stain (gel-staining dye)
Coomassie brilliant blue 1.25g
MilliQ water 325ml
Methanol 125ml
Glacial acetic acid 50ml
Gel de-staining solution 
MilliQ water 
Methanol 
Glacial acetic acid
325ml
125ml
50ml
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2.3.3 Western blot solutions
Transfer buffer
Tris base 3.02g
Glycine 14.4g
Dissolved in 800ml of milliQ water before the addition of 200ml methanol and stored 
at 4 °C before use.
lOx Tris buffered saline-Tween buffer (lOx TBS-Tween)
Tris base 48.4g
NaCl 160g
Made up to 1800ml with milliQ water after adjusting the pH to 7.6 with eonc. HCl 
and then 20ml Tween-20 was added before being made up to 2L with milliQ water 
and stored at 4 °C.
Ix Tris buffered saline-Tween buffer (Ix TBS-Tween)
MilliQ water 900ml
1 Ox TBS Tween 100ml
Membrane blocldng solution 
Non-fat powdered milk (Marvel) 5 g
Ix TBS-T ween 100ml
2.3.4 Microbial growth medium
SOB medium
Bacto tiyptone 20g
Bacto yeast extract 5g
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NaCl 0.5g
250mMKCl 10ml
Made up to IL with milliQ water after adjusting the pH to 7.0 with cone. NaOH. 
After sterilisation by autoclaving 5ml of sterile 2M MgCl2 was added.
2xYT medium
Bacto tryptone 16g
Bacto yeast extract lOg
NaCl 5g
Made up to IL with milliQ water and sterilised by autoclaving.
2xYT medium used for inoculations contained ampicillin (50pg/ml).
Agar plates
1.2g of Bacto agar was added to 100ml 2xYT medium and boiled to dissolve. The 
agar was then cooled to 50 °C before adding ampicillin. If required X-Gal and IPTG 
were added as follows: ampicillin stock solution (25mg/ml) was made up in milliQ 
water and added for a final concentration of 50pg/ml; 2% X-Gal stock solution was 
made in dimethyl formamide and used at 1:200; O.IM IPTG was dissolved in water 
and used at 1:400. IPTG was used as it induces the expression of the p-galaetosidase 
gene (lacZ) which reacts with X-Gal and produces a substance with a characteristic 
blue colour. Insertion of DNA fragments into the multiple cloning region (MCR) of 
plasmids that enable blue/white screening disrupts the lacZ gene alpha peptide that 
complements the defective lacZ in the host cells and as a result bacterial cells 
containing the recombinant plasmids will have a white appearance.
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2.3.5 Gel electrophoresis solutions
5 Ox TAE (Tris-acetate) buffer for DNA electrophoresis 
Tris acetate base 242g
Glaeial acetic acid 57.1
0.5M EDTA (pH 8.0) 100ml
Made up to IL with milliQ water.
Ix TAE buffer (for DNA electrophoresis)
MilliQ water 980ml
50x TAE 20ml
lOx TBE (Tris-borate EDTA) buffer for RNA electrophoresis
Tris base 107.8g
Boric acid 55g
EDTA (diNaiHiO) 9.3g
Made up to IL with milliQ water
Ix TBE buffer (for RNA electrophoresis)
MilliQ water 900ml
1 Ox TBE 100ml
2x TBE sample buffer 
lOx TBE buffer 
Glycerol 
MilliQ water
4ml
4ml
1 2 ml
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Then a small amount bromophenol blue dye and xylene cyanol FF dye was added for 
use as trackers in the electrophoresis procedure.
Agarose gel
Gels of the required percentage were made by dissolving the appropriate amount of 
agarose in Ix TAE buffer e.g. for a 1.2% (w/v) gel;
Agarose 0.6g
Ix TAE 50ml
for a 2 % (w/v) gel;
Agarose Ig
Ix TAE 50ml
Ethidium bromide
1 tablet (lOOmg) was dissolved in 10ml of milliQ water to give a final stock solution 
of lOmg/ml. For gel eleetrophoresis 2.5pl/50ml of melted agarose was added.
Agarose gel sample buffer 
6x gel sample buffer (blue/orange)
Jlcb DNA ladder (Marker) SOOng/pi 
DNA (lOOpg/ml) 20pl
6 x sample buffer 1 0  pi
MilliQ water 20pl
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2.3.6 Caspase activity solutions
Cell lysis buffer
Sucrose 864mg
NaCl 292mg
MgClz (6 H2O) 40.7mg
EGTA 190mg
HEPES 238mg
Made up to 100ml with milliQ water after adjusting pH to 7.0 with conc. NaOH and
stored at 4 °C.
Caspase assay buffer
HEPES 2.38g
Sucrose lOg
CHAPS O.lg
DTT 154mg
Made up to 100ml with milliQ water after adjusting pH to 7.25 with cone. NaOH and 
stored at 4 °C.
2.3.7 Radlo-immunoprecipitation (RIPA) solutions
RIPA buffer (O.lSMNaCl; O.OlMTris)
IMNaCl 30ml
IM Tris pH 7.4 2ml
Made up to 200ml with milliQ water.
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RIPA buffer + protease inhibitor solution
One Complete, mini protease inhibitor cocktail tablet (Roche) was dissolved in 10ml 
of RIPA buffer.
lOXRIPA detergent mix
Sodium deoxycholate lOg
Triton XlOO lOmls
Sodium dodecyl sulphate Ig
Made up to 100ml with RIPA buffer and dissolved by heating at 60 °C for 90 min.
2.4 General Procedures
All glassware, plasticware and solutions prepared for use in cell culture and nucleic 
acid procedures were sterilised using a Rodwell series 32 automatic autoclave. 
Sterilisation was carried out for 20 min at 121 °C at a pressure of 151b/in .^
Those methods routinely used in a number of procedures are described below and will 
be referred to when necessary.
2.4.1 Mammalian cell culture
Two mammalian cell lines were used during the course of this study:
HeLa cells
Human cervical carcinoma (ECACC no. 93021013) epitheloid cells that grow as 
monolayers continuously in culture. They were the first aneuploid, eontinuously 
cultui ed human cell line and are susceptible to a wide range of viruses.
8 1
BGMK cells
African buffalo green monkey kidney (ECACC no. 90092601) anchorage-dependent 
fibroblasts that grow continuously in cultuie. These cells are susceptible to a wide 
range of vimses including polio, echo, Coxsackie and reo vimses.
Culture
Both cell lines were grown in minimum essential medium (MEM), supplemented with 
10% (v/v) heat inactivated foetal bovine semm (FBS), 1% (v/v) penicillin 
(100U/ml)/streptomycin (lOOpg/ml) and non essential amino acids (lOOpM). 
Incubation of the cells was carried out at 37°C in a humidified atmosphere of 5% CO2 
in air. Once the cells formed a confluent monolayer, they were subcultured in the 
following mamier: the medium was aspirated and the cells were rinsed to remove 
semm-containing medium. Monolayers were rinsed in tiypsin-EDTA most of which 
was poured off and the cells were allowed to detach in the remaining liquid. Pre- 
waimed (37°C) MEM (10% FBS) was added to the detached cells and they were 
centrifiiged for 5 min at 1,500 rpm. The supernatant was then discarded. Both HeLa 
and BGMK cell lines, were split 1:10, by area of culture haiwested; all in fiesh MEM. 
The dilutions were added to new tissue culture flasks containing an appropriate 
volume of fi esh MEM.
2.4.2 Freezing of cell lines
Confluent cells were detached using tiypsin-EDTA and centrifiiged for 5 min at 
1,500 ipm. The cells were then resuspended in sufficient, pre-warmed (37°C) medium 
(90% (v/v) heat inactivated FBS, 10% (v/v) DMSO to give a final cell density of 4-6 
X 10^  cells/ml. 1ml aliquots of the resuspended cells were pipetted into ciyotiibes and
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frozen slowly to -70 °C overnight in an insulated box placed in the -70 °C freezer 
before transfer for storage in liquid nitrogen.
Cells were recovered from liquid nitrogen by rapid thawing of a frozen aliquot in a 
37°C waterbath. The cell suspension was then diluted with 10ml of MEM (pre­
warmed to 37 °C) and centrifuged at 1,500 rpm for 5 min to remove the DMSO. The 
cell pellet was resuspended in 5ml of growth medium, transferred to a small (T25) 
tissue culture flask and incubated at 37 °C in a humidified atmosphere of 5% CO2 in 
air. To ensure the complete removal of DMSO, after 24 hrs the medium was changed 
to remove DMSO that had difftised out of the cells overnight. The cells were then 
grown and subcultured (Section 2.4.1).
2.4.3 Cell counting
Cell density was determined by adding 200pl 0.4% trypan blue dye (w/v) in PBS to a 
2 0 0 |il cell suspension diluted as necessaiy to yield a countable number for analysis. 
Counting was carried out by adding a sample of the stained cell suspension onto a 
Neubauer Heamocytometer grid (Hawksley cristalite Neubauer). The number of cells 
present in the centre of the grid was then counted manually and the number of cells 
present per ml of cell suspension was calculated (the number of cells in the grid area 
multiplied by the dilution factor and multiplied by 1 0 , 0 0 0  gives the number of 
cells/ml).
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2.5 Viral culture techniques
2.5.1 Virus strain and growth
During the course of this study the vimses used were Mahoney strain of type 1 
poliovirus (designated as polio I), and Coxsackievims B type 4 (CVB4).
Polio I was propagated in BGMK cells. The cells were inoculated with virus 
(multiplicity of infection (m.o.i) of 50) and allowed to adsorb to the cells in a 37 °C 
incubator in a humidified atmosphere of 5% CO2 in air for 1 h, rocking gently eveiy 
10 min. This medium was then removed and replaced with medium identical to the 
growth medium (MEM) except that it was supplemented with 2% heat inactivated 
FBS instead of 10%. The inoculated cells were incubated for 24 hrs at 37 in a 
humidified atmosphere of 5% CO2 in air. After this period of incubation, virus 
propagation was complete and the vims was harvested by two cycles of ûeezing and 
thawing and a single cycle of centrifugation at 1,500 ipm -  to collect the vims- 
containing medium. Aliquots of this vims suspension were frozen at -70°C.
CBV4 was also propagated in BGMK cells and the same method as above for the 
creation of a vims stock was implemented. However, the inoculated cells were 
incubated at 37 °C for 48 his instead of 24 hrs (for polio I) since CVB4 replication is 
slower than PV replication, and this increased incubation period increased viral titre.
2.5.2 Virus titration (plaque assay)
For polio I and CBV4, the wells of 6 -well plates were seeded with 4 x 10^  BGMK 
cells in 2ml normal growth MEM and incubated at 37 °C in a humidified atmosphere 
of 5% CO2 in air until confluent. The vims stock was diluted 10'  ^ -  10'  ^ in PBSa (Ix
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PBS + 0.1 g/L CaCli). The incubation medium was then replaced with 0.2ml of virus 
dilution per well. PBSa (only) was used as a control. The vims was then allowed to 
adsorb by standing the plates for 1 hr at 37°C in a humidified atmosphere of 5% CO2 
and at 10 min inteiwals they were gently rocked. The wells were then overlayed with 
2ml of 0.8% agar (kept at 42°C) in MEM (double strength with 2% heat inactivated 
FBS) and allowed to set before being incubated for 2 days at 37°C in a humidified 
atmosphere of 5% CO2 . This period of incubation was followed by the addition of 
1ml to each well of the vital stain neutral red (300mg/ml). After 3 h the stain was 
removed and the dishes were replaced in the incubator for 1 h to fuither resolve the 
plaques. After this period the plates were removed from the incubator and the plaques 
counted. The plates were set up in duplicate and the viral titre was calculated in 
plaque-foiining units (pfii) per cell using the average number of plaques counted for 
the dilution.
2.5.3 Virus infection of cell lines
Monolayer cultures of HeLa cells were grown to confluence by incubation for 24-48 
hrs in normal growth medium. The cultures were then infected with either polio I or 
CBV4 (titrated in BGMK cells) at a multiplicity of infection of 15 pfu/cell in growth 
medium containing 2% (v/v) heat inactivated FBS instead of 10%. The vims was then 
allowed to adsorb by standing the culture flasks (or dishes) for 1 hr at 37 °C in a 
humidified atmosphere of 5% CO2 and at 10 min intervals they were gently rocked. 
The inoculum was then removed, and fresh normal growth medium was added. These 
cultures were then incubated at 37°C in a humidified atmosphere of 5% CO2 to allow 
the vims to grow as required. Mock-infection of cultures was carried out in a similar 
fashion but in the absence of vims.
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2.6 Flow cytometric analysis
HeLa cells were grown in 60 mm dishes (seeding density 1 x 10^  cells) and infected 
with CBV4 (Section 2.5.1). Mock-infected cell cultures were similarly prepared. At 
various times post-infection and post treatment, the culture media was removed from 
each flask, placed into universals and cultures were detached with 1.5ml of tiypsin- 
EDTA. Once the cells had detached, the cell suspension was then added to its 
respective universal (containing 2 % medium originally from the flask) to neutralise 
the enzyme. The cells were then centrifuged for 5 min at 1,500 rpm. The different 
binding and incubation conditions were performed according to the manufacturer’s 
protocol (Sections 4.4,4.5 and 4.7).
2.7 Immunoprécipitation
2.7.1 Preparing radiolabelled lysate
HeLa cells were grown in 35 mm dishes (seeding density 5x10^ cells/dish) and were 
labelled whenever required by the following procedure. At the selected time post 
treatment the inoculum was removed from the dishes and the cell sheet was gently 
washed 2 x in methionine (met) fi*ee medium and then incubated for 30 min in 2 mls of 
met free medium. After this period the cells were washed gently 2x in methionine-free 
(met-free) medium and incubated in a labelling mix which comprised 0 .5 mls of met 
free medium and [^^S]-methionine label (1.1 MBq/ml) before being incubated at 37°C 
for 90 min or longer. The labelling medium was then removed and the cell sheet was 
washed twice in ice-cold RJPA buffer. The cell sheet was then scraped into 360pl (per 
dish) ice-cold RIPA buffer + protease inhibitors (Pi) (in a chilled Eppendorf tube) and 
then 40pl of lOX RIPA detergent was added. Each tube was vortexed for 20 secs and
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then spun at 13,000 ipm for 30 min, 4 °C. The supernatant was aliquotted in lOOpl 
samples and stored frozen at -20 °C.
2.7.2 Immune Precipitation
One lOOpl aliquot of lysate was taken per precipitation, thawed on ice and lOpl 
aprotinin were added. Next, Ipl of monoclonal or polyclonal antibody (both in ascites 
fluid) was added to each lysate which was then mixed by hand and left to stand on ice 
for 45 min. After this period lOpl of protein A-sepharose (which had been swollen, 
washed x2 and resuspended in RIPA buffer to remove the dextran stabiliser) was 
added to each sample, mixed and kept on ice and mixed gently every 5 min for 1 h. 
The resin was then centrifuged (4°C 13,000rpm, 5 sec) to sediment the beads and the 
supernatant was then disposed of as radioactive waste. The pellet was washed 3x in 
1ml of RIPA buffer plus protease inhibitor and detergents, spinning briefly to pellet 
resin after each wash. After the final wash the pellet was resuspended in 20pl 2x SDS 
PAGE sample buffer, heated to 100°C for 5 min and 20 pi of sample was loaded per 
track on a polyacrylamide gel for electrophoresis until the dye-front reached the 
bottom of the gel (Section 2.8). The gel was then stained and destained (Section
2.8.2), dried down onto 3MM paper and exposed to X-ray film (Section 2.7.3).
2.7.3 Autoradiography
For autoradiography of [^^S]-methionine labelled samples on gels, Hyperfilm’^ '^  MP 
(Amersham Biosciences) was sensitized with a Sensitize™ Preflash Unit (Amersham 
Biosciences) to linearise response and improve sensitivity of detection, and placed 
over the dried gel in a film cassette (Amersham Biosciences). Exposure times varied 
depending on the procedure or the half-life of the radiation.
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2.7.4 Quantitation of radioactivity using scintillation
Scintillation experiments were caiiied out to determine the level of radiation 
incorporation in labelled cell lysates and the method used was as follows. 5 pi of 10% 
(w/v) TCA was added to lOpl of f  ^ S]-methionine radiolabelled sample in a LP3 tube 
and incubated on ice for 20 min. The mixture was then vortexed and the precipitate 
collected via vacuum by pouring the mixtuie through a Whatman GF/C glass fibre 
filter (Whatman pic), having pre-wet the filter with 1ml 10% TCA prior to adding the 
sample for vacuum filtration. The LP3 tube was then rinsed through the filter 2x with 
1ml 10% TCA and the filter rinsed once with 2ml of 70% ethanol. The filter was laid 
on a heating block and left to dry at 65°C for 30 min. After the incubation, the filter 
was added to a scintillation vial containing 5ml of Optiphase scintillation cocktail 
(PerkinElmer LAS Ltd) and counted in a Wallac model 1410 scintillation counter. 
The counts per minute (cpm) reflected the amount of radiolabel that was incorporated 
into the cells of each sample.
2.8 Separation of proteins in SDS-polyacrylamide gels
2.8.1 SDS-polyacrylainide-gel-elctrophoresis (SDS-PAGE)
The apparatus used was the Bio-Rad protein mini cell (Bio-Rad Laboratories. Ltd, 
UK). The proteins were separated on 10%, 12.5% or 15% resolving gels (Section
2.3.2). The gels were prepared and poured between clean mini-gel glass plates and 
were allowed to set for 10 min under an overlay of water-saturated butan-l-ol. The 
overlay was then discarded and the gel surface rinsed with water before poiuing the 
stacking gel and inserting a comb to fonn the wells for sample loading. Once the 
stacking gel was set, the comb was removed and the gel was assembled in its tank.
The central section of the tank was filled with running buffer and the outside was 
filled 1/3 of the depth of the tank. The samples were then loaded and the gel 
electrophoresed at lOOV for approximately 2 hrs. The samples were prepared by 
boiling them in 2x SDS-PAGE sample buffer for 5 min. After electrophoresis, the 
proteins were detected by Coomassie brilliant blue staining or were Western blotted.
For SDS-PAGE the marker used was the pre-stained broad range marker (New 
England BioLabs). Their sizes (Da) and sources were as shown in the following table:
Protein Source Molecular Weight (Da)
MBP-p-galactosidase E. coli 175,00
MBP-paramyosin E. coli 83,000
Glutamic dehydrogenase Bovine liver 62,000
Aldolase Rabbit muscle 47,500
Triosephosphate isomerase E. coli 32,500
P-Lactoglobulin A Bovine milk 25,000
Lysozyme Chicken egg white 16,500
Aprotinin Bovine lung 6,500
Table 2.2 The components of the SDS-PAGE marker.
2.8.2 Coomassie blue staining
The protein gel was rocked gently in a box containing stain solution for 30 min. The 
gel was then destained (Section 2.3.2) with successive changes of destain until the 
desired background had been achieved and the bands were clearly visible.
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2.9 Western blotting
2.9.1 Protein transfer
The proteins were separated by SDS-PAGE (Section 2.8) and the gel was equilibrated 
by soaking in three changes of transfer buffer (25inM Tris; 192mM glycine; 20% 
methanol) over a period of 15 min, before being transferred to nitrocellulose 
membrane (Immobilon'^’^ -P, Millipore) using a Semi-dry blotter (Trans-blot® cell, 
Bio-Rad Laboratories Ltd, UK) as per the manufacturer’s instructions. On the bottom 
electrode (positive) were placed in this order; four pieces of 3MM paper pre-soaked 
with transfer buffer, a piece of membrane soaked in transfer buffer, the gel (excluding 
all air bubbles and ensuring close contact with the filter and finally four more pieces 
of 3MM paper pre-soaked with transfer buffer. The top electrode was then placed on 
top (negative) and the gel was electroblotted at 15V for 30 min.
2.9.2 Immunostaining of Western blot
Proteins transferred onto a nitrocellulose membrane act as antigens that can be 
detected by visualising bound antibody. Detection of proteins is earned out by ECL 
(Enhanced Chemiluminescence, Pierce, UK), a light emitting non-radioactive method 
for the detection of specific immobilised antigens using a secondary antibody 
conjugated with horseradish peroxidase (HRP).
The Western blot was incubated in blocking buffer (5% diy milk in Ix TB S/Tween 
20) at 4°C for 2 hrs to saturate its binding capacity for any further protein. The blot 
was then incubated in primaiy antibody (diluted (with dilution volumes depending on 
antibody used) in 5% dry milk and Ix TB S/Tween 20) and rolled overnight at 4°C. 
After this period the blot was washed (3x 10 min) with IxTBS/Tween 20 to remove
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any unbound antibody, incubated in diluted secondary Ab-HRP and rolled at 4°C for 
1 h. The blot was then washed with IxTBS/Tween 20 (3x 10 min) and the proteins 
were detected by ECL using the HRP substrates A and B by National Diagnostics as 
per the manufacturer’s instmctions. The blot was drained, overlayed with equal 
volumes of substrates A and B (mixed together) and then left for 2 min. Excess 
solution was removed and the membrane was wrapped in cling film and exposed to 
X-ray film. Exposure times varied depending on the strength of the signal.
2.10 Cloning techniques
Standard methods were used (Sambrook et al., 1989) for DNA manipulations unless 
otlieiivise stated.
2.10.1 Polymerase chain reaction
Optimal conditions for amplification are dependent on the nature of the particular 
primer and target sequence used. Alteration of primer, dNTP or magnesium 
concentration, as well as the thermocycling protocol was sometimes required.
2.10, L I  PCR amplification o f DNA
A typical PCR reaction mix was made up by the addition of the following to a 0.75ml 
microfuge tube:
MilliQ water 60pl
1 Ox PCR buffer with MgCb 10pi
5mM dNTP mix 4pl
2BCstart (Section 5.10) (dil. 1:100 milliQ water) lOpl
2BCend or 2Bend (Scction 5.10) (dil. 1:100 milliQ water) lOpl
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Template DNA (2BCpus1000, Section 5.10) 5 pi
5 units of Taq DNA polymerase was then added and the reaction mix was overlaid 
with 30pl of liquid paraffin to minimise evaporation. The reaction mix was then 
incubated in a thermocycler incorporating 1 cycle of dénaturation (94°C, 5 min), 25 
cycles of denatuiation (94°C, 30sec), annealing (55 °C, 30 secs) and extension (72°C, 
VA min-2BC or 30 secs-2B), followed by a completion step (72°C, 10 min), before 
holding the temperature at 4°C. The PCR product was then checked on an agarose gel 
( 1.2%).
2.10.2 Purification of DNA
2.10.2.1 Ethanol precipitation
This method was mainly used to further purify and concentrate DNA prepared by 
mini and or midi-prep methods (Section 2.10.2.3 & 2.10.2.4). The volume of the 
sample was detennined and 1/3 volume 3M sodium acetate (pH 5.0) was added 
followed by 2.5 volumes 100% ethanol. The suspension was thoroughly mixed and 
left to stand overnight at -20 °C. It was then centrifuged (14,000rpm, 15 min), the 
supernatant discarded and the pellet washed once with 70% ethanol. The pellet was 
then left to diy on a heating block (37°C, 5 min) and was resuspended in an 
appropriate volume of buffer TE or Nuclease-free water (for RNA).
2.10.2.2 Phenol-chloroform extraction and ethanol precipitation
This method was mainly used to purify linearised DNA which was going to be used to 
make RNA. The method is as shown above (Section 2.10.2.1) except that before the 
addition of sodium acetate, the following steps were carried out:
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The volume of the sample was determined and increased to 100 pi with buffer TE. An 
equal volume of phenol-chloroform-isoamyl alcohol (24:1) was added and the 
suspension was mixed thoroughly and spun in a microfrige to separate the two phases. 
The upper aqueous phase was transfeiTed into a fr esh tube and 50pl of buffer TE was 
used to back extract the lower phase which was mixed thoroughly by vortexing and 
centrifugation. The resulting upper phase was transferred to the upper phase 
suspension which had previously been transferred into the fresh microfuge tube. This 
method then followed the method above (Section 2.10.2.1).
2.10.2.3 Small scale purification o f plasmid DNA (plasmid minipreps)
Purification of plasmid DNA from bacteria (Section 2.10.4.2) was earned out using 
the QIAprep Spin Miniprep Kit (Qiagen) as per the manufacturer’s instractions.
2.10.2.4 Large scale purification ofplasmid DNA (plasmid midipreps)
Large scale purification of plasmid DNA was carried out using the Qiagen 
HighspeedTf^ plasmid midi prep kit as per the manufacture’s instmctions. The DNA 
concentration was determined using a NanoDrop® ND-1000 Spectrophotometer.
2,10.3 Enzymes
2.10.3.1 Restriction enzyme digestion
Restriction enzyme digestions were earned out according to the manufacturer’s 
instmctions using the buffers provided by the manufacturer. The total reaction volume 
was adjusted as necessaiy according to the amount of plasmid DNA to be digested. 
For analysis puiposes, O.Spg of plasmid was digested in a lOpl reaction volume 
consisting of 6 pl of sterile milliQ water, Ipl of lOx enzyme buffer (supplied; 
Promega), Ipl of lOx BSA and 1 unit of restriction enzyme (Promega). The reactions
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were incubated at 37 °C for 2h and all of the reaction mixture was analysed by 
agarose gel electrophoresis; bands were detected by fluorescence using a UV 
transilluminator (UVI tec). Larger scale reactions and double digests for the 
preparation of fragments for ligation were also perfomied using lOpg of DNA in a 
50pl volume.
Enzyme Recognition Sequence Buffer
Kpn I GGTACVC J
Acc6S I GTGTACC D
Xbal TTCTAGA D
Sail GVTCGAC D
Spel ATCTAGT B
Xmn I GAANNTNNTTC B
Table 2.3 Restriction enzymes used in this study.
The recognition sequences and the reaction buffers used for optimum digestion. The 
symbol (Y ) indicates the cutting site.
2.10.3.2 DNA ligations
DNA ligations were performed using T4 DNA ligase. Vector DNA was appropriately 
digested, puiified and its concentration adjusted to lOng/pl. The ligation required a 
3:1 molar excess of insert DNA to vector. The following were added, along with the 
vector DNA in a microfuge tube stood on ice:
1 Ox ligation buffer 1 pi
25% polyethylene glycol Ipl
Insert DNA desired ng
MilliQ water made up to 10 pi
T4 DNA ligase 1 unit
94
The reaction mix was overlaid with 30pl liquid paraffin and incubated overnight at 
16°C. The ligation was stopped by the addition of Ipl 0.2M EDTA and further diluted 
by the addition of 9 pi of milliQ water. 7pl of the ligation mixtures were used for 
transformations (Section 2.10.4.2)
2.10.4 Growth and manipulation of bacterial cells
2.10.4.1 Preparation o f competent E.coli DH5
The host bacteria used throughout the cloning experiments were E.co/z strain DH5a 
made competent by the method described by Inoue and coworkers (Inoue et al., 
1990). Single colonies were used to inoculate 250ml of SOB medium and incubated at 
18°C with shaking until mid log phase (0 . 6  at ODgoo). The culture was then cooled on 
ice for 10 min and centrifuged (2,500rpm, 10 min, 4°C). The cell pellet was 
resuspended in 80ml of ice-cold transfonnation buffer (TB) (lOmM Pipes, 55mM 
MnCl2 , 15mM CaCl2 , 250mM KCl pH.7), incubated on ice for 10 min and 
centrifliged as before. The cell pellet was gently resuspended in 20ml TB and DMSO 
was added with gentle swirling to a final concentration of 7%. The suspension of cells 
was incubated on ice for 10 min before being aliquoted into 0.5ml pre-chilled 
cryotubes and immediately stored in liquid nitrogen. Prior to transformation the cells 
were thawed on ice.
2.10.4.2 Transformation ofDHSa E.coli competent cells
Transfonnation of competent DH5a cells was carried out as follows: Competent cells 
were allowed to thaw slowly on ice and 50 pi volumes transferred gently to pre 
chilled 1.5 ml microfiige tubes. 7pl of the ‘stopped’ ligation mixture or 0.5pg plasmid 
DNA was then added to the cells by moving the pipette tip through the cells as DNA 
was expelled. The mixture was allowed to stand on ice for 30 min before cells were
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heat shocked at 42°C for 45 secs in a heating block and placed on ice for another 5 
min. 2xYT (200pl) was added and the mixtme incubated at 37°C for 1 h to permit 
phenotypic expression. Aliquots of 65 pi were plated out onto antibiotic containing 
2xYT agar with or without IPTG as appropriate (Section 2.3.4) and plates were 
incubated at 37°C overnight. Well-isolated colonies were picked and minipreparations 
of plasmid DNA were made (Section 2.10.2.3) to screen for coixect constmcts. The 
colonies were transferred into 5ml 2xYT medium containing ampicillin (50pg/ml) in 
a capped 20ml sterile tube and incubated at 37°C overnight with shaking. For 
midipreps (Section 2.10.2.4), the transfoimed cells were added to 100ml 2xYT 
medium plus ampicillin (50pg/nil) and grown at 37°C overnight with shaking.
2.10.5 Agarose gel DNA electrophoresis
2.10,5.1 Gel electrophoresis
1.2 or 2.0% (w/v) electrophoresis grade agarose gels were made up in Ix TAB buffer 
(Section 2.3.5), dissolved by boiling and poured into flat-bed electrophoresis 
apparatus. Once set, the comb was removed and Ix TAB was added to tlie gel tank. 
Samples were mixed with 6x gel loading buffer and were loaded into wells of the 
agarose gel along with Ikb or lOObp DNA ladders. The gel was electrophoresed (4-6 
volts/cm) for various lengths (30-90 min) depending on the requirements for a small 
(50 X 70 mm) gel. Ethidium bromide was added in both dissolved agar and running 
buffer at a concentration of 0.5pg/ml. DNA bands were visualized using a UV 
transilluminator (UVI tec) and an image taken using the Gel documentation system 
(GDS) (UVP Imagestore 5000).
For RNA electrophoresis the same methods were employed as used for DNA 
electrophoresis except that Ix TBE buffer and 2x TBE sample buffer (Section 2.3.5) 
were used instead of Ix TAB buffer and 6x gel loading dye respectively.
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2,10.5.2 Gel purification o f digested DNA fragments
DNA was electrophoresed tlirough agarose gels as previously described (Section 
2.10.5.1). Fragments of DNA were puiified using the QIAquick Gel Extraction kit 
(Qiagen) as per the manufacturer’s instmctions. This method combines microspin 
teclmology and the selective property of silica-gel membranes to bind only DNA. 
DNA binds to the membrane while any contaminants pass through during 
centrifrigation.
2.10.6 Sequence analysis
The cloned plasmids (pGEM-T Easy-2B and pGEM-T Easy-2BC) were sequenced by 
Lark Technologies Inc. (Takeley, Essex, UK) using the ‘silver’ primer extension 
single reaction service and universal foiward (M13F) and reverse primers (M13R). 
Prepared samples contained lOOng/pl plasmid DNA in a total volume of lOpl.
2.11 Protein quantification
The protein concentration of cell lysates was assessed using the Bio-Rad DC protein 
assay (Bio-Rad Laboratories). The test is a dye-binding assay based on the differential 
colour change of the dye in response to different concentrations of protein (Lowry et 
al., 1951). The protein assay was earned out as described in the manufacturer’s 
instructions, with the optical density being measured at 750nm using a 
spectrophotometer (UVI 101 Biotech photometer; WPA). A blank sample of the dye 
without protein was mn to noimalise readings and several dilutions of the protein 
standard, bovine semm albumin (0.1-1.6mg/ml) were mn in parallel. The OD750
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values were plotted versus the concentrations of the standards, and the unknown 
protein concentrations were read from the standard curve.
2,12 Statistical analysis
Comparison of treatments against controls was made using Student’s unpaired t-test 
or one-way ANOVA using Bonferroni’s post-hoc test for multiple comparisons. The 
significance level chosen for the statistical analysis was p<0.05. The software package 
GraphPad Prism was used to cany out the analysis.
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Chapter 3
3 EFFECTS OF COXSACKIEVIRUS INFECTION ON 
MITOCHONDRIAL FUNCTION
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3.1 Introduction
Mitochondria are found in virtually all eukaiyotic cells and as the main producers of 
ATP through aerobic respiration, are essential to the nonnal life of animal cells. 
Paradoxically, mitochondria also play a central role in controlling the pathways that 
lead to cell death via apoptosis (Mignotte and Vayssiere, 1998).
ATP is generated by mitochondria through the mitochondrial electron transport chain 
(ETC) (Mitchell, 1961; Ernster and Schatz, 1981). As detailed in Section 1.3.2 and 
more clearly pictorially represented in Figure 3.1 (below), electrons flow through the 
ETC system to 0% (the terminal electron acceptor). This system is composed of four 
multi-subunit complexes (I-IV) and two mobile electron carriers (cytochiome c and 
ubiquinone). Electron transport through complexes I, III and IV is accompanied by 
the pumping of protons from the matrix to the intermembrane space, creating a 
membrane potential (ATm) and a pH gradient. ATP is produced by the reverse flow of 
the protons down this gradient from the inteimembrane space into the matrix 
generating energy to drive the FoFi-ATPase (complex V). The proteins that make up 
complexes I, III, IV and V are encoded in both nuclear and mitochondrial genomes 
and must be assembled in the mitochondrion. This necessitates smooth 
communications between compartments and coordinated gene expression from the 
two genomes (Poyton and McEwen, 1996). Abnormal ETC fiinctions (e.g. those 
resulting from chemical dismption or genetic defects), result in a deficiency in ATP 
generation, which may lead to cell death (Eguchi et al., 1997) or might conceivably 
affect cell function.
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Figure 3.1 The mitochondrial respiratory chain.
The mitochondrial respiratory chain consists o f complex I  (NADH Dehydrogenase), 
complex II (Succinate-Coenzyme Q Reductase), complex III (Coenzyme Q- 
Cytochrome c Reductase) and complex IV (Cytochrome c Oxidase). Electrons are 
carried from complex I  and II to complex III by the reduced form o f ubiquinone (UQ) 
and from complex III to IV by cytochrome c. These electron carriers are mobile and 
diffuse rapidly within the inner mitochondrial membrane. The generation o f ATP 
couples electron transport and oxidative phosphorylation via the transfer o f protons 
through complex V.
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Mitochondria store pro-death factors that can be released into the cytosol (Ki'oemer 
and Reed, 2000). These include apoptosis inducing factor (AIF) (Susin et al., 1999b), 
Smac/DIABLO (Du et al., 2000; Verhagen et al., 2000), Smac-related serine protease 
HtrA2 (Hegde et al., 2002; Verhagen et al., 2002), caspases (Yuan et al., 1993) and 
cytochrome c (Liu et a l, 1996; Kluck et a l, 1997). Their actions may lead to the 
induction of apoptosis via different mechanisms, such as DNA fragmentation (Susin 
et a l, 1999b), Ca^  ^ release (Demaurex and Distelhorst, 2003); collapse of 
(Waterhouse et a l, 2001); production of reactive oxygen species (ROS) (Chen et al, 
2003); and matrix swelling and outer membrane mpture (Vaiider Heiden et al, 2000).
The ETC itself influences some of these effects. ETC function is required for 
apoptosis induction by a variety of stimuli such as ceramide (Quillet-Maiy et al, 
1997), Ca^ "^  overload (Chauvin et al, 2001) and O2 deprivation (McClintock et al, 
2002). Respiration-deficient cells lacking a functional ETC are more resistant to 
apoptosis and complex I deficiency in leukaemic cells confers resistance to apoptosis 
(Kataoka et al, 1997).
Apoptosis may be viewed as a general defence mechanism against invading vimses 
because yields of any vims would be reduced by premature host cell death. Since this 
process is regulated by mitochondria, these organelles are logical targets for control 
by vimses. Vims infection of a vertebrate host cell sets up a dynamic inteiplay 
between the immune system and imiate resistance on one hand, and vims resistance 
strategies on the other. Infection by many vimses can trigger an apoptotic response. 
This usually reduces vims replication and consequently vimses have evolved 
mechanisms to block this process. Previously, only DNA viruses were thought to 
encode anti-apoptotic proteins; RNA viruses were believed to evade the consequences
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of apoptosis by rapid multiplication. However, in 1995 it was demonstrated that 
Poliovirus may encode both pro and anti-apoptotic functions (Tolskaya et al., 1995).
Disruption of active mitochondria is a distinctive feature of the early stages of 
programmed cell death and includes alterations to the oxidation-reduction potential of 
the mitochondria and changes in the AYm thought to result from the opening of pores 
in the mitochondrial membranes (Section 1.10.2.1). This allows ions and small 
molecules to pemeate through. The collapse of an ionic gradient decouples the 
respiratory chain leading to the release of cytoclirome c (Kroemer and Reed, 2000).
Since these mitochondrial changes occur early in apoptosis it seemed likely that anti- 
apoptotic effects would influence these processes. Previous work by others in our 
laboratoiy have shown that PV can affect mitochondrial fonction by inducing a 
decrease in cellular respiration (Koundouris et al., 2000). Consequently we wished to 
study mitochondrial fonction during infection by Coxsackievirus B4 (another PV-like 
agent) in order to detemiine whether this enterovirus may affect mitochondiia in the 
same way and also to gain a better understanding of the interactions between this 
vims, mitochondiia and apoptosis.
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Methods 
3.2 Measurement of total cellular oxygen consumption
Confluent HeLa cell monolayers were infected as previously described (Section
2.5.3). The cells were detached from flasks at different time points post infection by 
gentle scraping and resuspended in 0.5ml PBS (8x10^ cells/ml; coiTesponding to a 
density of 4.0 x 10^  cells in the chamber). The resuspended cells were then transfeiTed 
into a HansateclflM thennal-jacketed Clark-type oxygen electrode chamber (calibrated 
using sodium dithionite) maintained at 37°C, and the total cellular oxygen 
consumption was measured.
3.3 Assessment of mitochondrial electron tansport chain integrity
The integrity of the mitochondrial ETC was assessed in cells resuspended in a salt 
solution mimicking the intracellular environment (lOOniM KCl, 20mM NaCl, 0.5mM 
MgCli, 25mM Hepes, pH 7.2). HeLa cells were resuspended in 0.5ml (8.0 x 10*^  
cells/ml; corresponding to a density of 4.0 x 10^  cells in the chamber) of this salt 
solution before being transferred into the chamber of a Clark-type oxygen electrode 
and permeabilised by the addition of saponin (40pg/ml). Saponins are a gioup of 
naturally occurring plant glycosides which peimeabilise the plasma membrane 
without disturbing the mitochondrial frmction (Gennis, 1989; Kass et al., 1989). 
Penneabilisation was assessed using trypan blue (0.2% w/v), 90-95% of the cells were 
permeabilised under these conditions. Metabolic reagents were then used to supply 
electrons to complexes I and II (Table 3.1) or to inhibit electron flow through 
complexes I and III (Table 3.2). Successful electron supply should lead to increased 
electron flow along the chain to oxygen and thus an increase in oxygen consumption
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as measured in the oxygen electrode. A series of different concentiations were tested 
so that the most suitable working concentration of each supplement could be found.
3.4 TMRE-based flow cytometry to measure mitochondrial 
membrane potential using TMRE
HeLa cells were grown in 60 mm dishes (seeding density 1x10^ cells) and infected/ 
mock infected with CBV4 (Section 2.5.3) before haiwest with gentle scraping 
(Section 2.6). Cell pellets for each sample were resuspended in 1ml of PBS and Ipl of 
CCCP (lOmM) was added to the control sample, all were incubated for 3 min. 
Following this treatment, Ipl of the cationic lipophilic membrane permeable dye 
TMRE (50pM) was added in the dark to every sample except an unstained control. 
The samples were incubated at 37°C in a humidified atmosphere of 5% CO2 for 30 
min. Cells were sedimented (1,500 ipm, 5 min in a centurion centrifuge model no. 
1040D (Centurion Scientific Ltd. West Sussex, UK), the supernatant was discarded 
and the cells resuspended in 1ml of PBS. The samples were protected from light and 
processed immediately on a Beckman Coulter Epics XL flow cytometer (excitation 
549nm, emission 573nm). A minimum of 10,000 events were acquired in list mode 
and analysed using the FL-2 channel (575nm) to deteimine A'Pni changes.
3.5 Confocal microscopic analysis of mitochondrial membrane 
potential
HeLa cells seeded at a density of 2.5 x 10^  cells/well were grown on sterile Poly-L- 
lysine-coated 32mm x 32mm round coverslips (BDH) in 6-well plates. Poly-L-lysine 
aids cell attachment by enhancing electrostatic interactions between the negatively-
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charged cell membrane and positively-charged attachment surface (Leifer et al, 
1984).
Infected and control cells were harvested at various times post infection: In brief the 
media was removed and the cells were washed once with PBSa-g (PBS + CaCb - 
0.1 g/L) supplemented with D-Glucose (Ig/L). An appropriate volume of PBSa-g plus 
50iiM TMRE (excitation, 543nm; emission, 580 nm) and 50nM Mitotracker green 
(excitation, 490nm; emission, 515nm) was prepaied and 1ml added to each well and 
incubated at 37°C for 30 min (protected from light). The solution was removed, 
washed once with 1ml of PBSa-g and each coverslip was transferred to a Zeiss 
Perfusion Open and Closed (POC) cultivation chamber (which permits the exogenous 
addition of solutions to live cells growing on coverslips) (Pentz and Horler, 1992). 
1ml PBSa-g was added and the coverslip was analysed using a Zeiss LSM 510 META 
confocal microscope (excitation wavelength 488nm, argon laser line, Mitotracker; 
excitation wavelength 543nm He-Ne laser line, TMRE) and Zeiss multi-tracking 
software Version 3.2 SP2.
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Results
3.6 Oxygen consumption in HeLa cells
To investigate the effects of CVB4 infection on HeLa cell respiration, a Hansatech”^^ 
Clarke-type oxygen electrode was used. However, before this investigation could be 
carried out it was necessary to establish linearity of response in measured oxygen 
consumption and also to demonstrate that measured oxygen consumption was 
primarily due to mitochondrial activity. To determine tlie linearity of response, mock 
infected cells were counted and resuspended at different densities before their total 
oxygen consumption was measured (Section 2.4.4). A linear plot was produced 
indicating that an increase in cell number coiTcsponded to a proportionate increase in 
oxygen consumption. This is as expected due to an increase in the number of respiring 
cells (Figure 3.2).
To confimi that most of the cellular consumption of oxygen was due to the activity of 
mitochondria, Antimycin A (AA) (2pg/ml), an inhibitor of complex III in the ETC 
was used. On addition there was an immediate and total inliibition of oxygen 
consumption. This confiimed that mitochondrial activity was the principal (if not the 
sole) deteiminant of oxygen uptake under these conditions (Figure 3.3).
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Figure 3.2 Increase in ceil number results in an increase in oxygen consumption.
Various mock-infected HeLa cell densities were transferred into the chamber o f a 
Hansatech'^^ Clarke-type oxygen electrode and their basal rates o f oxygen 
consumption was monitored.
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Figure 3.3 Antimycin A blocks HeLa cell oxygen consumption.
HeLa cells (8.0 x 10  ^cells/ml) were transferred into the chamber o f a Hansatech^^ 
Clarke-type oxygen electrode and their basal rate o f oxygen consumption monitored 
before and upon addition o f AA (2pg/ml). Arrow indicates the addition o f antimycin 
A.
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3.7 PV blocks the mitochondrial electron transport chain
Previously Koundouris et al, (2000) had shown that PV infection of COS-1 and 
T47D cells led to a rapid decrease in total cellular respiration. This was attributed to 
inliibition of mitochondrial function at complex II. These findings were reproduced to 
demonstrate and confinn the correct functioning of the Hansatech™ Clarke-type 
oxygen electrode and extended to HeLa cells. ETC integrity was examined in PV- 
infected HeLa cells pemieabilised as described above and metabolic supplements 
providing electrons to complexes I and II (Table 3.1), and inhibitors of complexes I 
and III (Table 3.2), were added accordingly into the chamber.
Pyruvate (10 mM) -  Malate (1 mM) Combined to introduce electrons into 
complex I
Succinate (20 mM) An electron donor for complex II
Table 3.1 The metabolic reagents used to donate electrons to complex I and II of 
the respiratory chain.
Rotenone (2 pg/ml) Blocks complex I and hence prevents 
electron transfer from complex I to UQ.
Antimycin A (2 pg/ml) Blocks the chain at complex III between 
Coenzyme Q-Cytochrome c Reductase 
and Cytochrome c, thereby preventing the 
oxidation of NADH and succinate.
Table 3.2 The metabolic inhibitors used to block electron flow through complex 
I and III of the respiratory chain.
110
Addition of pynivate -  malate caused only a slight stimulation of oxygen 
consumption even in mock infected cells (Figure 3.4a). This is a common 
obseiwation, fhstly because pymvate -  malate are relatively weak electron donors and 
secondly because the intrinsic level of these substrates may be high in the cells 
anyway. However, rotenone led to an obvious reduction in electron transport 
suggesting that electrons were indeed flowing through complex I. This inhibition was 
subsequently overcome by the addition of succinate (which introduces elections at 
complex II) and this in turn could be blocked by AA which prevents onward 
transmission of electrons from complex III. These observations were similar in 
infected and mock-infected cells but over time the extent of succinate stimulation was 
observed to decrease in infected cells dropping by 45% at 4 hours post-infection 
(h.p.i) (Figure 3.4 a-c). Thus it was concluded that the system used here functions in 
the same way as that used by Koundouris et al., (2000) and that poliovims induces 
defects in HeLa cells similar to those reported in COS-1 and T47D.
Figure 3.4 Effect of polio I infection on the mitochondrial respiratory chain.
The results are shown below. HeLa cells were mock-infected (panel a), or virus- 
infected for 2h (panel b), or 4h (panel c) (Section 2.5,3). At 2 h and 4 h post-infection, 
the cells were resuspended in a salt solution that mimicked the intracellular 
environment, added to the chamber o f a Hansatech'^^ Clarke-type oxygen electrode 
and permeabilised with saponin (Section 3.3). Oxygen consumption by mitochondria 
was monitored following the addition o f pyruvate -  malate, rotenone, succinate and 
antimycin A (shown by arrows in this order left to right above each trace). For mock- 
infected cells, the respiration rates did not vary by more than 10% over a 4 h period. 
One experiment representative o f three independent experiments is shown.
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3.8 CVB4 does not inhibit HeLa cell respiration
The basal respiratory rates of HeLa (4.0 x 10^  -total cell number in chamber) cells 
following infection with CVB4 (m.o.i 15 pfu/eell) were monitored by measuring total 
cellular oxygen consumption in a HansatechT"  ^thermal-jacketed Clarke type electrode 
(Clark, 1960) (Section 3.2). Infection with CVB4 was found to cause no significant 
decrease in the cellular respiration of HeLa cells. The basal respiratory rate of HeLa 
cells was 31.1 ± 1.39 nM 0 2 /min/lO^ and this rate increased only slightly over a time 
course of 24 h (Figure 3.5). Although the respiratory rates for CVB4 infected cells 
were slightly lower than the respective moek-infeeted cell sample, this effect was not 
significant as statistical analysis of infected cell rates compared with mock infected 
gave a P > 0.05 against a significant difference. Microscopic examination showed that 
pronounced cytopathic effect (CPE) was not observed until 15 h.p.i. Further, analysis 
of the ETC following CVB4 infection of HeLa cells using metabolic substrates and 
inhibitors (data not shown), showed that infection with CVB4 had no affect on 
electron flow though the mitochondrial respiratory chain.
Mock-infected
Time (h)
Figure 3.5 CBV4 infection has no effect on HeLa cell respiration.
Confluent monolayers o f HeLa cells were infected with CBV4 and the basal rate o f 
oxy’gen consumption at 0, 4, 8, 12, and 24 h post-infection was recorded using a 
Hansatech^^ Clarke-type oxy’gen electrode (Section 3.2). Each time point represents 
the mean ± SE o f three independent experiments.
113
3.9 CVB4 promotes an increase in
Koundouris et a l, (2000) reported inhibition of electron flow at complex II of the 
mitochondrial electron transport chain, a finding which we have reproduced. 
However, these researchers also used TMRE staining in fluorescence microscopy to 
show that A'Pni actually increased despite this inhibition of respiration (Koundouris et 
al., unpublished observations). Our data above suggested that CVB4 might differ from 
PV in its effect on mitochondria and thus we sought also to determine its effect if any 
on AT^ m.
We adopted flow cytometiy as the instmment of choice in order to obtain greater 
sensitivity and an objective measuiement of any effects. This technique measures the 
A'Pni of mitochondria in individual cells since the level of fluorescence emitted by 
TMRE accumulating in mitochondria is proportional to the A'Pm (Scaduto and 
Grotyohann, 1999). Mitochondria were confirmed as the primaiy site of TMRE 
accumulation in this process by the addition of CCCP (10 pM). This is a 
protonophore uncoupler of mitochondrial respiration (Figure 3.6 pinlc histogram). 
CCCP caused the collapse of the AY^, which is detected as a shift of this pink 
histogram to the left relative to mock-infected TMRE treated cells which attain a 
finictional AYm (green histogram). This showed that CCCP caused the complete loss 
of TMRE from the mitochondria and ablation of AYm. HeLa cells were grown in 
60mm dishes, mock- or CVB4-infected and incubated in medium containing TMRE 
before flow cytometric analysis (Section 3.4). The results show that 4 h infected cells 
(black histogram) emit a lower level of TMRE fluorescence than that from mock- 
infected cells (green histogram) as shown by the leftward shift of the histogram for 
infected cells relative to mock-infected (Figure 3.6b). This suggests that at 4 h, the
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infected cells have a lower membrane potential. It should be noted that the height of 
the peak is representative of the number of events recorded, (the number of cells that 
passed through the sorter). Thus a large histogram peak is indicative of a high number 
of cells within that population.
However, by 8 h, the infected cells have a greater fluorescence intensity than their 
mock-infected controls as evidenced by a rightward shift in the histogram. This 
indicates that by 8 h CBV4 infection has brought about an increase in AYm over that 
in mock-infected cells (c). This increase in AY,n was still evident (although reduced in 
magnitude) at 12 h ( d )  but was abolished by 24 hrs (e). At this late time infected and 
control cells showed similar fluorescence intensities. Also at this late time we 
identified a low intensity peak amongst the cell population with markedly reduced 
AYnv This was interpreted as the appearance of apoptotic or necrotic cells and 
coincided with the observation of virus-induced cell death in culture.
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Figure 3.6 CBV4 Infection causes an increase in AYm
TMRE fluorescence o f infected and mock-infected cells was analysed using EXP032 
ADC and WinMDI softw>are. Cells were un-treated (blue), treated with TMRE plus 
CCCP (pink) or infected (black) or mock-infected (green) at 0 (a), 4 (b), 8 (c), 12 (d) 
and 24 h (e). One experiment representative o f three independent experiments is 
shown.
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3.10 CVB4 infection does not reduce mitochondrial membrane 
potential
The results described above imply that AYm was not only maintained but actually 
increased during CVB4 infection. However, an alternative explanation could attribute 
these obseivations to artefactual virus-induced redistribution of the dyes or to the 
possible reduction in the number of mitochondria per cell in virus infection; it was 
possible that infected cells might have lost the mitochondria from their cytosol due to 
plasma membrane damage. These potential effects were investigated using TMRE in 
combination with another fluorescent probe- Mitotracker green. Mitotracker green 
localizes to mitochondria independently of their AYm and its accumulation depends 
only on the number of mitochondria within a cell. TMRE localisation is AYm 
dependent and consequently, immunofluorescent examination of dual stained cells 
allows an assessment of the general appearance of the mitochondria and whether the 
observed mitochondria (from mock-infected or infected cells) have the ability to 
maintain AYm.
As illustrated (Figure 3.7), the mitotracker fluorescence channel shows that the 
mitochondria in CVB4 infected cells had a similar appearance to those of mock- 
infected cells over 24 hours. CVB4 infected cells also maintained mitochondrial AY^ 
(TMRE and merged panels). The white arrow represents the intensity profile of the 
merged image showing co-localisation of the dyes.
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Figure 3.7 CVB4’s maintenance of A'Fm correlates with morphologically and 
functionally homogeneous mitochondria.
HeLa cells were mock- or CVB4 infected at the times shown and co-loaded with 
Mitotracker green and TMRE. The merged panels together with the profiles illustrate 
the level o f co-localisation. The profile was generated by passing a white arrow 
through a respective cell in the merged panel. The green line in the profile represents 
the intensity o f mitotracker and the red line represents the intensity o f TMRE.
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3.11 Discussion
Some of the first evidence linking mitochondi'ia to the control of cell death came from 
the study of ETC inhibitors such as rotenone and antimycin A, in which use of these 
inhibitors lead rapidly to tlie induction of apoptosis (Wolvetang et al., 1994). The 
importance of the ETC was fliilher highlighted when loss of mitochondrial membrane 
potential was revealed to be an early indicator of the onset of apoptosis (Zamzami et 
al., 1995b; Zamzami et al, 1995a).
Host cell suicide provides a stiong selection pressure for viruses to develop anti- 
apoptotic mechanisms. Since mitochondria are central to apoptosis, virus-specific 
functions may target this organelle. The involvement of RNA vimses in this strategy 
has only recently been discovered and remains poorly characterised (Tolskaya et al, 
1995). In this chapter we have investigated whether CVB4 infection can affect the 
mitochondria and found that unlike PV infection, CVB4 has no significant effect on 
the electron transport chain (Figure 3.4 and 3.5); any effects on total cellular 
respiration were minor.
However, CVB4 targeting of mitochondria cannot be ruled out, and we have shown 
that infection leads to an increase in ATm from 4-12 h.p.i. This mimics the effects of 
PV since Koundouris (un-published observation) found similar events in PV infection 
even though electron transport was inhibited. It should be noted that an increase in 
fluorescence using TMRE depends primarily on the number of TMRE molecules 
sequestered by mitochondria. Thus, an increase in TMRE fluorescence should directly 
reflect an increase in However, TMRE has been shown to be influenced by dye 
proximity, and highly localized concentrations have been found to lead to
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fluorescence quenching (Metivier et al., 1998). Although at first sight unrelated to 
these findings, Shigesato et al., (1995) have reported swelling of mitochondria late in 
enterovirus infection. If occurring, this increase in organelle volume could influence 
TMRE fluorescence by altering the intermolecular proximity between TMRE 
molecules leading to an apparent increase in fluorescence even though membrane 
potential has not actually changed. However, previous work suggests that this is not 
the case. The probe tetraphenylphosphonium ion (TPP^, can be used to monitor 
AT^ m in cells radiometrically using the tritiated derivative of TPP^ in the absence of 
spectral interferences (Budd and Nicholls, 1996). In agreement with the TMRE results 
presented in this chapter, studies using the TPP^ system have found that in response to 
enterovirus infection of HeLa cells, an increase in TPP^ sequestration occurs (Lacal 
and Carrasco, 1982; Schaefer et al., 1982). Additionally, to avoid any chance of this 
effect we used a significantly lower concentration (50nM) of TMRE. At this level, 
dye quenching is not thought to be significant (Scaduto and Grotyohann, 1999).
Direct imaging of live mitochondria using dual labelling (TMRE and Mitotracker 
green) allowed us to eliminate the possibility that the A'Pm increase was due to trivial 
effects such as loss of mitochondria from the cell and broadly confirmed TMRE data 
from flow cytometry. The cell samples for this imaging were seeded on coverslips 
pre-treated with poly-L-lysine (Section 3.5). However, in this analysis we did not 
observe cells that had lost their AT'm at 24 h.p.i which were detected by flow 
cytometry. One possible explanation for this could be that these cells may have lost 
membrane integrity and may have been removed during the staining processes. 
However, those cells that maintained AT^ remained healthy possibly due to 
suppression of cell death by the virus.
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The results presented here suggested that although CVB4 infection of HeLa cells has 
no gross effect on cellular respiration, the vims does affect mitochondria in a more 
subtle way (by increasing ATm) and implies that CVB4 infection of HeLa cells may 
promote an anti-apoptotic effect. This hypothesis will be developed in the following 
chapters.
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Chapter 4
4 COXSACKIEVIRUS B4 INFECTION AND 
PERTURBATION OF THE APOPTOTIC CASCADE
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4.1 Introduction
We have shown that CVB4 infection of HeLa cells leads to an increase in 
mitochondrial membrane potential. As a decrease in ATm is an early indicator of 
programmed cell death, the opposite effect observed suggested that Coxsackieviruses 
may have the ability to modulate and oppose the onset of apoptosis.
Many vimses can trigger apoptosis. Since this can restrict infection it may be 
advantageous for the host as in baculovims infection for example (Clem and Miller, 
1993). However, it is becoming increasingly apparent that vimses have developed 
mechanisms to counter this infection limiting host response. Such mechanisms have 
been identified mainly in DNA vimses (Benedict et al., 2002). These have a large 
coding capacity and thus room to encode host modulation proteins. In contrast, RNA 
vimses were previously thought not to carry an anti-apoptosis gene; genome space is 
limited and rapid replication may allow these vimses to escape the consequences of 
host apoptosis. However, data now suggest that poliovims (PV) possesses both pro- 
and anti-apoptotic functions (Tolskaya et al., 1995; Koyama et al., 2001; Belov et al., 
2003; Romanova et al., 2005). Pro-apoptotic fiinctions arise early in infection and 
expression of proteinases 3C^ ™ and 2A^ ™ in the absence of vims replication results in 
the induction of apoptosis (Barco et al., 2000; Goldstaub et al., 2000). However, 
during active ongoing vims infection, the pro-apoptotic actions of these protems are 
inhibited by vims-specified anti-apoptotic functions. These anti-apoptotic functions 
also render infected cells resistant to non-viral apoptotic stimuli such as actinomycin 
D and cycloheximide (Tolskaya et al., 1995).
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The apoptotic pathway is very flexible and capable of responding to a wide variety of 
stimuli. Sensors for these triggers relay signals along converging routes into the 
intrinsic (mitochondria-dependent) pathway or extrinsic (death receptor) pathway. 
Wlien activated, intracellular sensors, like p53, propagate signals to the mitochondria 
via pro-apoptotic members of the Bcl-2 subfamily such as PUMA (BH3 only 
member) or as more recently found, can send this message alone (Chipuk et al., 2004; 
Chipuk et al., 2005); with the resulting effect subsequently leading to the 
oligomerisation of Bax in the outer mitochondrial membrane. This promotes the 
release of cytochrome c causing a decrease in the AT'm. Once in the cytoplasm, 
cytochrome c, and dATP/ATP bind to Apaf-I, which induces a confonnational change 
in Apaf-I and facilitates the binding of procaspase-9. The resulting apoptosome 
complex promotes the autocatalytic activation of procaspase 9 to caspase 9. Caspase-9 
then cleaves procaspase-3 to its active form, which, with other executioner caspases 
such as caspase-7 cleave key substrates in the cell leading to chromatin condensation 
and flagmentation, organelle disintegiation and eventually death. In contrast, the 
tumour necrosis factor (TNF) superfamily members act at the cell membrane by 
binding to and oligomerising death receptors such as FasL. This cross-linking of the 
receptor with its ligand recmits a signalling complex consisting of F ADD and pro­
caspase-8 or 10 (the DISC). These recmited pro-caspases are then activated and 
released into the cytosol. These then activate tlie main executioner caspases-3 and -7 
as above, setting the stage for death. In addition to activating caspases, this pathway 
has branches that signal to the mitochondi'ia, since activated caspase-8 tmncates Bid 
protein into its active form (tBid), which then translocates to the mitochondrial 
membrane and complexes with Bax promoting the release of cytochrome c in the 
same way as oligomers of Bax alone (see above). This establishes a link between
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intrinsic and extrinsic pathways and further highlights the central position of 
mitochondria in the regulation of apoptosis.
However, little is known about the molecular mechanisms by which RNA viruses 
interact with this signalling cascade and thus we sought to identify any anti-apoptotic 
function in CVB4 and determine its mode of action.
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Methods 
4.2 Phase contrast microscopic analysis of cellular morphology
To analyse any CVB4 induced CPE HeLa cells were grown in 60mm dishes (seeding 
density 1x10^ cells) and infected with CVB4 (Section 2.5.3) or mock-infected and at 
various times p.i. the cell samples were viewed under a phase contrast light 
microscope (magnification X200) to deteimine cellular morphology.
4.3 Fluorescence microscopic analysis of cell nuclei
To analyse changes in nuclear morphology following infection with CVB4, confluent 
monolayers of HeLa cells were grown on autoclaved Poly-L-lysine (Section 2.3.1 & 
3.5) coated 22mm x 22mm square coverslips (BDH) and infected (or mock-infected) 
with CVB4 (Section 2.5.3). At various times p.i. cells were treated with a 4% 
parafoimaldehyde fixative (2ml/coverslip) which was prepared as a 2x concentrate 
(8% w/v in 2x PBS), with stining on a heating block to dissolve and was diluted 1:1 
with milHQ water for use. After incubating the cells in this fixative at 4°C for 30 min 
they were washed once in PBS and stained with DAPI 14.3mM, (diluted 1:10,000 in 
PBS; 2ml/well) for 10 min at room temperature (protected from light). DAPI is a 
water-soluble cell-permeant dye that emits an intense blue fluorescence upon binding 
to dsDNA. The coverslips were mounted onto microscope slides (BDH) that 
contained a 50% (v/v) solution of glycerol and Ix PBS used as a vector shield. 
Stained cells were examined under UV light using a Zeiss Axiovert 135 fluorescence 
microscope (excitation wavelength >350nm; emission wavelength >460nm), 
magnification X400.
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4.4 Flow cytometric analysis of phosphatidylserine translocation
To analyse changes in the externalisation of the phospholipid phosphatidylserine to 
the outer surface of the cell plasma membrane (an early event in apoptosis) an 
Annexin V (a high affinity phospholipid binding protein) apoptosis detection kit, 
according to the manufacturer’s instructions (Merck Biosciences Ltd, Nottingham 
UK) was used. HeLa cells were grown in 60mm dishes (seeding density 1x10^ cells). 
Cells were treated as appropriately depending on the experiment, harvested as 
described in Section 2.6 and resuspended in 1ml Ix PBS. 0.5ml (5.0 x 10^  cells) of 
each suspension was transfened to a microfuge tube and centrifiiged at 1500ipm for 5 
min; pellets were resuspended in 0.5ml ice cold Ix binding buffer (5x binding buffer- 
as supplied diluted 1:5 in milliQ water) and 1.25pl Annexin V FITC (as supplied) was 
added and the samples were incubated at room temperature for 15 min (protected 
from light). Samples were centrifiiged at 1500rpm for 5 min and resuspended in 
0.5ml ice cold Ix binding buffer, followed by the addition of lOpl of the vital dye 
propidium iodide which was used to identify necrotic cells that had lost their cell 
membrane. Samples were placed on ice before analysis using a Beckman Coulter 
Epics XL flow cytometer (argon laser, excitation wavelength 488 nm). A minimum of
10,000 events were acquired in list mode while gating the forward and side scatters to 
exclude cell debris and analyzed in FLl (FITC detector, 518nm) and FL2 (PE 
detector, 620nm).
4.5 Flow cytometric determination of DNA content
A typical feature of apoptosis is the fragmentation of DNA. To analyse this in cells 
using flow cytometiy, this study was performed by a modified procedure from 
Nicoletti et al., (1991). HeLa cells, mock- or CVB4 infected at various times p.i. were
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harvested as in Section 2.6, pelleted and fixed in an ice-cold solution of 70% (v/v) 
ethanol: 30% Ix PBS by gradual addition whilst vortex mixing and incubated at 4°C 
overnight. This gradual vortex mixing technique rendered all samples suitable for 
analysis as heavily clumped cells were readily separated by the processing. The 
samples were centrifuged at 2,500rpm for 5 min and pellets incubated in 1ml Ix PBS 
supplemented with lOpg/ml propidium iodide and 1 mg/ml RNase A for 30 min at 
37°C (protected from light). Analysis was carried out using a Beckman Coulter Epics 
XL flow cytometer (argon laser, excitation wavelength 488nm). A minimum of
10,000 events were acquired in list mode while gating the forward and side scatters to 
exclude propidium iodide-positive cell debris and analysed in FL-3 (PI detector, 
620nm) for the appearance of cells in the sub-Gl region.
4.6 Confocal microscopic analysis of mitochondrial membrane 
potential during apoptosis
In order to directly determine the effect of apoptosis induction on in CVB4 
infected cells, HeLa cells were mock-infected or CVB4 infected, before STS 
treatment. Cells were then stained with Mitotracker green and TMRE as previously 
described (Section 3.5). The method was followed as in Section 3.5 except that 
before the staining step a mock-infected cell sample was incubated with Ipl of the 
A'Fni loss-inducing dmg, CCCP (lOmM).
4.7 Flow cytometric analysis of caspase-3 activation
The activation of caspase-3 was followed by flow cytometric detection of HeLa cells 
immunostained for active caspase-3 using a monoclonal antibody specific for the 
active form of caspase-3 and which has no reaction with procaspase-3; a procedure
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previously reported (Macanas-Pirard et al., 2005). This was supplied as a kit by BD 
Bioscience, Oxford, UK and used according to the manufacturer’s instructions. HeLa 
cells were grown in 60mm dishes (seeding density 1 x 10® cells) and treated as 
appropriate to the experiment. Cells were haiwested as in Section 2.6, washed twice 
with 1ml Ix PBS and resuspended in 0.5ml Cytofix/Cytoperm (20 min on ice). 
Samples were centrifiiged at 1500ipm for 5 min, the supernatant discarded and the 
cell pellets washed twice with 0.5ml Perm/Wash buffer (to permeabilise the cells) at 
room temperature. Finally, cell pellets were resuspended in Ix Perm/Wash buffer 
supplemented with PE-conjugated anti-active caspase-3 antibody and incubated for 30 
min at room temperature to stain the activated en2yme. After staining, excess 
antibody was removed by washing the cells once with Perm/Wash buffer before 
resuspension in 0.5ml Perm/Wash buffer for analysis. Samples were analysed using a 
Beckman Coulter Epics XL flow cytometer (argon laser, excitation wavelength 
488nm). A minimum of 10,000 events were acquired in list mode, while gating the 
forward and side scatters to exclude cell debris, and analyzed in FL-2 (PE detector, 
575nm) for neo-epitope appearance.
4.8 Analysis of caspase-3 activity
To assess the activity of caspase-3 in HeLa cells under various conditions, a 
fluorogenic substrate linked to a DEVD (Asp-Glu-Val-Asp) caspase-3 recognition 
sequence was used. HeLa cells, treated accordingly, were harvested by gentle 
scraping and washed once with Ix PBS. Each sample was resuspended in 30pl lysis 
buffer (Section 2.3.6) and cells were dismpted by three cycles of snap-freezing and 
thawing. Cell debris was removed by centrifugation at 14000 rpm for 30 min (4°C) 
and supernatants were assayed for protein content using a Bio-Rad protein test kit
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according to the manufacturer’s instructions (Bio-Rad Laboratories Ltd, 
Hertfordshire, UK). 80 }ig of sample protein was assayed for DEVDase activity with 
20jiM Ac-DEVD-AFC in caspase assay buffer (Jones et al., 1998) (Section 2.3.6). 
Cleavage of this substrate releases AFC (7-Amino-4-trifluoromethylcoumarin), 
yielding a measurable fluorescent signal which can be detected using a SpectraMAX 
Gemini XS fluorescence microtitre plate reader (Molecular devices, Wokingham UK) 
at an excitation wavelength of 355nm and an emission wavelength at 538nm. 
Readings were taken at 5 min intervals over a 60 min period at 37°C for each sample 
generating a curve for the release of AFC. The slope of the curve was used to measure 
the rate of release of AFC and this was then expressed as pmol AFC released/min/mg 
protein, using AFC standards of known concentration to generate a standard cur ve. In 
some experiments, cell extracts were prepared from mock- or virus-infected cells and 
combined with recombinant active human caspase-3 (0.3pg/ml), to investigate the 
effect of viral proteins on caspase-3 activity.
4.9 Confocal microscopic analysis of cell nuclei
HeLa cells were grown and treated for fixation as previously described (Section 3.5). 
However, for this analysis the wells were washed once with PBSa (Ix PBS + CaCb - 
0.1 g/L) following removal of the 4% paraformaldehyde fixative before staining with 
DRAQ-5 in PBSa (lOpM; 1 ml/well) for 3 min at 37°C (protected from light). DRAQ- 
5 is a pure synthetic compound which binds to DNA with a high affinity, and permits 
the direct visualization of apoptotic cells. Cells were washed once with PBSa and then 
mounted as previously described (Section 3.5). Stained cells were viewed under a 
Zeiss LSM 510 META confocal microscope using a 633nm HeNes laser line.
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Results
4.10 CVB4 infection does not induce apoptosis early in infection
Under non-permissive conditions e.g., when complete vims replication is suppressed 
by the use of a drug such as guanidine-HCl, poliovims infection leads to the clear 
induction of apoptosis (round and highly condensed nuclei and foimation of apoptotic 
bodies). However, under fully productive conditions these changes are suppressed and 
cells die instead from a characteristic necrotic CPE consisting of deformed and 
elongated nuclei with partial chromatin condensation (Tolskaya et al., 1995; 
Romanova et al., 2005). In our experiments, and under pennissive conditions, CVB4 
induced an increase in mitochondrial membrane potential early in infection. This 
might reflect an anti-apoptotic action similar to that seen in poliovims. For this reason 
it was essential to deteimine whether apoptosis was being induced by the vims and 
held in check, or whether it was simply not being induced at all.
CVB4-infected HeLa cells were monitored by phase contrast microscopy. Rounded 
cells appeared by 12 h.p.i (Figure 4,1) and increased by 24 h.p.i. Although typical 
enteroviral CPE is the prominent feature of infection, this was only largely seen by 24 
h.p.i and this examination alone could not exclude induction of apoptosis in some 
cells. We sought specific evidence for apoptosis (foimation of rounded small bleb like 
chromatin- apoptotic bodies) /necrosis (defoimed and elongated nuclei) by examining 
cell nuclei using DAPI staining. Figure 4.2 shows that by 8 h.p.i CVB4-infected cells 
showed no signs of cell death at all and cells appeared similar if not identical to mock 
infected controls. However, by 12 h.p.i (and to a much greater extent, by 24 h.p.i), 
features of necrosis were visible: cells shrank slightly and chromatin became 
elongated and was redistributed towards the peripheiy of the cell (shown as red
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arrows), with a proportion of cells showing signs of apoptotic body formation (white 
arrows). Although many cells showed signs of CPE a sub-population of cells with 
intact nuclei could also be observed (Figure 4.1).
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Figure 4.1 Morphological changes of HeLa cells during CVB4 infection.
HeLa cells were mock-infected or infected with CVB4 and at the times shown 
analysed by phase-contrast light microscopy. Magnification X200.
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Figure 4.2 CVB4 does not trigger apoptosis during early permissive infections.
HeLa cells were mock-infected or infected with CVB4 and at the times shown, fixed  
with 4% paraformaldehyde and stained with DAPI. The nuclei were visualized by 
fluorescence microscopy and photographed. CPE is shown by distortion o f  the nuclei 
and cell shrinkage (indicated by red arrows) and apoptotic cells are indicated by 
white arrows. Magnification X400.
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4.11 Effect of CVB4 infection on plasma membrane integrity
The previous data suggests that in common with poliovims (Tolskaya et a l, 1995), 
CVB4 induces cell death by necrosis and any tendency to induce apoptosis is 
controlled, since apoptosis was only apparent during the latter stages of vims 
replication and not during the early period. In order to investigate this control further 
we sought evidence for early events in the apoptotic cascade.
One such marker is the translocation of phospholipid phosphatidylserine (PS) from 
the inner to the outer leaflet of the plasma membrane. This exposes PS on the exterior 
of the cell where it may be recognised by phagocytes that then engulf apoptotic cells. 
However, in vitro ^ we can use this effect as an early marker for the onset of apoptosis 
and monitor its progression using the rapid high affinity phospholipid-binding protein 
annexin V (AV) which combines with PS. The distribution of AV may be monitored 
conveniently if this protein is conjugated to Fluorescein isothiocyanate (FITC). 
Addition of this protein to intact cells probes for the cell surface exposure of PS, 
however in the later stages of apoptosis the cell’s plasma membrane becomes leaky 
and AV can also react with PS on the internal surface. Thus it is important to 
distinguish AV reaction with intact cells (indicative of early apoptosis) from its 
reaction with peimeable cells which may indicate a late apoptotic or necrotic event. 
This distinction can be made using propidium iodide (PI) to stain DNA. This dye 
cannot pass tlnough intact plasma membranes and thus intact cells show no DNA 
staining (Venues et al, 1995).
Staining of CVB4-infected HeLa cells with both AV and PI confirmed that apoptosis 
had not commenced by 4 h.p.i. Neither membrane nor DNA staining was evident and
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there was no significant difference between mock-infected and infected cells in the 
AV and PI quadrants (bottom right and top right quadrants respectively) (Figure 4.3). 
By 8 h.p.i the percentage of intact cells (AV-/PI-, bottom left quadrants) had 
decreased from 92.5% (4 h.p.i) to 83.4% (8 h.p.i) and the percentage of apoptotic 
(AV+/PI-, bottom right quadrants) cells had increased from 4.6% (4 h.p.i) to 9.7% (8 
h.p.i). No such changes occuiTed in mock-infected cells. Interestingly, by 12 h.p.i the 
percentage of healthy (AV-/PI-) cells had not changed significantly although the 
percentage of early apoptotic (AV+/PI- ) cells had decreased by 5.7% and the 
percentage of late apoptotic - necrotic cells (AV+/PI+ ) had increased by 4.1%. This 
increase in double positive cells (presumably dead or nearly dead) increased further 
by 24 h.p.i, but again only a slight decrease in the percentage of double negative 
(healthy) cells occurred. This finding suggests that a few cells that developed early 
apoptotic features progressed to late apoptosis and death but the bulk of the 
population remained viable. This could be explained by the production of an anti- 
apoptotic function by the virus, although it should be stressed that the increase in the 
percentage of double positive cells after 12 h.p.i (and more pronounced by 24 h.p.i) 
may comprise both apoptotic and necrotic cells. Thus we used another test (Section 
4.12 below) to confirm these results.
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Figure 4.3 Effect of CVB4 replication on HeLa cell membrane integrity.
Mock- and CVB4- infected cells were incubated with Annexin V-FITC and PI at the 
times shown. Annexin V-FITC vs. PI binding was analysed by flow cytometfy and are 
shown as dot plots o f fluorescence staining. One experiment representative o f four 
independent experiments is shown.
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4.12 Confirmation of apoptotic induction in CVB4 infected cells
Fragmentation of DNA into oligonucleosomal subunits is a typical feature of 
apoptosis and an irreversible and late (downstream of PS externalisation) event that 
commits the cell to die (Kroemer et al., 1998; Liu et al., 1998). Although 
condensation of the chromatin, pyknosis and apoptotic body formation are late stage 
apoptotic events (as previously analysed Figure 4.2) to Anther confirm the apoptosis 
results found previously using another independent test, mock and CVB4 infected 
HeLa cells were fixed, stained with propidium iodide (PI) and analysed for DNA 
content by flow cytometry (Section 4.5). Correlating with the previous findings, the 
data show that only by 24 h.p.i did cells show clear signs of apoptosis (Figure 4.4). 
Again, confiiming the previous results, the proportion of apoptotic cells (sub-Gl 
position in the histogram) during the early stages of infection have a similar DNA 
content to those of the respective mock sample.
4.13 Confirmation of nuclear morphology in CVB4 infected cells
The results from previous data show that following CVB4 infection, during the early 
replicative phase, a decrease in mitochondrial membrane potential occurs (Figure 
3.6). This is indicative of an early event in apoptosis and this is also confirmed in 
Figure 4.3, since during this early replicative period a small percentage of cells 
revealed external exposure of PS. However, the reduction in mitochondrial membrane 
potential was short lived and soon returned to a similar degree as those from mock- 
infected cells (although slightly higher) (Figure 3.6). Further, although those cells 
with PS exposuie may progress to cell death there was no observable induction of 
apoptosis in the infected cell population until 24 h.p.i (although CPE was observed by
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12 h.p.i) (Figures 4.2 and 4.4). These findings suggest that CVB4 may induce 
apoptosis but that soon afterwards additional virus effects block the progression of 
this process in all but a few of the cells infected. Data also suggest that this anti- 
apoptotic function may be active between 8 and 12 h.p.i. As the TMRE result in 
Section 3.9 showed that the A'Fm increase for infected HeLa cells was higher at 8 
h.p.i than at 12 h.p.i and that this high increase (at 8 h.p.i) was found to be maintained 
at 10 h.p.i (data not shown), it was important to address at what time point this 
putative anti-apoptotic function may be greatest. This was necessary since if CVB4 
encodes a viral anti-apoptotic function the longer the virus has to replicate the greater 
the amount of this ftinction would be present (e.g. more of the function at 10 h.p.i. 
than 8 h.p.i). Thus to investigate this further the nuclear morphology of HeLa cells at 
10 h was analysed to determine whether a CPE type of cell death was present as found 
at 12 h.p.i (Figure 4.2) or whether anti cell death function was still maintained as seen 
at 8 h.p.i (Figure 4.2). As Figure 4.5 (panel b) shows, no signs of cliromatin 
condensation in CVB4 infected cells at this time could be observed; with the cells 
showing a similar nuclear appearance to the mock-infected sample (panel a).
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Figure 4.4 Effect of CVB4 replication on DNA fragmentation.
Mock- and CVB4- infected cells were fixed stained with PI and analysed for DNA 
content by flow cytometry at the times shown. Each histogram represents the mean 
±SE o f three independent experiments. The positions o f the apoptotic cells (Sub-Gl) 
are marked.
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Figure 4.5 CVB4 does not trigger apoptosis between 8 and 12 h.p.i.
HeLa cells were mock (a) or infected (b) with CVB4 for lOh, fixed with 4% 
paraformaldehyde and stained with DAPI. The nuclei were visualized by fluorescence 
microscopy and photographed. Magnification X400.
4.14 Anti-apoptotic effect o f CVB4 infection in HeLa cells
Many mechanisms exist that oppose apoptosis. Shimizu et al., (1996), showed that 
loss of can be prevented by the cell’s own anti-apoptotic protein, Bcl-2. The 
mode of action of this protein in regulating ATm to control apoptosis is poorly 
understood but it is known to oppose the loss of A'Fm caused by apoptotic inducers 
(Shimizu et al., 1998). Similarly, PV infection confers resistance to HeLa cells and 
protects them against the apoptosis-inducing stimuli cycloheximide and actinomycin 
D. We sought similar protective effects in CVB4 infection by comparing the 
susceptibility of infected and mock-infected cells to an apoptosis inducer. Efficacy of 
the stimulus was assessed by examining the cells for alterations in mitochondrial 
membrane potential and PS exposure. As ATm studies on CVB4 infected HeLa cells 
showed that between 8 and 12 h.p.i an increase in A4^ m occurred, and PI staining had 
considerably increased by 12 h.p.i compared with the 12h mock-infected sample
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(Figure 4.3), this suggested that any anti-apoptotic period may be downstream from 
this 12 h.p.i time point. Thus, HeLa cells were infected for 2, 4 and 6 hrs before they 
were challenged with staurosporine (STS) for 4 Ins. STS is an antibiotic produced by 
the bacterium Streptomyces staurosporeus that induces apoptosis by inhibiting protein 
kinases (Kabir et al., 2002). 4 h of dmg treatment was chosen so that we could 
kinetically monitor any suppressive changes during a total of 6 h to 10 h infection, 
thereby monitoring suppression before the 8 h.p.i time point in which we saw an 
increase in ATm and monitoring it after this time to identify the ‘di'op off period for 
any suppressive effect. Before these experiments were conducted, flow cytometric 
analysis with TMRE and dye exclusion assays using tiypan blue were carried out to 
assess the drug concentration required to induce AT^ m reduction within 4 hrs without 
conferring loss of membrane integrity. The concentration determined was 0.5pM. At 
this concentration, tiypan blue permeable cells were less than 5% after 4 hrs of diirg 
treatment and thus we were confident that annexin V measurement of PS exposure 
would assess external PS rather than that on the inner leaflet
As Figure 4.6 (panel a) clearly shows, HeLa cells infected for 2 h or 4 h before STS 
treatment for 4 h had a similar percentage of apoptotic cells as compared to the mock- 
infected 4 h STS treated sample. However, when HeLa cells were infected with 
CVB4 for 6 h prior to treatment, there was a significant suppression in the extent of 
apoptosis induction by STS; with no greater suppressive effects seen with longer 
infection times (data not shown). The number of cells with PS exposed was reduced 
from 34.4% ±3 .7  in mock-infected cells treated with STS to 11.3% ± 2.7 in CVB4- 
infected cells exposed to the inducer of apoptosis (p<0.001) (panels b and c). Further 
(as shown in these same panels), in addition to having a significantly reduced 
apoptotic (AV+/PI-) population, in CVB4 + STS treated cells there was a significantly
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greater percentage of non-apoptotic (AV-/PI-) compared with mock-infected STS 
treated cells. Taken together, this data showed that CVB4 infection of HeLa cells did 
have an anti-apoptotic function conferring resistance to the apoptotic effects of STS. 
Moreover, the data showed that this suppressive effect occurred in a time dependent 
manner as only cells infected for 6 h prior to challenge with STS for 4 h could 
suppress apoptotic induction by STS.
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Figure 4.6 CVB4 confers an anti-apoptotic state to infected HeLa cells.
a) HeLa cells were infected for 2 h, 4 h and 6 h before treatment with STS (0.5 pM) for 
a further 4 h or mock infectedfor 6 h followed by treatment with STS for 4 h. The cells 
were then incubated with Annexin V-FITC and PI as previously described (Section 
4.4). Each bar shows the % non-apoptotic cells (AV-/PI-) (black bars) or the 
combined % o f early and late apoptotic cells (A V+/PI- plus A V+/PI+ respectively 
(grey bars)), b) (below) shows representative quadrants o f the 10 h experiment in a), 
c) (below) shows Statistical analysis o f the non-apoptotic (AV-/PI-), early apoptotic 
(AV+/PI-) and late apoptotic (AV+/PI+) population o f cells from the 10 h 
experiments in b). All data are the mean + SD o f three-four independent experiments 
and were analyzed for the difference from mock-infected cells (a, p<0.001) or the 
difference from mock-infected STS treated cells (b, p<0.001).
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4.15 Maintenance of mitochondrial membrane potential in CVB4 
infected STS treated cells
Since the data have shown that CVB4 infection of HeLa cells can suppress the 
translocation of PS from the imier to the outer leaflet of the cell membrane in the 
presence of STS, and the anti-apoptotic protein Bcl-2 has been shown to suppress the 
loss of A'Pni induced by apoptotic stimuli (Shimizu et al., 1998), we next tested 
whether the CVB4 anti-apoptotic ftinction could also maintain ATm in the presence of 
the apoptotic inducer, STS. Using confocal microscopy to directly view live cells. 
Figure 4.7 shows that addition of CCCP (a protonophore uncoupler of AYm) totally 
abolishes AW  ^ shown as a loss of TMRE staining, since TMRE stains the 
mitochondria in response to a ftmctional AY^; mitotracker green stains mitochondria 
independent of AYn, maintenance. HeLa cells treated with STS also showed a loss of 
TMRE staining as apoptosis promotes a collapse of AYm due to a loss of 
mitochondrial membrane integrity. However, infection of HeLa cells for 6 1ms prior to 
the addition of STS for 4 hrs was able to promote the maintenance of AYm as shown 
by TMRE staining and co-localisation between the two dyes. This result ftuther 
confirms that CVB4 has anti-apoptotic function at this time period.
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M ocklOh 
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Mitotracker TMRE Merged
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Figure 4.7 CVB4 infection can maintain AYm during apoptotic induction.
HeLa cells were mock- or CVB4 infected and treated with STS as indicated, before 
being co-loaded with Mitotraker green and TMRE. A mock-infected cell treated with 
CCCP prior to incubation with Mitotraker green and TMRE was used as a control. 
The merged panels illustrate the level o f co-localisation.
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4.16 Maintenance o f nuclear morphology in CVB4 infected STS 
treated cells
AnnexinV and TMRE provide a monitor of early apoptosis. In order to see if these 
effects also extended to the induction of late apoptotic events we examined nuclear 
shrinkage and chromatin condensation in CVB4 infected cells challenged with STS. 
These changes are later stage events in the apoptotic cascade. As clearly shown, HeLa 
cells treated with STS for 4 hrs showed nuclear shrinkage and the formation of 
apoptotic bodies (Figure 4.8 panel a). In contrast cells infected with CVB4 for 6 hrs 
before challenge with STS for 4 hrs (panel b) showed few of these signs of apoptosis
Figure 4.8 CVB4 infection suppresses STS induced nuclear destruction.
HeLa cells were mock infected and treated with STS (0.5pM) for 4 h (a) or infected 
for 6 h before challenge with STS for 4 h (b). Cells were fixed with 4% 
paraformaldehyde and stained with DAPI. The nuclei were visualized by fluorescence 
microscopy and photographed. Apoptotic cells indicated by round and highly 
condensed nuclei and apoptotic body formation are indicated by arrows. 
Magnification X400.
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4.17 CVB4’s anti-apoptotic function does not prevent caspase-3 
activation
Most of the morphological changes (Figure 4.6) observed during the apoptotic 
process are mediated by caspases (Section 1.7). Central to the execution of apoptosis 
is the activation of caspase-3, which like other members of the caspase family is 
initially present as an inactive proenzyme. In apoptotic cells these proenzymes are 
processed by self-proteolysis or cleavage by another protease. Given that activation of 
this execution caspase-3 from its initial 32kDa proenzyme to a heterodimer of 17 and 
12kDa subunits occurs towards the end of the activation cascade, a decrease in the 
activation of this caspase would reflect an upstieam interference with the apoptotic 
machineiy. We therefore examined the activation of this key caspase in mock- and 
CVB4 infected HeLa cells challenged with STS. Caspase-3 activation was assessed 
by flow cytometiy using a phycoerythrin (PE)-conjugated anti-active-caspase-3 
antibody (Section 4.7). This antibody only recognizes the cleaved active pl7/p20 
fragments but does not measure the activity of the caspase-3 it detects. Previous data 
(Section 4.14) showed that infection of HeLa cells for 6 hrs before dmg addition for 4 
hrs (10 h total infection) could protect HeLa cells from apoptotic cell death. As 
analysis was always carried out only after the addition of STS (for 4 hrs) to cells pre­
infected for 6 hrs, it was possible that anti-apoptotic flmction could be active not just 
at 10 h.p.i (6 h.p.i then 4 Ins STS) but could be apparent anytime between 6-10 h.p.i. 
Thus, infected cells were challenged with STS from 6 h.p.i. and sampled at hourly 
inteivals over 4 hrs; the final time point being the period at which anti-apoptotic 
flmction has previously been observed (6 h.p.i plus STS 4 h - 10 h total infection).
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Surprisingly, analysis of the histograms (Figure 4.8) demonstrates that cells infected 
with CVB4 for 6 his and then challenged with STS for 1 h (i.e. 7 h infection incl. 1 h 
STS histogram) showed a greater activation of caspase-3 (5.2%) than cells treated 
with 1 h STS alone (2.6%); difference of 2.6%. A similar finding was observed in 
cells infected for 6 hrs and treated with STS for 2 his (i.e. 8 h infection incl. 2 h STS 
histogram- (10.6%)) compared with 2 h STS alone (7.6%); difference of 3%. The 
extent of this increase was reduced at 9 h; 9 h infection incl. 3 h STS histogram (24%) 
compared with 3 h STS alone (23.6%); difference of 0.4%. At the time point when 
anti-apoptotic suppression has been shown (10 h infection incl. 4h STS), this period 
was shown to have a slight reduction in the activation of active caspase-3 over the 4 h 
STS treated sample alone. However, this reduction can not account for the large 
suppressive effects found for PS externalisation. Therefore, our results demonstrate 
that the execution of apoptosis was prevented by CVB4 in spite of the apparently 
noimal activation of the apoptotic machineiy.
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Figure 4.9 CVB4 infection suppresses little caspase-3 activation with STS.
Mock-infected HeLa cells were treated with STS (0.5jliM) or carrier solvent (DMSO) 
or infected before treatment with the drug at the times shown. The samples were then 
immunostained with a PE-conjugated active caspase-3 antibody and analysed by flow  
cytometry. Each histogram represents the mean ±SE o f four independent experiments. 
The positions o f the apoptotic cells (Ap) are marked. No significant difference was 
found for the data presented above.
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4.18 CVB4’s anti-apoptotic function induces direct suppression of 
caspase-3 activity
Although the result in Section 4.17 showed that CVB4s anti-apoptotic function could 
not be attributed to an inhibition in the activation of caspase-3, this clearly posed a 
problem since activation of this key effector caspase should bring about apoptosis in 
the cell, but this was not happening in this system. However, processed caspases are 
not necessarily always catalytically active since the processing and activation of 
caspases are known to be under the control of “inhibitor of apoptosis proteins” (lAPs). 
These are a family of proteins that bind to and inhibit caspases directly (Deveraux et 
al., 1998) and were originally identified in baculovirus infection where they were 
responsible for the suppression of apoptosis observed in that system (Clem et al, 
1991; Clem and Miller, 1994).
To ftilly detennine whether modulation of caspase-3 had any role in the anti-apoptotic 
function of CVB4, investigation of caspase-3 activity in the infected cells was 
required. Accordingly, HeLa cells were either mock- or CVB4 infected before 
treatment with STS. Lysates were prepared and incubated with the fluorescent 
caspase-3 substrate Ac-DEVD-AFC. This mimics the known caspase-3 cleavage site 
(DEVD). This substrate would also detect active caspase-7, although with lower 
affinity. As shown in Table 4.1, pre-infection of HeLa cells for 6 hrs before challenge 
with STS for 4 hrs (10 h total infection) caused a significant suppressive effect on the 
cleavage and liberation of this DEVD substrate, compared with the mock-infected, 
STS treated sample alone. This suggested that the CVB4 infection may prevent 
cleaved caspase-3 from actually frinctioning and cleaving its own targets downstream 
in the apoptotic cascade.
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This result indicates that CVB4 infection of HeLa cells induced a suppressive affect 
on caspase-3 activity. However, these results could not confirm whether this 
suppressive effect was due to a direct effect of the virus on caspase-3, or whether 
instead the virus promoted a modulation of a host cellular function that conferred 
upon the host cell the ability to suppress caspase-3 activity. Further, this result could 
not confirm that the inhibition was due to direct interference with caspase-3 activity 
and not due to inhibition of its correct proteolytic activation or inhibition of a related 
caspase that can metabolize DEVD, such as caspase-7. Addressing this problem 
required the use of a recombinant active caspase-3 protein which had the functioning 
catalytic properties of host formed active caspase-3 but which could be added 
exogenously to cell lysates. To this end, HeLa cells were mock or CVB4 infected for 
10 hrs and the lysates were obtained as previously described (Section 4.8). These 
lysates were then incubated with a known amount of recombinant active caspase-3 
protein for 1 h on ice and the samples were then assayed for DEVDase activity 
(Section 4.8). Table 4.2 shows that the activity measured in the extraets from CVB4- 
infected cells was substantially suppressed despite the addition of equal amounts of 
recombinant caspase-3. These findings clearly demonstrate that CVB4 was generating 
a caspase-3 inhibitoiy activity that was at least partially responsible for the anti- 
apoptotic effect reported here.
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Mock 1 . ±  .
C \\U 9.7±3.0
101.8±23.4
C \  B4 + STS 77.9±24.1
* p<0.05, significantly different from staurosporine-treated mock-infected cells.
Table 4.1 CVB4 infection suppresses caspase-3 activity in HeLa cells.
HeLa cells were mock-infected or infected with CVB4 for 6 hrs before being treated 
with staurosporine (STS, 0.5 pM; or DMSO-control) for 4 hrs. At the end o f the 
incubation period cell lysates were prepared and tested for DEVDase activity as 
described (Section 4.8). The data are the means ±  SEM o f four independent 
experiments.
Mock + rccomb casp-3 
C \ B4 + reconib casp-3
598.76±13.9
374.57±10.6
** p<0.01, significantly different from mock-infected lysate treated with recomb 
casp-3.
Table 4.2 CVB4 infection leads to the expression of a protein that directly 
inhibits caspase-3 activity.
Cells were mock-infected or infected with Coxsackievirus B4 (CVB4) for 10 hrs 
before lysis and preparation o f post-mitochondrial supernatant. Recombinant human 
caspase-3 was subsequently added to equal amounts o f cell extract protein and its 
DEVDase activity assayed at 37^ C as described (Section 4.8). The data are the means 
+ SD o f four independent experiments.
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4.19 CVB4’s anti-apoptotic function protects HeLa cells against 
other apoptotic stimuli
The results reported in the previous sections have demonstrated that CVB4 has anti- 
apoptotic fimction which can protect HeLa cells from death by STS-induced 
apoptosis. However, this suppression of cell death can not be assumed to occur when 
apoptosis is triggered by all inducers since these may differ m the efficiency with 
which they affect the various components of the apoptotic cascade (Annis et al., 
2001). Thus we examined the anti-apoptotic effects of CVB4 when apoptosis was 
triggered by Actinomycin D (Act D; 0.5pg/ml) and TNF-Related Apoptosis-Inducing 
Ligand (TRAIL; 40ng/ml). Act D is a transcription inhibitor that foims a stable 
complex with DNA, blocking the movement of RNA polymerase. TRAIL is a 
cytokine molecule that binds to TRAIL receptors (TRAIL-R) on the cell surface to 
initiate the receptor mediated pathway of apoptotic induction.
As shown in Figure 4.10, CVB4 infection of HeLa cells for 6 lirs before challenge 
with both Act D (b panels) or TRAIL (c panels) halved the proportion of apoptotic 
cells (AV+/PI- (bottom right quadrant)) and most importantly in the case of TRAIL 
(like that shown for STS), increased the proportion of intact (AV-/PI- (bottom left 
quadrant)) cells, compared with the respective controls. However, there is a noticeable 
difference when Act D was used. Although vims infection was able to reduce the 
number of apoptotic cells induced by this treatment as well as those above, in this 
case we did not see the preservation of cell viability. Instead, the decrease in the 
number of apoptotic cells was balanced by an equivalent increase in the number of 
propidium iodide-positive cells. This strongly suggests that in the case of Act D, 
CVB4 infection has either caused a shift in the mode of cell death away from
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apoptosis and towards primary necrosis or has accelerated the transition from 
apoptosis to secondary necrosis such that at any time point the overall number of 
purely apoptotic cells appeared reduced.
These findings at the early stages of apoptosis were also detected when late apoptotic 
changes were examined since nuclear condensation and apoptotic body fonnation 
were also suppressed (Figure 4.11 (a, b)). To further confirm the nuclear morphology 
results for all the stimuli, the use of a laser scanning confocal microscope was 
employed together with the dye DRAQ-5. DRAQ-5 is a nuclear dye which binds 
rapidly with high affinity to DNA and does not photobleach (Section 4.9), As 
confirmed in Figure 4.12 (b-d), infection before pre-treatment with the apoptotic 
inducer suppressed nuclear destruction which is prominent in the respective control 
treated cells. Of great importance was the need to determine whether the inability of 
CVB4 to suppress caspase-3 activation significantly was due to the stimulus used, as 
the degree of suppression of the activity of active caspase-3 was veiy significant. As 
the use of Act D or TRAIL produced a doublet peak (with the peak farthest right 
indicative of the proportion of active caspse-3 in the sample) but the position of the 
active caspase-3 peak was different for the two drugs, gating of cleaved caspase-3 was 
positioned differently for each of the drugs and thus two separate sets of histograms 
are presented (Figure 4.13 a, b). As can be clearly seen, CVB4 infection prior to 
treatment with either of the inducers lent only slight suppression (~5%) in the 
activation of caspase-3 which could not account for the difference shown for Annexin 
V-FITC binding. Taken together, these results imply that CVB4 infection opposes 
both the mitochondrial and death receptor pathways of apoptosis without preventing 
the activation of the apoptotic machineiy, but instead prevents caspase-3 activity.
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Figure 4.10 CVB4 suppresses Act D and TRAIL induced PS translocation.
HeLa cells were infected with CVB4 for 6 h or mock-infected for 6 h before exposure 
to Act D (0.5pg/ml) or TRAIL (40ng/ml) or carrier solvent (DMSO) for a further 4 h. 
The samples were then incubated with Annexin V-FITC and PI and analysed by flow  
cytometry. One experiment representative o f three independent experiments is shown.
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a) 4h Act D
4h TRAIL
10h CVB4 incl. 4h Act D
10h CVB4 Incl. 4h TRAIL
Figure 4.11 CVB4 suppresses Act D and TRAIL induced nuclear degradation.
HeLa cells were treated fo r  4 h with Act D (O.Sjug/ml; a) or TRAIL (40ng/ml; b) or 
CVB4 infected fo r 6 h before this 4 h drug treatment. Cells were fixed with 4% 
paraformaldehyde and stained with DAPI. The nuclei were visualized by fluorescence 
microscopy and photographed. Apoptotic cells indicated by round and highly 
condensed nuclei and apoptotic body formation are indicated by arrows. 
Magnification X200.
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a 10h Mock 10h CVB4
b 4h STS lOh CVB4 Incl. 4h STS
c 4h Act D 10h CVB4 Incl. 4h Act D
4h TRAIL 10h CVB4 incl. 4h TRAIL
Figure 4.12 CVB4 suppresses nuclear degradation induced by various stimuli.
HeLa cells were mock- or CVB4 infected for 10 h (a) or treated fo r 4 h with STS 
(0.5pM; b), Act D (0.5fig/ml; c) or TRAIL (40ng/ml; d) or CVB4 infected for 6 h 
before this 4 h drug treatment. Cells were fixed with 4% paraformaldehyde and 
stained with DRAQ-5. The nuclei were visualized by laser scanning confocal 
microscopy. Bar = 20pm.
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Figure 4.13 CVB4 suppresses little caspase-3 activation induced by Act D or 
TRAIL.
HeLa cells were mock- or CVB4 infected and after 6 h, either mock-treated or treated 
with Act D (0.5pg/ml; a) or TRAIL (40ng/ml; b) for 4 h. The samples were then 
immunostained with a PE-conjugated active caspase-3 antibody and analysed by flow  
cytometry’. Each histogram represents the mean ±SE o f three independent 
experiments. The positions o f the apoptotic cells (Ap) are marked. No significant 
difference was found between the respective drug treated samples.
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4.20 Discussion
As obligate intracellular entities, viruses require that their host cells remain viable 
long enough to permit replication. Counter measuies mounted by a host’s immune 
and innate resistance systems must weigh up the balance of sacrificing these infected 
cells for the good of the organism as a whole. Thus activation of apoptosis is a crucial 
method of controlling viral spread and it is becoming increasingly apparent that many 
vimses manipulate the apoptotic pathways to further their replicative success.
The typical CPE seen in enterovims infections, and here in CVB4 infections, is 
necrotic in nature and emerges from the successful activity of apoptosis-suppressing 
fiinctions encoded by the enterovirus genome which oppose the onset of apoptosis 
triggered by other elements of virus gene expression (Tolskaya et al., 1995). These 
anti-apoptotic virus fiinctions are also active against other non-viral inducers which 
activate the extrinsic or intrinsic apoptotic pathways. Anti-apoptotic effects emerged 
between 8 and 12 h.p.i, but a few cells were observed to enter apoptosis early in 
infection and these appeared to progress to death. The extent of the anti-apoptotic 
effect was found to be time-dependent suggesting the longer CVB4 has to replicate, 
the greater the proportion of the putative anti-apoptotic fimction that can be made.
This suppression of apoptosis did not involve suppression of pro-caspase-3 cleavage 
which proceeded in STS treated cells whether or not these had been virus infected. 
Although, phosphatidylserine release and generation of cleaved procaspase-3 are both 
early events in apoptosis, the kinetics of their activation is different. This difference in 
kinetics was first shown by Naito et al., (1997) when they reported that 
phosphatidylserine translocation to the outer surface of the plasma membrane occurs
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downstream of caspase activation duiing apoptosis. They showed that 
phosphatidylserine was externalized on the plasma membrane of cells when caspases 
were activated, but when inhibitors of caspase-3 were used an inhibition of 
phosphatidylserine externalization occuned; this suggests that active caspase-3 has a 
role in promoting phosphatidylserine translocation. This link was first suggested by 
Martin et al., (1996) and Vanags et al., (1996), and was subsequently corroborated 
(van Engeland et al., 1998; Fadeel et al., 1999b).
Although our results showed only negligible suppression of active caspase-3 
fonnation, an impairment of the activity of the enzyme once made could not be ruled 
out. Indeed, HeLa cells infected with CVB4 before challenge with STS had a 
significantly reduced caspase-3 activity compared with STS treated cells alone, and 
infected cell extracts inliibited the activity of recombinant caspase-3.
This inability of CVB4 to greatly suppress the activation of pro-caspase-3 to its active 
form, yet significantly suppress its activity is reminiscent of the activity of the lAP 
proteins which can bind directly to the active site of caspases and inhibit their activity. 
Deveraux et al., (1998) investigated lAP interference on caspase-3 fimction and 
showed that the human lAPs, XIAP, cl API and cIAP2 could inhibit active caspase-3 
directly, thereby blocking its downstream targets, but had no effect on suppressing the 
activation of pro-caspase-3 to its active form.
In investigations into whether this suppressive function was restricted to STS-induced 
apoptosis (induces apoptosis via a Bcl-2 sensitive, Bax-dependent intrinsic pathway) 
(Tafani et al., 2001) by using other apoptotic stimuli to activate different apoptotic 
pathways it was found that by using either actinomycin D (Act D; induces apoptosis
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via a Bcl-2 sensitive intrinsic pathway) or TRAIL (induces apoptosis via a TRAIL-R 
sensitive, extrinsic pathway), CVB4s anti-apoptotic function could reduce the 
proportion of apoptotic cells by over 50% compared with the dmg treated cells alone. 
Interestingly, only infected cells challenged with STS or TRAIL could increase the 
proportion of intact non-apoptotic cells, with Act D challenge of infected cells 
causing a negligible change in tire proportion of intact cells but an increase in the 
proportion of necrotic cells. Consistent with this was the finding that the nuclear 
morphology of infected cells challenged with TRAIL showed little signs of cell death 
but infected cells challenged with Act D did show slight necrosis with partial 
condensation of the chromatin and cell rounding. This similar suppression of 
apoptosis (like that shown with STS) was accompanied by a similar slight suppression 
of the activation of active caspase-3.
During our investigations, a study by Campanella et al., (2004) showed that by 
manipulating intracellular calcium the Coxsackievirus B3 (CVB3) protein 2B could 
inhibit apoptosis. In agreement with our results they also found that CVB3 infection 
of HeLa cells reduced nuclear damage and caspase-3 activity and caspase-3 activation 
in response to apoptogenic stimuli. However, this suppression of caspase-3 activation 
was greater than the small effect seen in our studies and may be due to the fact that 
the group only showed that expression of 2B caused a decrease in caspase-3 
activation by apoptotic inducers. This groups report did not include an investigation 
of CVB3 in vivo infection and its effects on the activation of caspase-3; that is they 
did not infect the cell with CVB3 thereby expressing a full complement of all the viral 
proteins but instead showed the effect of one protein (2B) on caspase-3 activation. 
This suggests, for our work, a situation in which 2B production during the viral life 
cycle may attempt to inhibit caspase-3 activation but that in vivo this suppression is
167
being masked by pro-apoptotic proteins such as 2 A ^  (Goldstaub et ah, 2000) and 
3 Cpio (Barco et al, 2000) hence resulting in negligible inhibition of pro-caspase-3 
processing. The reports that showed anti-apoptotic function in PV (Tolskaya et al., 
1995) and CVB3 (Campanella et ah, 2004), used cycloheximide and Act D whose 
effects are similar to those encoded by the enterovirus 2A^ *“ and 3C^ ™ respectively. 
Thus, the ability of CVB4 to increase the number of intact HeLa cells when 
challenged with both STS and TRAIL, but not Act D may highlight the ability of 
CVB4 to suppress cell death using various mechanisms, and indicate once again the 
powerful selective pressure imposed by the apoptotic cascade.
A surprising feature of CVB4s anti-apoptotic function is that it has the ability to 
maintain in the presence of STS. This initially suggests that cytochrome c is still 
present in the mitochondria. However, as STS has been widely reported to promote 
the release of cytochrome c (Tafani et al., 2001), which is then able to promote the 
cleavage of pro-caspase-3 to its active form, and this anti-apoptotic function could not 
suppress the cleavage of pro-caspase-3 this suggested that cytochrome c was not 
present in the mitochondria, yet AYm could still be maintained. A report by 
Waterhouse et al., (2001) suggests an answer to this paradox. They showed that 
during apoptosis, if caspase activity is inhibited ATm initially decreases and is then 
restored and the cytochrome c released into the cytosol can still be used by the 
mitochondria to maintain AT^ m. Of most importance, a recent paper by the same group 
(Ricci et al., 2004) showed that to maintain ATm during apoptosis induction, the 
activity of active caspase-3 has to be inhibited since a downstream substrate of 
caspase-3 is complex I in the mitochondrial electron transport chain.
1 6 8
We next investigated whether a CVB4 encoded protein was interacting with active 
caspase-3 to suppress its activity and promote an anti-apoptotic effect.
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Chapter 5
5 EFFECTS OF THE COXSACKIEVIRUS NON- 
STRUCTURAL PROTEINS ON THE APOPTOTIC
MACHINERY
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5.1 Introduction
Although induction of apoptosis by vims infected cells can be triggered by 
mechanisms such as activation of caspases and modulation of cellular anti-apoptotic 
proteins, a number of vimses are known to encode functions that inliibit this mode of 
host cell death (O'Brien, 1998). By inhibiting or delaying the destmction of the host, 
the amount of time for vims growth may be increased. In contrast, vims induction of 
host cell death may be used as a mechanism to promote the dissemination of viral 
progeny at the end of replication by releasing the progeny in membrane bound 
apoptotic blebs. Thus, although induction of the apoptotic program by the host may be 
a strategy to limit viral spread and pathogenicity, it is becoming increasingly apparent 
that vimses have evolved mechanisms to suppress the host cell suicide triggered by 
their presence within the cell until a point is reached when viral release is desired. 
Indeed, adenovims El A and ElB genes encode functions which trigger and suppress 
the induction of apoptosis respectively (Rao et al., 1992; Benedict et al., 2001; 
McNees and Gooding, 2002). Dual pro- and anti-apoptotic functions have also been 
reported to be encoded by other large DNA containing vimses such as African swine 
fever vims, baculovims, Epstein-Barr vims, herpes simplex vims and papillomavirus 
(Clem et al., 1991; Bmn et al., 1996; Duckett et al., 1996; Desaintes et al., 1997; 
Neilan et al., 1997; O'Brien, 1998; Jerome et al., 1999; Marshall et al., 1999; Benedict 
et al., 2001; Bellows et al., 2002; Benedict et al., 2002; Hay and Kannourakis, 2002; 
Boy a et al., 2003).
Accumulating evidence suggests that this dual modulatory ability may also occur in 
the picornavims poliovims (PV) (Tolskaya et al., 1995; Koyama et al., 2001; Belov et 
al., 2003; Romanova et al., 2005). Expression of PV non-structural proteins 3C^ ™ and
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have been found to induce apoptosis, however, little is known about the viral 
anti-apoptotic fiinction(s). A recent investigation found that PV non-stmctural protein 
3A suppressed apoptosis induced by Tumour Necrosis Factor (TNF) by blocking the 
transport of the TNF receptor to the outer side of the plasma membrane (Neznanov et 
al., 2001). However 3A could not prevent apoptosis induced by Fas (another member 
of the TNF superfamily) or staurosporine, suggesting that this blockage was specific 
to the TNF receptor and not the extrinsic or intrinsic apoptosis pathways. Also, we 
found drat infection of HeLa cells with CVB4 lent protection even against 
staurosporine, suggesting that protem 3A may not be the only anti-apoptotic function 
that may be encoded by enterovirases. Indeed, in the same study Neznanov and 
colleagues also reported that expression of non-structural viral proteins 2B and 2BC 
also lent some protection to the death inducing effects of TNF in HeLa cells.
We have shown that CVB4 can inhibit apoptosis possibly by direct interaction with 
active-caspase-3 inhibiting its function. This is also consistent with the lack of nuclear 
condensation or apoptotic blebbing in infected cells challenged with TRAIL since this 
dmg can also bring about caspase-3 activation via receptor mediated activation of 
procaspae-8. Thus, we next sought to determine the viral anti-apoptotic function(s) 
that were mediating this cell survival.
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Methods
5.2 Immunoprécipitation and co-precipitation studies
Physical association between proteins was sought by co-precipitation (also termed 
pulldown) experiments. Antibody targeted to any protein will also bring about the co­
precipitation of any proteins attached to the target molecule (provided that they do not 
prevent antibody binding). These experiments were carried out in exactly the same 
manner as usual immunoprécipitation, except that the primary target need not 
necessarily be labelled as long as label is present in any co-precipitated protein. If 
another labelled protein is attached to the primary antigen this will also be 
precipitated and can be analysed by SDS-PAGE followed by autoradiography (Figure
5.1).
Add Protein A-Sepharose1
upernatant
Centrifuge
4- reclpitate
Figure 5.1 Schematic representation of the principle of co-immunoprecipitation.
An antibody added to a mixture o f radiolabelled (*) proteins binds specifically to its 
antigen (A). I f  this antigen interacts with another labelled protein (J) the addition o f 
Protein A-sepharose (an immobilized antibody’ binding protein) will absorb this 
complex from solution. Upon centrifugation this complex is brought down in the pellet 
(precipitate).
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5.3 In vitro coupled transcription-translation experiments (T^T 
reaction)
The TNT T7 Quick coupled Transcription/Translation kit (Promega) based on the 
rabbit reticulocyte lysate system was used as outlined in the manufacturer’s protocol 
to produce proteins in vitro. The reaction (lOpl total volume) was performed using 
nuclease-free water, Ipg 2B or 2BC plasmid DNA, Igl Redivue™ L-[^^S]- 
methionine (>37 TBq/mmol) (Amersham Biosciences pic, Buckinghamshire UK) and 
6pi TnT® Quick Master Mix (Promega, Southampton UK). The components were 
mixed gently by pipetting and incubated at 30°C for 90 min.
5.4 Immunoprécipitation of T^T reaction products with caspase-3
CVB4 2B and 2BC non-structural proteins were made as described above (Section 
5.3). Each lOpl reaction volume was then diluted 1:10 by addition of 90pl IX RIPA 
detergent mix (lOX RIPA detergent mix diluted to IX with RIPA buffer) (Section 
2.3.7) before the addition of recombinant active caspase-3 (2.25pg/100pl). These 
samples were then incubated at 4°C for 1 h before being immunoprecipitated with 
human anti-active caspase-3 polyclonal antibody and analysed by SDS-PAGE (12.5% 
or 15% mini-gel) (Section 2.8) and autoradiography (Section 2.7.3).
5.5 Preparation of capped RNA from DNA
Linearised DNA (Section 5.14) was purified using phenol-chloroform extraction and 
ethanol precipitation as previously described (Sections 2.10.2.2 and 2.10.2.1 
respectively). For the transcription reaction the following solution was prepared on ice 
in microflige tubes as per the manufactures instmctions (Roche, UK):
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Nuclease free water made up to 20pl
T7-CapScribe buffer (part of T7 CapScribe kit-Roclie, UK) 4pl
Linearised purified plasmid DNA 0.5pg
T7 RNA Polymerase (part of T7 CapScribe kit-Roche, UK) 2pl
This solution was mixed and incubated on a heating block for 2 h at 37°C.
Once the RNA had been made it was purified as follows:
1 pi DNase 1 (Ambion, Cambridgeshire UK) was added and the sample was incubated 
on a heating block at 37 °C for 15 min. Following this, 115pl nuclease-free water and 
15 pi ammonium acetate stop solution (Ambion, Cambridgeshire UK) was added. The 
volume of the sample was determined and an equal volume of phenol-chloroform was 
added. The sample was mixed for 2 min, centrifuged (14,000ipm) for 2 min and the 
aqueous (top) layer was added to a fi'esh microflige tube. Back extraction of the 
remaining phenol-chlorofoim was caiTied out using 50 pi nuclease-free water and 5 pi 
ammonium acetate stop solution. This solution was mixed and centrifuged (as above) 
and the resulting aqueous layer was added to the aqueous layer in the previous (fiesh) 
microflige tube. The volume of the aqueous sample in the fresh tube was deteimined 
and an equal volume of chloroform was added. Again this solution was mixed, and 
centrifuged with the aqueous solution being transferred to a fresh microflige tube. The 
volume was determined, an equal volume of isopropanol was added and the 
suspension was thoroughly mixed and left to stand for 1.5 h at -20 °C. It was then 
centrifuged (14,000rpm, 15 min), the supernatant discarded and the pellet washed 
once with 70% ethanol. The pellet was then left to dry on a heating block (37°C, 5 
min) and was resuspended in 20pl of Nuclease-free water.
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5.6 RNA transfection expression studies
To determine the expression levels of protein in RNA transfected cells, transient 
transfections of HeLa cells were perfoimed using TransMessenger™ transfection 
reagent (Qiagen, Crawley UK) as per the manufacturer’s instructions and the method 
was as follows:
HeLa cells were grown in 35mm dishes (seeding density 1.5 x 10^  cells) at 37®C in a 
humidified atmosphere of 5% CO2 in air, until the cells were 40-60% confluent. 
When the cells were confluent, the transfection reagents were prepared by diluting 4pl 
of Enliancer R (part of the TransMessenger™ kit) in Buffer EC-R (part of the 
TransMessenger'i'’^  kit). 2pg of Luciferase RNA made from a Luciferase DNA 
template containing a T7 promoter (Promega, Southampton, UK) was added (the final 
volume being lOOpl-adjusted using buffer EC-R). The sample was then mixed by 
vortexing for 10 secs and incubated at room temperature for 5 min. 8pi of 
TransMessenger transfection reagent (part of the TransMessenger™ kit) was then 
mixed with the RNA-Enhancer R mixture and incubated for 10 min at room 
temperature to allow transfection complex formation. During this period the cells 
were washed with 3ml Opti-MEM® (without serum) and once this period was over, 
0.9ml of Opti-MEM® (without semm) was added to the vial containing the RNA 
transfection complexes, mixed and then this mixture was added drop-wise onto the 
cells. The cells were incubated as before for 4 lirs. The transfection complexes were 
then replaced with pre-warmed (37 °C) Opti-MEM® (with semm) and the cells were 
then incubated for a further 6 hrs. After this time, the cells were scraped in 200pl cell 
culture lysis reagent (Promega, Soutliampton, UK) (diluted 1:5 using milliQ water), 
transferred to a microfuge tube and left to stand on ice for 5 min. The sample was then 
centrifiiged (14,000rpm for 5 min at 4°C) and the supernatant transferred to a fresh
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tube. As the protein luciferase catalyses the oxidation of the substrate luciferin 
resulting in the generation of a flash of light, to determine protein expression levels 
using this RNA transfection method 20pl of luciferase transfected cell lysate 
(equilibrated to room temperature) was mixed with lOOpl of luciferin (equilibrated to 
room temperature) in luminometer tubes and the tube was immediately placed in a 
luminometer and the amount of Light Units detected was measured.
5.7 RNA transfection of HeLa cells
HeLa cells were grown in 60mm dishes (seeding density 3x10^ cells) and transfected 
as above (Section 5.6) except that the volumes used were doubled and the 
concentration of RNA used was doubled to factor for the increased dish size, which 
was required in order to have enough transfected cells for the subsequent DEVDase 
assay. 4pg of RNA was transfected for a total of 10 h before haiwest.
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Results
5.8 Detection of active caspase-3 using immunoprécipitation and 
Western blot analysis
Co-precipitation of proteins with caspase-3 depended on the ability of the system to 
precipitate caspase-3 itself. In order to address this issue, we pre-labelled mock- 
infected cells with [^^S]-methionine for 2 h (Section 2.7.1) and then induced apoptosis 
by STS treatment (0.5 pM; 7 h). When apoptosis was advanced (cells having a greatly 
shrunken appearance), cells were lysed and processed for immunoprécipitation using 
an antibody specific for active caspase-3. Precipitates were analysed by 
autoradiography (Section 2.7.3). However, this analysis failed to reveal any bands 
(data not shown). This was attributed to onset of apoptosis which prevented label 
incorporation and slow turnover in the zymogen. In order to overcome this we 
subjected the immunoprecipitates to Western blot analysis [(12.5%; mini-gel; anti­
active caspase-3 polyclonal antibody-specifically for Western blotting (1:2000; BD 
Bioscience-PharMingen, Oxford) followed by peroxidase-labelled goat anti-rabbit 
IgG (1:2000; Dako, Cambridge)], to detect even unlabelled caspase-3. Figure 5.2 
shows that treatment of cells with STS causes the activation of caspase-3, which was 
detected as the expected 18kDa fragment (p i8) from apoptotic but not from mock- 
treated cells. The active caspase-3 antibody used for Western blotting (sometimes 
refeiTcd to as CMl) only recognises the large (p i8) subunit of active caspase-3 and 
does not recognise the small (pi2) subunit of active caspase-3 or the p32 procaspase-3 
(zymogen) (Srinivasan et al., 1998). To further confirm the specificity of this 
immunoprécipitation teclmique, similarly treated cells were immunoprecipitated with 
a monoclonal antibody to pro-caspase-3 and were then subjected to Western blot 
analysis on a 10% mini-gel [1:1000; BD Bioscience-PharMingen, Oxford) followed
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by peroxidase-labelled goat anti-mouse IgG (1:2000; Dako, Cambridge)]. Figure 5.3 
shows that treatment of cells with STS promotes the loss pro-caspase-3 (32kDa); with 
the detection of this 32kDa molecule only in the mock-treated lane.
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Figure 5.2 Isolation of active caspase-3 by immunoprécipitation.
HeLa cells were treated as shown and IP and Western blotted using active caspase-3 
antibody. The 18kDa (pi8) large subunit o f active caspase-3 can be clearly seen in 
the STS treated lane and not the mock treated track. Note the presence o f the broad 
bands migrating ~47-59kDa which are the immunoglobulins o f the caspase-3 
antibody used for IP which were recognised by the secondary antibody during the 
Western blotting procedure.
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Figure 5.3 Isolation of pro-caspase-3 by immunoprécipitation.
HeLa cells were treated as shown and IP and Western blotted using antibody to the 
pro-caspase-3. A 32kDa band, indicative o f pro-caspase-3 can be clearly seen in the 
mock-treated lane but not in the STS track. Additionally broad bands o f the 
immunoglobulins o f the pro-caspase-3 antibody used for IP which were recognised by 
the secondary antibody during the Western blotting procedure can be seen.
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5.9 Interaction of CVB4 proteins with active caspase-3
We next investigated whether a viral protein was interacting with active caspase-3 by 
making use of a recombinant active human caspase-3 protein (Section 4.18). 
Radiolabelled lysates (labelled for 90 mins- Section 2.7.1) were prepared from both 
mock and vims-infected cells (cells were mock or virus infected for 8 h before 
labelling). Lysates were then mixed with recombinant caspase 3 (2.25pg/100pl) and 
incubated for 1 h at 4°C before the caspase-3 in the samples was immunoprecipitated 
as above. Since the caspase-3 used was not labelled it is not visible in the resulting 
autoradiographs, however any cell or virus proteins that are labelled should be seen 
and since under these conditions, the shut-down of cellular protein synthesis by CVB4 
infection causes viral proteins to be the main proteins that are radiolabelled (Roberts 
et al., 2000), in the infected lysate track the only proteins observed are viral proteins 
(Figure 5.4). No bands were detected using the 10 h mock-infected cell lysates, but a 
48kDa protein was visible in the 10 h infected cell lysates. This is a similar weight to 
that expected for CVB4 protein 2BC (computed Mr 48,228) (Jenkins et al., 1987).
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Figure 5.4 CVB4 protein interaction with caspase-3.
HeLa cells were mock or CVB4 infected before incubation with a recombinant casp-3 
protein as shown. A 48kDa band which corresponds to CVB4 non-structural protein 
2BC is observed in the virus track whereas no proteins can be seen in the mock- 
infected track.
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5.10 Cloning of the 2BC and 2B coding sequences
The interaction detected above was weak and required confirmation. Attempts to 
improve the labelling or precipitation failed and it was decided to adopt an alternative 
approach and express protein 2BC alone using an expression vector. This should 
provide a supply of well-labelled protein whose interaction with caspase-3 could be 
more clearly studied. As 2BC is the precursor of CVB4 non-stmctural protem 2B, it 
was also necessaiy to clone this protein to identify which section (if any) confers the 
ability for an interaction with caspase-3.
cDNA clones encoding these proteins were already available in the laboratory as 
pUSlOOO plasmid constructs (prepared by Dr Christopher Johnson), The 2B and 2BC 
coding regions were selectively amplified by PGR using primers designed to insert 
start and stop codons to flank each sequence and incorporate a Kozak consensus 
sequence around the initiation codon. This sequence greatly facilitates binding of 
niRNA to the small ribosome. A Kpn I site was added upstream of the coding region 
and Xba I sites were added downstream to facilitate subcloning. The primers 2BCstart 
(sense) and 2BCend (anti-sense) were used to amplify the 2BC gene whereas primers 
2BCstart and 2Bend (anti-sense) were used for amplification of the 2B gene (Table 5.1).
2BCstart "CTGGTACCATGGGAGTGAAAGATTACGTTG"'
2BCend ^'GCTCTAGATCAGGGGCCTTGGAATAGCG^'
2Bgnd ^'GCTCTAGACCCGTTGTTACTGCCGTTCAG^'
Table 5.: Sequences of the three primers, 2BCstartj 2BCend and 2Bend used for the
cloning of the genes corresponding to proteins 2BC and 2B.
The region in red identifies the Kpn I  recognition sequence, the blue regions identify 
the Xba I recognition sequence, the bold region identifies the introduced start codon, 
and the underlined regions identify stop codons.
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The PCR products were generated using Taq DNA polymerase (Promega, 
Southampton) and cloned into the vector pGEM-T Easy (Promega, Southampton; 
Figure 5.5). This vector has been commercially modified by the addition of a 3'- 
terminal thymidine (T) to the 3' ends, creating a T-overhang which can associate with 
the extra adenosine (A) added during amplification, thereby increasing the ligation 
efficiency of Taq polymerase amplified PCR inserts. After sequence analysis of the 
pGEM-T Easy- 2BC and 2B inserts, the gene sequences were then subcloned into 
expression vector pGEM-3Z (Promega, Southampton).
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Figure 5.5 Diagrammatic representation of pGEM-T Easy vector.
This cloning vector was used for the insertion o f purified PCR products (with 
adenosine overhangs created during the PCR reaction by Taq polymerase) within the 
thymidine (T) overhangs. The plasmid contains an ampicilin resistance gene (Amf); 
the MCR is situated within the lacZ gene, thus enabling blue/white colony selection.
(Source: http://www.promega.com/figures/popup.asp?fii=1473va)
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5.10.1 Cloning of the 2BC coding sequence
The vector pUSlOOO (encoding a 2BC gene sequence), was amplified in a PCR 
reaction using the primers 2BCstart and 2BCend and Taq DNA polymerase (Section
2.10.1.1). The PCR product was electrophoresed on a 1.2% agarose gel (Section
2.10.5.1) alongside a Ikb DNA size marker. A prominent band was observed that 
migrated at the expected size of the sequence encoding 2BC (approximately 1,300 bp) 
(Figure 5.6, lane 2).
3,000
1,500
1,000
1,300bp
Figure 5.6 1.2% agarose gel of the PCR product containing the 2BC coding 
sequence.
The band (indicated by the arrow) in lane 2 corresponds to the expected size for 2BC. 
Lane 1 is the Ikb DNA size marker.
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The PCR product was purified by gel extraction (Section 2.10.5.2) and its 
concentration was determined by adding Ipl of this DNA to a NanoDrop® ND-1000 
Spectrophotometer (NanoDrop Technologies, Wilmington, US), which instantly 
provides a measurement of the DNA concentration. The product was ligated into 
pGEM-T Easy and used to transfomi E.coli DH5a cells (Section 2.10.4.2). 
Recombinant clones were selected by blue/white screening (Section 2.3.4). Plasmids 
from the white colonies were isolated (Section 2.10.2.3) and the presence of the insert 
was confirmed by restriction enzyme digestion (Section 2.10.3.1) followed by 
agarose gel electrophoresis.
As the pGEM-T Easy vector has an EcoK I site flanking the thymidine overhangs 
(where the 2BC coding sequence was inserted), EcoR. I was used to screen for the 
presence of a l.Skb fragment indicative of the 2BC cDNA cloned into pGEM-T Easy. 
Since the 2BC coding region has an internal EcoR. I site 450bp downstream of the 5' 
end, two 2BC fragments would be expected; one 450bp and the other approximately 
850bp (l,300bp -  450bp). Six colonies were screened, and as can be seen in Figure 
5.7 all the colonies yielded these two fragments following EcoR. I digestion.
The primers used for the production of the 2BC cDNA were designed to introduce a 
Kpn I site on the 5' end of the coding region and dAiXba I site downstream from this. 
Although all the colonies examined contained the 2BC cDNA fragment, this finding 
could not confirm weather the Kpn I or Xba I sites had been introduced correctly. 
Since these sites are required to sub-clone the 2BC cDNA fragment into the vector 
pGEM-3Z it was important to verify their presence. Since Kpn I and Xba 1 require 
different buffers to be used during restriction digestion it was decided to use 
restriction endonuclease Acc65 I. This is a neoschizomer of Kpn 1 which can cleave in
186
the same buffer as Xba I (Section 2.10.3.1). However, these two enzymes failed to 
release the inserted cDNA but led to the linearization of the constructs suggesting that 
one enzyme was unable to cleave (data not shown). Separate digestion confirmed that 
six colonies could be cut with Acc65 1 but none were cleaved by Xba I suggesting that 
this site was either not present or was not available to the enzymes (data not shown).
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Figure 5.7 1.2% agarose gel of EcoR I digested recombinant pGEM-T Easy-2BC 
plasmids.
Lane 1: Ikb DNA ladder, lanes 2-7: plasmids derived from 6 white colonies, lane 8: 
uncut colony 2 plasmid (from lane 3). Arrow at 3,000 bp represents the pGEM-TEasy 
vector and the other two arrows indicate the 2BC cDNA cut fragments.
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To further try to select for colonies without base changes (which would be sent for 
sequencing) we next determined the orientation of the inserted cDNA in these clones 
using the fact that the inserted sequence contains an asymmetrically positioned Spe 1 
105bp downstream of the 5' end of the coding sequence. Since the cloning vector 
contains only a single Spe 1 site located in the MCR, cleavage with this enzyme will 
release a band of either 1.3kb or 105bp. Figure 5.8 shows the result, a 1.3kb fragment 
was released from all the clones. This indicated that in each case the inserted cDNA 
was in the correct orientation.
3,000—
1,500—
1,000 750
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•1,300bp
Figure 5.8 1.2% agarose gel of Spe /  digested recombinant pGEM-T Easy-2BC 
plasmids.
Lane 1: Ikb DNA ladder, lanes 2-7: plasmids derived from 6 white colonies. Arrow at 
3,000 bp represents the pGEM-T Easy vector and the arrow at 1,300bp indicates the 
2BC cDNA fragment.
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Thus before the 2BC cDNA could be sub-cloned into pGEM-3Z (for the subsequent 
in vitro production of this protein and inRNA preparation) it was necessaiy to confirm 
the identity and integrity of the open reading frame to be expressed. The colony in 
lane 5 (Figure 5.8) was cultured further and the plasmid was extracted and purified 
(Section 2,10.2.3) for subsequent sequencing (Section 2.10.6).
Results obtained using an M l3 forward sequencing primer confirmed that the ATG 
start codon and the Kpn I site had been successfully introduced at the 5' end of the 
2BC cDNA (Figure 5.9 (a)). Using the M13 reverse sequencing primer it was shown 
that the stop codon TGA (sense) had been successfully introduced. However, 
although Xba I was not able to cut 2BC, the Xba I site was found to have been also 
successfiilly introduced. This lack of cleavage was probably due to méthylation since, 
E.coli synthesize a DNA méthylation (dam) enzyme which methylates the N6- 
position of the adenine residue in the sequence GATC (Hattman et al., 1978) in order 
to prevent cleavage of its own host sequences by restriction endonucleases. Xba I is 
sensitive to dam méthylation and as tliis Xba I sequence (TCTAGA) was next to a 
stop codon (TCA) together the sequence had a méthylation recognition sequence (in 
blue) TCTAGATCA with the adenine in red probably having been methylated.
189
2BC insertpGEM-T Easy
1201C 0 11080 907 060
ZGGG A f tT T C G f tT T C T GGTRCQ VTGGG AGTGAAAG ATTACGT TGAG CAAC T T G G T A A T G C  T TT  TGG 
EcoR I Kpn I Start codon
2BC insertpGEM-T Easy
2BCend primer
1 4 0 1 5 0120 13 0
GGG GC CT TGG A A T A G C G C C T C A A G G G l
)0  1 0 0  
G C G G C  CG C G A A T TC 3V C T A G TG A T T G C T C T A G  pIt
110
Xba IEcoR I Spe I Stop codon
A Â
Figure 5.9 Sequence chromatograms of the pGEM-T Easy-2BC recombinant 
clone.
(a) shows the chromatogram using the M l3 forward primer and (b) shows the 
chromatogram using the MIS reverse primer, which reads the reverse complement o f 
the sequence. Note that the TCA is the reverse complement o f the TGA stop codon and 
the Xba I sequence is next to the stop codon.
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5.10.2 Cloning of the 2B coding sequence
The p u s  1000 containing 2BC cDNA was also used as a template to amplify the 2B 
coding sequence by PCR. The primers 2BCstart and 2Bend and Taq DNA polymerase 
were used as described in Section 2.10.1.1. The PCR products were electrophoresed 
on a 2% agarose gel (Section 2.10.5.1) alongside a lOObp DNA marker in order to 
verify the presence of the 2B DNA. The expected size of this product is 
approximately 320bp and a band of this size was observed (Figure 5.10, lane 2).
1,500
1,000
320bp
Figure 5.10 2% agarose gel of the PCR product containing the 2B coding 
sequence.
The band (indicated by the arrow) in lane 2 corresponds to the expected size for 2B. 
Lane 1 is the lOObp DNA size marker.
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The 2B PCR product was gel purified and ligated into vector pGEM-T Easy as above. 
Digestion of six white colonies with EcoK I showed that only three of the six colonies 
contained the 2B insert (data not shown). Subsequent digestion with Acc65 I and Xba 
I (separately) showed that all three colonies could be cut with both enzymes and thus 
indicated that the introduced restriction sites were present. To check the orientation of 
the 2B cDNA fragments, the endonuclease Spe I was again used. The Spe I site is 
105bp downstream from the 5' end, and since the 2B coding sequence is 320bp, if 2B 
is in the right orientation cleavage of 2B with Spe I should yield an approximately 
215bp (320bp-105bp) fragment. As Figure 5.11 shows, all three colonies contained 
plasmids with the 2B cDNA insert in the same orientation.
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Figure 5.11 2% agarose gel of Spe 1 digested recombinant pGEM-T Easy-2B 
plasmids.
Lane 1: lOObp DNA ladder, lanes 2-4: plasmids derived from 3 white colonies. Arrow 
at approximately 215bp is indicative o f the 2B cDNA fragment.
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215bp
Subsequent sequencing (carried out as described in Section 2.10.6) of the plasmid 
containing the 2B cDNA in lane 3 (Figure 5.11) confirmed that the ATG start codon 
as well as the TA A (sense) stop codon were successfully introduced. In addition, it 
was shown that the Kpn I and Xba 1 sites were successfully introduced (Figure 5.12). 
Interestingly, the Xba I site on the 2B cDNA fragment is several base pairs away from 
this TA A stop codon whereas this restriction site is adjacent to the TGA stop codon 
sequence in the 2BC cDNA fragment. This latter result thus lends more credence to 
the idea that cleavage of 2BC cDNA with Xba I could not occur due to méthylation.
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Figure 5.12 Sequence chromatograms of the pGEM-T Easy-2B recombinant 
cione.
(a) shows the chromatogram using the M13 forward primer and (b) shows the 
chromatogram using the M l3 reverse primer, which reads the reverse complement o f 
the sequence. Note that the TTA is the reverse complement o f the TAA stop codon.
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5.10.3 Sub-cloning of 2BC and 2B coding sequences into vector pGEM-3Z
As the aim of cloning the 2BC and 2B cDNA molecules was to express Üiem using an 
in vitro system, these coding sequences required sub-cloning into a vector which was 
capable of this. The vector chosen was pGEM-3Z (Promega, Southampton; Figure 
5.13), as this vector can be used for highly efficient synthesis of proteins in vitro by 
direction from a T7 RNA polymerase promoter.
m m  1193? AâiW " If 2260h'm\ m m
/  /  Amp
/  /
[21
IF I 1 slarlÉooR 1 0
Kpn] lO31
/fms 1 e 1 21Srital 33BarnH I 26Kùâ 1 ,32
ACÙ ! fimù P 29•10jRSI'i1 m.54Ell 56
Tspa m  1
Figure 5.13 Diagrammatic representation of pGEM-3Z vector.
This vector was used for the insertion ofpurified 2BC and 2B fragments. The plasmid 
contains an ampicilin resistance gene (Amp’); the MCR is situated within the lacZ 
gene, thus enabling blue/white colony selection.
(Soiuce: http://www.promega.com/figures/popup.asp?fn=0278va)
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Although our original intention had been to excise the inserts using the Xba I and Kpn 
I sites, the difficulty in cleaving our 2BC clones with Xba I  necessitated the choice of 
an alternative enzyme in this case. It was decided that Sal I would be used since it is 
present in both vectors, functions in the same buffer as Acc65 I (which is a 
neoschizomer of Kpn I) and will still provide for a correctly orientated clone of the 
cDNA. Thus, pGEM-3Z was linearised by digestion with Acc65 I and Sal I (Section 
2.10.3.1) and purified (Sections 2.10.5.2 and 2.10.2.1), Although the 2B cDNA 
fragment could be cut with Xba I it was decided that for unifonnity of approach we 
would also use Sal I in this case. Hence, the 2BC and 2B cDNA fragments were 
excised by Acc65 I and Sal I digestion of pGEM-T Easy-2BC and pGEM-T Easy-2B 
constructs respectively and gel extracted (Section 2.10.5.2). Each insert was then 
ligated into the linearised vector and the products of the ligation reactions were used 
to transform E.coli DH5a cells (Section 2.10.4.2), Six transfomiants were tested for 
the presence of the 2BC and 2B cDNA fr agments (in vector pGEM-3Z) by restriction 
enzyme digestion using Acc65 I and Sal I followed by gel-electrophoresis. As shown 
in Figures 5.14 and 5.15, all six colonies picked for both 2BC and 2B contained the 
respective cDNA fragments.
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Figure 5.14 1.2% agarose gel of pGEM-3Z-2BC construct digested with Acc6S I 
and Sal I.
Lane 1: Ikb DNA ladder, lanes 2-7: plasmids derived from 6 white colonies, lane 8: 
uncut colony 4 plasmid (from lane 5). Arrow at approximately 2,700bp represents the 
pGEM-SZ vector and the arrow at approximately l,300bp is indicative o f the 2BC 
cDNA fragment.
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Figure 5.15 2% agarose gel of pGEM-3Z-2B construct digested with Acc65 1 and 
Sal I.
Lane I: lOObp DNA ladder, lanes 2-7: plasmids derived from 6 white colonies, lane 
8: uncut colony 2 plasmid (from lane 3). Arrow at approximately 2,700bp represents 
the pGEM-3Z vector and the arrow at approximately 320bp is indicative o f the 2B 
cDNA fragment.
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5.11 In vitro expression and immunoprécipitation of 2BC and 2B
To study the possible interaction of CVB4 non-structural proteins 2BC and 2B with 
active caspase-3, these proteins were prepared and radiolabelled in vitro using a 
coupled transcription translation reaction applied to clones pGEM-3Z-2BC and -2B. 
These labelled proteins were tlien mixed with recombinant active human caspase-3 
and immunoprecipitated with antibody to this enzyme as described in Section 5.4. 
Protein 2BC was found to co-precipitate with the caspase (Figure 5.16). This band 
was not present in the no-antibody control, confii*ming that 2BC was directly 
interacting with the recombinant active caspase-3 protein and was not present for 
artefactual reasons such as inefficient washing or direct interaction with the protein A- 
sepharose beads. Protein 2B could not be visualized in this analysis because of the 
interference of excess globin in the reticulocyte lysate (Figure 5.17). As this globin 
migrates as a broad band 10-15kDa and 2B is ~llkDa, the presence of 2B would be 
masked; which has previously been reported to occur for Coxsackievirus B3 protein 
2B using this technique (van Kuppeveld et al., 1995). However, even though excess 
globin was removed during this procedure and thus could no longer mask the position 
expected for protein 2B, unlike for protein 2BC, 2B did not co-precipitate with 
caspase-3. Since the plasmid can still fiinction to generate 2B in vitro (see below) and 
protein 2BC could be prepared and visualised using this reticulocyte method, we have 
no reason to believe that 2B was not produced.
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Figure 5.16 CVB4 protein 2BC interacts with active caspase-3.
S]-methionine labelled protein 2BC (lane 1) was immunoprecipitated with (lane 2) 
and without (lane 3) caspase-3 antibody and analysed by SDS-PAGE (12.5% mini­
gel) and autoradiography.
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Figure 5.17 CVB4 protein 2B does not interact with active caspase-3.
[^^S]-methionine labelled protein 2B (lane 1) was immunoprecipitated with (lane 2) 
and without (lane 3) caspase-3 antibody and analysed by SDS-PAGE (15% mini-gel) 
and autoradiography. Note, interference o f the excess globin (migrating as a broad 
hand below 15kDa) in the reticulocyte lysate masks the appearance o f the expected 
position for protein 2B.
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5.12 Recombinant protein 2BC inhibits caspase-3 activity
Although the result in Section 5.11 showed that 2BC could interact with active 
caspase-3, this result could not confirm whether the suppression of caspase-3 activity 
during CVB4 infections (Section 4.18) was due to this protein-protein interaction. 
Indeed, interaction of 2BC with caspase-3 might even induce an increase in caspase-3 
activity. Unfortunately, we could not test this directly using the TnT product since 
excess globin and other translation system components perturbed the caspase activity 
assay. Thus in order to address this question we expressed these two proteins in HeLa 
cells, prepared lysates from these cells and then tested the lysates for their capacity to 
inliibit recombinant caspase-3 in the same way that we had earlier tested virus- 
infected cell lysates for this capacity (Section 4.18). RNA was prepared using T7 
RNA polymerase to transcribe the inserted cDNA in vitro from the pGEM-3Z 
transcription vectors and introduced into HeLa cells by transfection.
As a control, RNA prepared from a luciferase cDNA template containing a T7 
polymerase promoter was also made to determine the level of protein expression. In 
order to prepare run-off transcripts that teiminate at the same point, the vectors must 
be linearised downstream from the end of the ORF to be expressed. This was 
achieved using Sal I to linearise the pGEM-3Z-2BC and -2B constructs and Xmn I for 
the luciferase DNA template (Section 2.10.3.1). Each linearised vector was purified 
by gel-extraction (Section 2.10.2.2) and 0.5pg of each was used in a transcription 
reaction. The RNA produced was purified by plienol-chloroform extraction (Section
5.5). The in vitro transcription reaction adds a 7-methylguanosine cap to the 5' end of 
the messenger RNA (niRNA) during transcription. This cap is important for 
recognition and proper attachment of the mRNA to the ribosomes, and it also helps to
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protect from Rnases. The concentration of each purified RNA product was determined 
using a NanoDrop® ND-1000 Spectrophotometer and to verify that the RNA had not 
been cleaved by RNases, Ipl of each RNA was run on a 1.2% agarose gel using Ix 
TBE buffer; with samples having been loaded in 2x TBE sample buffer (Section
2.3.5).
As shown in Figure 5.18 a clear band was obtained for each RNA product indicating 
that the RNA was intact.
28S 4,712
18S 1,869
Luciferase mRNA 
2BC mRNA
2B mRNA
Figure 5.18 1.2% agarose gel of mRNA products.
Lane 1: 28S and 18S eukaryotic RNA size marker, lanes 2-4: are the indicated (by 
arrows) mRNA products synthesised by in vitro transcription from linearised DNA 
templates.
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Transfection efficiency was confirmed using HeLa cells mock-transfected and 
transfected with luciferase mRNA. Cells were harvested at 10 h and tested for 
luciferase activity (Section 5.6). As shown (Figure 5.19), transfection of luciferase 
mRNA using this RNA transfection method led to the expression of a large amount of 
luciferase enzyme compared with the mock-transfected control. Other studies in the 
lab have confimied 6-10 his as the optimum period for expression from transfected 
mRNA.
>  12.5- 
1  10.0-IÜB
%
7.5-
5.0-
•5 2.5-
CC 0.0-
No-mRNA Luciferase mRNA
Figure 5.19 Expression of luciferase mRNA in HeLa cells.
HeLa cells were mock or transfected with luciferase for 10 h before assaying for 
luciferase activity. Transfection with luciferase mRNA shows considerable expression 
compared to transfection with no mRNA. Note that 10 h transfection was found to be 
the optimum transfection period in which expression ofhiciferase was at its greatest.
2 0 2
mRNA for 2B, 2BC and luciferase were then transfected into HeLa cells and after 10 
h, the lysates were extracted and mixed with recombinant active caspase-3 protein and 
incubated on ice for 1 h before assaying for caspase-3 activity as previously described 
(Section 4.8). As can be observed (Figure 5.20), only expression of protein 2BC 
could significantly suppress the activity of caspase-3 whereas expression of 2B or a 
luciferase control did not have this suppressive effect. Taken together our data show 
that CVB4 non-structural protein 2BC can interact with active caspase-3 and that this 
interaction reduces caspase-3 activity in cleaving its target substrates.
800
600 -
Q.
O)
400 - **
200  -
Q.
Figure 5.20 Ectopically expressed protein 2BC but not 2B inhibits caspase-3 
activity.
HeLa cells were transfected with 2BC or 2B mRNA, and after 10 h a cell extract was 
prepared to which recombinant active caspase-3 was added and assayed for 
DEVDase activity. Controls include transfection with no mRNA and mRNA encoding 
for luciferase (Luc). All data are the mean + SD o f 4 independent experiments.
**p<0.01.
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5.13 Discussion
In previous chapters we have shown that CVB4 infection of HeLa cells can modulate 
the apoptotic machinery. The finding that infected HeLa cell lysates can suppress the 
catalytic activity of recombinant active caspase-3 proteins added exogenously (Table 
4.2) suggested that infection of these cells leads to the expression of a protein that can 
directly inhibit caspase-3 activity. Since caspase activity is widely known to be 
modulated by direct protein-protein interactions, for example by the ZAP family of 
proteins (Verhagen et al., 2001), co-immunoprecipitation studies were carried out as a 
method to determine whether a protein-protein interaction with active caspase-3 was 
mediating this suppression.
The finding that infecting cells with CVB4 and incubating the resulting lysate with a 
recombinant active caspase-3 protein and antibody to active caspase-3 (which had 
been shown previously to be functionally active in cleaving the DEVD caspase-3 
substrate; Table 4.2) could co-precipitate the recombinant caspase-3 with a viral 
encoded methionine radio-labelled protein, could not positively mle out the notion 
that infection with CVB4 was promoting the induction of a host protein which was 
interacting with caspase-3. However, the result did strongly support a viral origin due 
to the fact that host cell protein syntheis would have been shut-down in the infected 
lysate and thus only viral proteins would have been labelled and observed to interact 
with caspase-3. Also, lending more support for this idea, no viral proteins or host 
proteins were obviously pulled down during immunoprécipitation studies, when 
similar lysates (without recombinant active caspase-3) were incubated with a 
monoclonal antibody specific to the pro-form of caspase-3 (data not shown), 
suggesting that the viral protein specifically targeted the active form. The size of this
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protein tentatively suggested that CVB4 protein 2BC co-precipitated with active 
caspase-3. As protein 2BC is the precursor of protein 2B, which has recently been 
shown to have anti-apoptotic function by mediating calcium flux (Campanella et al., 
2004), it was vital to detennine whether 2BC had this function and moreover, whether 
the 2B or the 2BC component encoded this active caspase-3 protein-protein 
interaction ability. Confirming the previous result, in vitro synthesized protein 2BC 
and not 2B was able to interact with active caspase-3. This result suggests that the 2C 
component of 2BC may mediate this interaction.
Although 2BC was shown to interact with caspase-3, only the expression of the 2BC 
protein in HeLa cells confmned that this interaction actually inhibited apoptosis. 
Other RNA virus encoded proteins are known to interact with caspases as well; the 
NS3 protein of Langatvinis (Flaviviridae) interacts with caspase-8, although in this 
case it is to activate apoptosis (Prikliod'ko et al., 2001; Prikhod'ko et al., 2002). 
Interestingly, this interaction seemed to be mediated by a helicase domain and our 
analysis shows that a similar domain is present on the 2C component of 2BC. This 
may further support the possibilities for physical interaction, although it cannot 
explain the difference in effect which these interactions may have; stimulation of 
apoptosis by Langat vims and inhibition by CVB4. In the case of CVB4, the vims 
protein may be acting as an lAP. Many of these are characterised by the presence of a 
zinc RING-finger domain (Verhagen et al., 2001). A similar domain is also present on 
the carboxyl temiinus of protein 2C (Pfister et al., 2000). Moreover, this zinc finger 
domain consists of a cysteine rich repeat. Such a repeat is a conserved feature of the 
tumour necrosis factor receptor superfamily and this may suggest a role for 2BC as a 
decoy protein in sequestering procaspase-8 proteins and thus preventing them from 
clustering at the DISC. This would have the effect of perturbing the function of the
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death receptor pathway. This could explain the dismption of the TRAIL-activated 
pathway that we have shown to be suppressed during CVB4 infection (Section 4.19).
The most compelling evidence for an anti-apoptotic function of 2BC was recently 
raised for poliovirus. Banerjee et al., (2004) reported that PV 2C (a protein with 
strong homology to CVB4 protein 2C) can bind to the PV protease 3C and inhibit its 
proteolytic activity. Further, they reported that protein 2C contained several serine 
protease inhibitor motifs (serpin motifs) that might account for this function. The 
best-studied viral serpin is CrmA, a poxvirus protein that inhibits both cysteine and 
serine proteases involved in the regulation of host inflammatoiy and apoptotic 
responses (Komiyama et al., 1994; Komiyama et al., 1996) including caspase-3 
(Tewari et al., 1995). Intriguingly, despite this activity against cysteine proteases, 
CrmA lacks cysteine protease inhibitor motifs. This may suggest that serine and 
cysteine proteases share some common features of geometiy such that serpins may 
sometimes be active on both classes of protease (Komiyama et al., 1994). 
Consequently, the serpin motifs present in the 2C moiety of 2BC might allow 2BC to 
bind to active caspase-3 and inliibit its proteolytic function, although a role for 2C 
alone to interact with caspase-3 is uncertain as only 2BC but not 2C could be 
observed (Figure 5.4) to co-immunoprecipitate with caspase-3.
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Chapter 6
6 GENERAL DISCUSSION
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Viruses induce a multitude of alterations in the structure and metabolism of their host 
cells. This subversion alerts the host, activating some of the most ancient (non- 
inimune or imiate) anti-viral defence mechanisms; these include apoptosis (Everett 
and McFadden, 1999). This system for regulated cell death is conserved across the 
animal kingdom from animals to nematode worms (Sulston et al., 1983; Ellis and 
Horvitz, 1986). It is becoming increasingly apparent that during their long co- 
evolutionary host relationships, most viruses have acquired various mechanisms to 
modulate these host cell responses that would otherwise limit virus replication. Large 
genome DNA vimses are known to devote multiple genes to ‘host controT whilst 
small-genome RNA vimses have been proposed to encode multiftinctional proteins 
with (overlapping) flinctions in roles in both vims reproduction and modulation of 
host-cell defence mechanisms (Mahalingam et al., 2002). As enteroviral RNA is 
known to persist in human tissues for many years (Feuer et al., 2004) and there is 
clear evidence from work on PV (Gosselin et a l, 2003) that suppression of apoptosis 
may lead to viral persistence, it is possible that a large part of enterovims 
pathogenesis both in vitro and in vivo and persistence in the body may be due to the 
modulation of apoptosis. However, the molecular mechanisms responsible for this 
modulation remain uncharacterised. Enterovimses such as PV and Coxsackie B 
vimses control cell death through anti-apoptotic functions (Tolskaya et a l, 1995; 
Tolskaya et a l, 1996; Agol et a l, 2000) but the identity of the enteroviral anti- 
apoptotic fimction was unknown. This study suggests that enterovims protein 2BC 
plays an important role in suppressing apoptotic host cell responses.
Mitochondria are essential in the regulation of apoptosis (Orrenius, 2004). 
Unsuiprisingly therefore, the list of vimses that have been found to target this 
organelle is increasing. Apoptosis is an energy-dependent process, requiring the
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coiTect functioning of the mitochondrial electron transport chain (ETC). In this study, 
infection of HeLa cells with CVB4 and subsequent treatment of these cells with 
metabolic substrates and inhibitors showed that unlike PV infection, CVB4 infection 
does not affect the ETC, and induces only minor effects on cellular respiration. 
Mitochondrial membrane potential (A'Pm) is even increased by CVB4 infection and 
maintained at early stages in the infection, although this is reversed at later times. 
Direct imaging of live mitochondria during this infection period showed that infected 
cells had a similar functionality to those of the mock-infected cells. As loss of 
membrane potential is widely accepted as an early indicator of the onset of apoptosis 
(Zamzami et al., 1995b; Zamzami et al., 1995a), these findings suggest that the virus 
may actively oppose apoptosis by preventing the loss of A'Pm and maintaining the 
function of the mitochondria.
The lack of a decrease in AYm suggested that other features of the apoptotic process 
might also be suppressed. Indeed, translocation of the phospholipid 
phosphatidylserine (PS) to the outer leaflet of the plasma membrane, propidium 
iodide staining and typical condensation of chromatin were only evident during the 
late stage of the vims replication cycle, coinciding with the late stage A'Pm decrease, 
and in agreement with Carthy et al., (1998). These authors showed that 
Coxsackievims B3 (a close relative of CVB4) induces apoptosis late in the vims life 
cycle. These authors did not seek any early apoptosis inhibitory effect. The use of the 
apoptosis-inducing dmgs staurosporine (STS), TNF-related apoptosis-inducing ligand 
(TRAIL) and actinomycin D (Act D) went some way to address this and showed that 
CVB4 confeiTed an anti-apoptotic fimction on HeLa cells. Noteworthy, was the 
demonstration that CVB4 infection could increase the proportion of non-apoptotic 
(AV-/PI-) HeLa cells and suppress the translocation of PS, and the loss of membrane
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integrity (reduction in PI staining) in STS and TRAIL treated cells but not in Act D 
treated cells. Act D treatment of infected cells resulted in a suppression in PS 
translocation but an increase in PI staining and no increase in the proportion of non- 
apoptotic cells compared with the ding alone. Tolskaya et al., (1995) found a similar 
feature in PV infected cells treated with Act D. They showed that pre-infection of 
HeLa cells with PV could suppress the Act D-induced DNA laddering, yet they still 
found that the cells undeiwent necrosis during this inhibition period. An explanation 
for this necrotic shift may lie with the vims proteins. PV encoded protein 3C^ ™, like 
Act D, is a transcription inhibitor which has also been shown to have a pro-apoptotic 
function by inducing caspase-dependent cell death (Barco et al., 2000). In the cell, the 
addition of Act D may overwhelm any anti-apoptotic function, driving the cell death 
pathway towards necrosis. Indeed, the balance between apoptosis and necrosis can 
often depend on the intensity of the initial insult (Bonfoco et al., 1995). This 
possibility requires investigation using cDNA transfections of the vims genomes with 
and wiüiout flmctional 3C^ °^ in Act D treated cells to confinn this.
Importantly, amiexin V-propidium iodide studies showed that any anti-apoptotic 
function occurred in a time-dependent fashion consistent with the idea that with 
increasing time more of the putative anti-apoptotic fimction could be expressed. The 
greatest protection confened upon the cell was found to beat 10 h.p.i, by 24 h.p.i no 
protection was induced (data not shown). As CVB4 could protect against apoptosis 
inducers that stimulate both the death receptor and mitochondrial apoptosis pathways, 
this suggested that a feature common to both pathways was being modulated. As PS 
translocation is known to be induced by the action of the key effector caspase, 
caspase-3 (Martin et al., 1996), it was initially sui*prising to find that infection of cells 
with CVB4 prior to the use of the apoptotic inducers could not suppress the activation
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of the pro-caspase-3 zymogen to its active foim. More remarkable was the finding 
that despite caspase-3 activation, pre-infected STS treated cells at this same time 
period could maintain ATm. Caspase-3 is the most prevalent caspase in the cell and is 
the caspase ultimately responsible for the characteristic apoptotic phenotypes due to 
its downstream substrate cleavages (Zimmemiann et al., 2001). During the 
mitochondrial-mediated apoptosis pathway, cytochrome c (a component of the ETC) 
is released from the mitochondria and into the cytosol to form a complex with dATP, 
Apaf-1 and procaspase-9 (apoptosome complex) which leads to the activation of 
caspase-9 and the subsequent activation of caspase-3. Thus, with the loss of 
cytochrome c (as evidenced by the activation of caspase-3) one would expect that the 
AYm would collapse (Waterhouse et al., 2001; De Giorgi et al., 2002); although until 
recently it was thought that loss of A'Pm preceded cytochrome c release due to 
mitochondrial penneability transition. However, it has remarkably been shown that if 
the activity of caspases is inhibited, the low levels of cytochrome c dispersed 
throughout the cell can be sufficient to maintain the fimction of the ETC and ATP 
synthesis in the permeabilised mitochondria (Waterhouse et al., 2001). More recently 
it was shown that active caspase-3 targets complex I of the mitochondrial transport 
chain which causes a loss of AY^ (Ricci et al., 2004). This tentatively suggests that 
the reason why A'Pm was maintained in the Waterhouse et al., (2001) study was 
because caspase-3 activity and thus cleavage of complex I was suppressed, hence 
maintaining the mitochondrial ETC system. Consistent with this postulation we found 
that the CVB4 infected STS treated cells could suppress the activity of caspase-3 
suggestive of a similar mechanism occurring in our study. It should also be mentioned 
that Waterhouse et al., (2001) also observed a decrease and then an increase in AT^ 
following treatment of a pan-caspase inhibitor to cells undergoing apoptosis; a 
situation that we observed in CVB4 infected cells using flow cytometiy and TMRE.
211
Further, this reversal period (in our study) was during the 10 h time point in which we 
observe a suppression of caspase-3 activity and is thus suggestive that this change 
(decrease and subsequent increase in ATm) was mediated by the suppression of 
caspase-3 activity, although this speculation requires further investigation into the 
effect of other caspases on ATm. Additionally, the finding that incubation of CVB4 
infected lysates with a recombinant active caspase-3 protein could suppress the 
activity of tliis protein lent support to the idea that a viral protein was interacting in 
some way, although the possibility that infection was leading to the expression of a 
host encoded protein that was mediating this suppression could not be i*uled out. 
Indeed, despite co-immunoprecipitation of recombinant caspase-3 with the tentatively 
identified CVB4 encoded 2BC, it was only when recombinant 2BC rather than its 
processed foim 2B was pulled down that the nature of the interacting protein could be 
positively identified. As RNA vims proteins have been shown to co-precipitate with 
caspases and induce apoptosis (Prikliod'ko et al., 2002), expression studies of these 
recombinant proteins and caspase-3 activity assays were of paramount importance in 
confirming that 2BC but not 2B can interact with and inhibit the activity of active 
caspase-3. It should be reiterated that late during infection, after viral replication has 
taken place, signs of apoptosis become apparent, indicating that the anti-apoptotic 
effect of the 2BC interaction with active caspase-3 delays rather than blocks the 
apoptotic program. This late stage featm*e of apoptosis may be beneficial to CVB4 by 
killing the host cell, thereby enabling the spread (possibly by phagocytic engulfinent 
in vivo) of vims progeny witliout eliciting an immune response.
It is interesting that 2BC, composed of both proteins 2B and 2C was found to interact 
whilst 2B alone could not. However, the conclusion that the 2B portion of 2BC does 
not participate in the inhibition process rests on the assumption that 2B behaves in the
2 1 2
same manner whether on its own or attached to 2C. There is evidence from 
subcellular distribution and functional studies that this may not be the case (Barco and 
CaiTasco, 1998; Moffat et a l, 2005). Nevertheless, it is likely that the anti-apoptotic 
property of 2BC resides in the 2C portion of the protein. Many functions have been 
attributed to 2C although its exact role remains to be detennined. Analysis of the 
sequence of CVB4 2BC using the multiple alignment tools ClustalW (Thompson et 
a l, 1994) and DiAlign (Morgenstem et al, 1996), identified regions in the protein 
with similarity to serpins (Table 6.1). All identified regions of similarity reside in the 
2C portion of the protein and we did not find such domains in the 2B region (Table 
6.1 and Figure 6.1). Lending support to this finding, a recent report proposed that 
poliovims 2C contained several serpin similarity regions (Banerjee et a l, 2004) in 
similar locations to those found for CVB4 2C. This is not suiprising given that 2C is 
the most conseiwed protein among picornavimses; with the degree of similarity 
between CVB4 2C and PV 2C further highlighted in Figure 6.2. Finding these seipin 
domains is of importance since serpins are protease inhibitors believed to act by 
binding to the active site and preventing a protease from associating with its substrate.
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Figure 6.1 Schematic diagram of domain structures of PV 2C.
The diagram shows the location o f domains o f serpin homology as well as domains 
previously reported. The numbers indicate the amino acids from N (I) to C-termini 
(329) o f the PV 2C polypeptide Adapted from Banerjee et ai, (2004). Note: in 
comparing CVB4 2BC aligned residues with the PV 2C sequence shown here, it 
should be remembered that in the table above, the addition o f 2B (which is residues 1- 
99 in 2BC) increases the CVB4 2C sequence by 99 residues. Hence CVB4 2BC 
residue 309 thus corresponds to CVB4 2C residue 210.
The best studied viral serpin is CrmA, a poxvirus protein that inhibits both cysteine 
and serine proteases involved in the regulation of host inflammatory and apoptotic 
processes (Komiyama et al., 1996). Although CrmA has been widely reported to 
inhibit caspases-1 and -8, it has also been reported to inhibit caspase-3 (Tewari et al., 
1995). As CVB4 2BC was found to have conserved local sequence similarity with 
CrmA (Table 6.1), this lends more credence to the notion that 2BC is interacting with 
caspase-3 to inhibit its downstream substrate targeting. Further, 2BC was found to 
have a considerable degree of similarity with the active site (P17) region of caspase-3 
(Table 6.1). As the active site region is between caspase-3 residues 25-175 and 2BC 
aligned along residues 55-120, this is consistent with the idea that any suppression of 
caspase-3 activity is mediated by protein-protein interactions and is in agreement with 
the co-immunoprecipitation result findings. Again, only the 2C component of 2BC 
was found to align with caspase-3 (Table 6.1). It should be mentioned however, that 
similarity alone does not confirm interaction and thus the identity of the critical 
domains mediating this interaction are still to be determined.
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a)
2 B -  CVB4 GVKD YVEQLGNAFGSGFTNQICEQVNLLKESLVGQDSILEKSLICALVKIISALVIWRNH 6 0
2 B -P V  GITNYIESLGAAFGSGFTQQISDKITELTNM VTS--TITEiaiLKNLIKIISSLVIITRNY 58
*  : . * * * * * * * # * * _  * * *  ^ * , î  t . .  ; *  * *  * *  * * * * * * ; ★ * * .
2B-C V B 4 DDLITVTATLALIGCTSSPWRWLKHKVSQYYGIPMAERQ 99
2 B -P V  EDTTTVLATLALLGCDASPWQWLRICKACDVLEIPYVIKQ 97•* ** ******** .***.**.;* .; **  ^ .*
CVB4 2B aligned with PV 2B produces: a global alignment score of 50 and has 97
residues aligned with an identity of 51%.
b)
2 C-CVB4 NNGWLKKFTEMTNACKGMEWIAVKIQKFIEWLKVKILPEVKEKHEFLSRLKQLPLLESQI 6 0
2C -P V  GDSWLIGCFTEACNAAKGLEWVSNKISKFIDWLKEKIIPQARDIOiEFVTKLRQLEMLENQI 6 0, ******* . **  ^*** . *** * * ; ; ; * ; * * ; * * * *
2C-CVB4 ATIEQSAPSQSDQEQLFSNVQYFAHYCRKYAPLYAAEAKRVFSLEKICMSNYIQFKSKCRI 1 2 0
2C -P V  STIHQSCPSQEHQEILFNNVRWLSIQSKRFAPLYAVEAKRIQKLEHTINNYIQFKSKHRI 1 2 0** **. , . , : : **. . ******** ★*
2 C - CVB4 EPVCLLLHGSPGAGKSVATNLIGRSLAEKLNSSVYSLPPDPDHFDGYKQQAWIMDDLCQ 1 8 0
2C -P V  EPVCLLVHGSPGTGKSVATNLIARAIAERENTSTYSLPPDPSHFDGYKQQGWIMDDLNQ 1 8 0 ^ ; * ; *  ^******* _ ******** _ ******* *
2C-CVB4 NPDGKDVSLFCQMVSSVDFVPPMAALEEKGILFTSPFVLASTNAGSINAPTVSDSRALAR 2 4 0
2C -P V  NPDGADMKLFCQMVSTVEFIPPMASLEEKGILFTSNYVLASTNSSRISPPTVAHSDALAR 2 4 0
‘k ' k ' k - k  *  .  * * * * * * *  . *  .  *  . * * * *  . * * * * * * * * * *  .  * * * * * *  .   ^ *  *  *  *  ; *  *  *  *  *
2C-CVB4 RFHFDMNIEVISMYSQNGKINMPMSVKTCDEECCPVNFKRCCPLVCGKAIQFIDRKTQVR 3 0 0
2C -P V  RFAFDMDIQVMNEYSRDGKLNMAMATEMCKNCHQPANFKRCCPLVCGKAIQLMDICSSRVR 3 0 0
*  *  * * * ; * • * •   ^ * * ,  . * * » * *  * .  * * . î  * ^ * * * * * * * * * * * * * * * .  * ; ; * *
2C -CVB4 YSLDMLVTEMFREYNHRHSVGATLEALFQ 3 2 9
2C -P V  YSIDQITTMIINERNRRSNIGNCMEALFQ 3 2 9
*  *  ;  *  ;  ,  *  ;  ; *  *  * *  * *  * * * * * *
CVB4 2C aligned with PV 2C produces: a global alignment score of 62 and has 329 
residues aligned with an identity of 63%.
Figure 6.2 Sequence alignments of PV and CVB4 2B and 2C proteins.
The alignment was created using the ClustalW (Thompson et al., 1994) algorithm 
located at the European Bioinformatics Institute launch server, a) CVB4 2B 
(GenBank accession no. P08292 extracted from residues 1000-1098) aligned 
with PV 2B (GenBank accession no. NP_740472). b) CVB4 2C (GenBank accession 
no. P08292 extracted from residues 1099-1427) was aligned with PV 2C (GenBank 
accession no. NP_740473. The global alignment and identity values are also shown 
for alignments a and b with a considerable degree o f similarity shown to be conserved 
for both alignments.
Symbols: *, identical in sequence and alignment; :, conserved substitutions observed; 
semiconseiwed substitutions.
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Another interesting finding was that the 2C region of 2BC also has similarity with a 
member of the lAP family of protease inhibitors XIAP (Section 1.11). lAPs are 
evolutionarily conserved proteins that were first identified in baculoviruses. The 
mammalian protein, XIAP, is a potent inhibitor of caspases-3 and -7 and it has been 
shown that a linker domain between the domains designated baculoviras lAP repeat 
(BIR) 1 and BIR 2 is essential in interacting with the active site of caspase-3 and 
inhibiting its activity. Mutations in this site inactivate this inhibitory effect (Suzuki et 
al., 2001b). The 2C component of 2BC shows considerable similarity with this linker- 
BIR2 domain region in XIAP (Table 6.1), but is located away from the region of 2C 
that aligns with caspase-3. This may suggest another point of interaction between 
2BC and caspase-3 in its inhibitory function and mutagenesis studies should be 
carried out on the 2C component to identify whether the putative serpin regions or the 
potential linker-BIR region promotes interaction with caspase-3. Additionally, as 
shown in Figure 6.1, PV 2C (and other 2C proteins from picornavimses) have a C- 
terminal zinc finger domain. Interestingly, XIAP has a C-temiinal zinc RING finger 
domain which has ubiquitin-protein ligase activity and catalyses the ubiquitination of 
active caspase-3, targeting it for degradation (Yang et al., 2000; Suzuki et al., 2001a). 
It is unlikely that CVB4 (or possibly PV) 2BC (or 2C) acts in this way before 10 h.p.i 
however, since we showed (Chapter 4) that the proportion of active caspase-3 
generated in CVB4 infected cells treated with any of the apoptosis inducers was 
unchanged compared to that obseiwed following the use of the inducers alone. But a 
ubiquitin-mediated anti-apoptotic role for CVB4 2BC or 2C cannot be ruled out and 
should be investigated flirther by monitoring the appearance and loss of caspase-3, as 
well as other caspases, following pre-infection and apoptosis induction by drug 
treatment.
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Despite these observations there remains no direct demonstration that the anti- 
apoptotic activity we have observed resides in the 2C region. Indeed, recently this 
protein has been assigned a pro-apoptotic role (Liu et al, 2004). However it is by no 
means clear that all of these activities would be present in 2BC, it is quite possible 
that activities of 2C as part of 2BC are quite distinct from those induced by 2C when 
cleaved from the 2B moiety. Thus, a situation may be occurring in which the addition 
of 2B to 2C allows it to maintain a caspase-3 inhibitoiy effect, but processing of 2BC 
confers an opposite effect. This interesting and exciting hypothesis will need to be 
investigated fiirther.
Another potential role for CVB4 2BC (or 2C) maybe its ability to inhibit endogenous 
enterovims-mediated apoptosis. It has been found that PV 2C can interact with PV 
encoded protein 3C^ "^ ° and 2A^‘° to inhibit their proteolytic activity (Banerjee et al., 
2004). These authors also found that PV 2BC but not 2B could inhibit the proteolytic 
activity of 3C '^°. This is consistent with our results showing that CVB4 2BC but not 
2B can inhibit the proteolytic activity (mediated by protein-protein interaction) of 
caspase-3. As 3C^ ”^ and 2A '^° induce apoptosis via a caspase-3 dependent pathway 
(Calandria et al, 2004) and mutation of the seipin domains shown in Figure 6.1 
abrogated this PV 2C mediated protease inliibitory fimction (Banerjee et al, 2004), 
this is consistent with the idea that as well as inhibiting the activity of active caspase- 
3 and possibly other caspases, CVB4 encoded 2BC (or 2C) and PV 2C (or 2BC) may 
interact with 3Œ'° and 2A^‘°. This interaction may occur during the early period of the 
vims replication cycle inhibiting its pro-apoptotic function, and may disassociate 
during the latter stages of this cycle to promote the induction of apoptosis and 
facilitate the release of viral progeny. It should also be stressed that as 3C^ ™ and 2A^‘° 
induce apoptosis via a caspase-3 activation pathway, the ability of 2BC to suppress
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caspase-3 activity would also allow it to inliibit the pro-apoptotic action of these viral 
proteins. This latter notion raises the possibility that the 2BC inliibitoiy action of 
caspase-3 may have evolved to specifically antagonise the effects of 3C^ "^ ° and 2A^ ™. 
These intriguing links between pro-apoptotic and anti-apoptotic enteroviral proteins, 
if confirmed, further highlight the elaborate way vimses with limited genomic 
capacity have evolved to maintain a suiwival advantage.
It should not be forgotten that while our work was in progress, a group reported that 
Coxsackievirus B3 prevented apoptosis in response to Act D and cycloheximide, and 
demonstiated that the anti-apoptotic effect was mediated by the 2B protein 
(Campanella et al, 2004). The mechanism of 2B action was identified to involve a 
decrease in Golgi and endoplasmic reticulum Ca^  ^ content. Endoplasmic reticulum 
Ca^  ^is known to play a very important role not only in apoptosis but in cell death in 
general (Kass and Orrenius, 1999; Orrenius et a l, 2003). Indeed, the pro- and anti- 
apoptotic properties of Bax and Bcl-2 have in part been linked to their ability to 
modulate the ER Ca^  ^ content (Nutt et a l, 2002; ScoiTano et a l, 2003). Taken 
together, these data show that Coxsackie viruses may use at least two mechanisms (in 
addition to those described above) to suppress apoptosis upon infection. A first 
mechanism operates at the level of ER Ca^  ^ content tlnough 2B-mediated pore 
formation (van Kuppeveld et a l, 2005) and a second mechanism involves a direct 
inhibition of executioner caspase-3 by 2BC (this study). Both mechanisms may not 
necessarily operate together as one noticeable difference between the two studies is 
that in our experimental system the proteolytic activation of caspase-3 by the inducers 
of apoptosis was not significantly impaired. It is possible that a critical intracellular 
level of 2B is required for pore formation within the ER (van Kuppeveld et al, 2005), 
and hence decreases its content of Ca^ .^ Here, we used a lower multiplicity of
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infection (15 vs. 50 pfti/cell) which is known to alter the cellular response to infection 
(Rasilainen et al., 2004a). This may alter the balance between the mechanisms 
causing the caspase-3 inhibition pathway to become the predominant anti-apoptotic 
mechanism observed under our experimental conditions. Finally we cannot rule out 
differences in apoptotic modulation between CVB4 and CVB3.
Conclusion of this work camiot be made without tiying to address the fundamental 
question: What advantage does the anti-apoptotic function of 2BC provide to CVB4 
in its interaction with its host cells? At least under in vitro conditions host cell death 
by apoptosis, appears to be detrimental to the virus because it would occur earlier than 
virus-induced necrotic-like CPE, and would presumably decrease vims replication 
(Zhang et al., 2002). Cell death by apoptosis is thus a sign that vims replication is 
impaired or intermpted (Tolskaya et al., 1995; Agol et al, 2000; Zhang et a l, 2002; 
Gosselin et al, 2003; Calandria et a l, 2004; Romanova et a l, 2005). However, when 
the execution of apoptosis is blocked by peptide-based caspase inhibitors, viral 
replication and progress to CPE are not affected or only slightly delayed (Carthy et 
a l, 1998; Ahn et al, 2004). This demonstrates that the intrinsic anti-apoptotic 
properties of enterovimses may be advantageous for their survival by allowing more 
time for viral replication to occur (Carthy et a l, 2003). The impact of the form of cell 
death in vivo is more difficult to assess. Both cell death by necrotic-like CPE and 
apoptosis have been documented in cardiomyocytes, neurons and pancreatic p cells 
(Feuer et a l, 2003; Saraste et a l, 2003; Rasilainen et a l, 2004b). Inhibition of 
apoptosis in favour of a necrosis-like CPE would be expected to lead to acute organ 
damage with an associated inflammatory response. In contrast, cell death by apoptosis 
and phagocytosis of the dying cell would counteract viral spreading and avoid 
inflammation. However, this may lead to viral-induced autoimmunity and chronic
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disease such as seen in dilated cardiomyopathy (Whitton and Feuer, 2004), which is 
responsible for approximately 50% of the more than 57,000 cardiac transplants now 
registered worldwide (Hosenpud et ah, 2001). Taken together, an understanding of the 
mechanisms responsible for the induction or inliibition of apoptosis by Coxsackie B 
vimses may elucidate the molecular mechanisms of this group of vimses in 
precipitating different diseases and may yield new strategies for the control of viral 
infections by providing valuable information which could lead to the production of 
vaccines and other anti-viral dmgs.
In summary, the results presented in this thesis demonstrate that CVB4 has anti- 
apoptotic activity and this activity suppresses both the death receptor-mediated and 
mitochondrially-mediated pathways. Further, this anti-apoptotic capacity is the result 
of a suppression of caspase-3 activity, which is due to CVB4 protein 2BC directly 
interacting with caspase-3 and preventing this effector caspase from cleaving its 
downstream substrates. Future mutagenesis studies on the 2C region of 2BC and 
analysis of other caspases will need to be carried out (as described above) to 
determine how selective this caspase-mediated inhibition is. Moreover, the role of 
2BC in regulating vims encoded apoptotic functions will need to be determined, since 
considering the importance of apoptosis or inliibition of apoptosis in causing some of 
the diseases previously mentioned, a better understanding of this virus-induced 
modulation of apoptosis may have important therapeutic implications.
The findings presented in this thesis are summarised diagrammatically in Figure 6.3 
(below), in which a model of the molecular mechanism of the CVB4-mediated 
suppression of apoptosis is shown.
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Figure 6.3 Schematic representation of the suppression of apoptosis by CVB4 
protein 2BC in HeLa cells.
The representation shows the working relationship between the induction o f apoptosis 
by drugs or viral proteins and the inhibition o f apoptosis by protein 2BC ’s interaction 
with proteases. The solid red and black arrows (and solid inhibitory symbols) 
represent the results obtained in this thesis and the blue arrows show the results 
obtained by others, with the red dotted inhibitory symbols showing a proposed 
negative apoptosis regulatory mechanism that is still to be investigated.
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